<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>AP4B1 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>AP4B1</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q9Y6B7" target="_blank" class="term-link">
                        Q9Y6B7
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "AP4B1";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q9Y6B7" data-a="DESCRIPTION: AP4B1 encodes the beta-1 subunit (beta4-adaptin) o..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>AP4B1 encodes the beta-1 subunit (beta4-adaptin) of the heterotetrameric adaptor protein complex 4 (AP-4), which consists of epsilon (AP4E1), beta4 (AP4B1), mu4 (AP4M1), and sigma4 (AP4S1) subunits. Unlike clathrin-associated AP-1, AP-2, and AP-3 complexes, AP-4 forms a non-clathrin coat on vesicles departing from the trans-Golgi network (TGN). AP-4 mediates signal-dependent sorting and export of transmembrane cargo proteins from the TGN to endosomal compartments and pre-autophagosomal structures, recognizing YXXOE-type sorting signals. Key cargoes include ATG9A (autophagy machinery), APP (amyloid precursor protein), DAGLB (endocannabinoid synthesis), SERINC1/3 (lipid scramblases), Sortilin (lysosomal enzyme trafficking), and AMPA/delta-2 glutamate receptors (neuronal polarity). The beta4 subunit contains an N-terminal trunk domain involved in complex assembly and a C-terminal ear (appendage) domain that recruits the accessory protein tepsin through a conserved hydrophobic binding site. AP-4 complex assembly requires the AAGAB chaperone, which stabilizes subunits and prevents proteasomal degradation. AP-4 plays critical roles in autophagosome biogenesis (via ATG9A trafficking), lysosome function (via Sortilin), neuronal polarity (via glutamate receptor sorting), and axonal endocannabinoid signaling (via DAGLB). Loss of AP-4 function results in cargo retention at the TGN and impaired autophagy, particularly affecting axonal compartments in neurons. Biallelic loss-of-function mutations in AP4B1 cause spastic paraplegia type 47 (SPG47), part of the AP-4 deficiency syndrome characterized by severe intellectual disability, progressive spasticity, and structural brain abnormalities including thin corpus callosum.</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016192" target="_blank" class="term-link">
                                    GO:0016192
                                </a>
                            </span>
                            <span class="term-label">vesicle-mediated transport</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0016192" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IBA annotation based on phylogenetic inference. AP-4 mediates vesicle-mediated transport from the TGN to endosomal compartments. This is well-supported by literature showing AP-4 exports cargo (especially ATG9A) via non-clathrin-coated vesicles.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Vesicle-mediated transport is a core function of AP-4. The complex forms vesicle coats at the TGN and mediates cargo export to endosomes and peripheral sites. The IBA annotation appropriately captures this core function at the right level of specificity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                                        PMID:10436028
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AP4B1/AP4B1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">AP-4 mediates signal-dependent export of selected cargos--most prominently ATG9A--from the TGN to endosomal/peripheral compartments that support autophagosome formation.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005794" target="_blank" class="term-link">
                                    GO:0005794
                                </a>
                            </span>
                            <span class="term-label">Golgi apparatus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0005794" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation based on UniProt subcellular location mapping. AP-4 localizes to the trans-Golgi network, which is part of the Golgi apparatus.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While more specific TGN annotations exist (GO:0005802), this broader Golgi apparatus annotation is not incorrect. AP-4 is found at the TGN which is part of the Golgi.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006886" target="_blank" class="term-link">
                                    GO:0006886
                                </a>
                            </span>
                            <span class="term-label">intracellular protein transport</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0006886" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from InterPro domain mapping. AP-4 mediates intracellular protein transport by sorting cargo proteins from the TGN to endosomal destinations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Intracellular protein transport is a well-supported function of AP-4. The complex sorts cargo proteins including ATG9A from TGN to endosomes. This is an appropriate level of specificity for an IEA annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                                        PMID:10436028
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The mu4 subunit of the complex specifically interacts with a tyrosine-based sorting signal, indicating that, like the other three AP complexes, AP-4 is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008104" target="_blank" class="term-link">
                                    GO:0008104
                                </a>
                            </span>
                            <span class="term-label">intracellular protein localization</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000117
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0008104" data-r="GO_REF:0000117" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from ARBA machine learning. AP-4 controls intracellular localization of cargo proteins by mediating their export from TGN.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> AP-4 is involved in protein localization as it determines where cargo proteins end up within the cell. The complex exports ATG9A and other cargos from TGN to endosomal/peripheral locations. This broader term is appropriate for computational annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0015031" target="_blank" class="term-link">
                                    GO:0015031
                                </a>
                            </span>
                            <span class="term-label">protein transport</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0015031" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from combined automated methods. Protein transport is a parent term of the more specific vesicle-mediated transport.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Protein transport is a core function of AP-4. The complex mediates transport of transmembrane cargo proteins from TGN to endosomal destinations. While broader than vesicle-mediated transport, this annotation is not incorrect.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016192" target="_blank" class="term-link">
                                    GO:0016192
                                </a>
                            </span>
                            <span class="term-label">vesicle-mediated transport</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0016192" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from InterPro domain mapping. Duplicate of the IBA annotation for the same GO term.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the same term as the IBA annotation but with IEA evidence from InterPro. Both annotations are valid - the IEA provides domain-based evidence while IBA provides phylogenetic evidence. Vesicle-mediated transport is a well-established core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                                        PMID:10436028
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030117" target="_blank" class="term-link">
                                    GO:0030117
                                </a>
                            </span>
                            <span class="term-label">membrane coat</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0030117" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from InterPro. AP-4 forms a membrane coat (non-clathrin) on vesicles budding from the TGN.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> AP-4 functions as a membrane coat complex on TGN-derived vesicles. The beta4 subunit is an integral component of this coat.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                                        PMID:10436028
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/26542808" target="_blank" class="term-link">
                                        PMID:26542808
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The heterotetrameric (œµ-Œ≤4-Œº4-œÉ4) complex adaptor protein 4 (AP-4) is a component of a non-clathrin coat involved in protein sorting at the trans-Golgi network (TGN).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030131" target="_blank" class="term-link">
                                    GO:0030131
                                </a>
                            </span>
                            <span class="term-label">clathrin adaptor complex</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0030131" data-r="GO_REF:0000002" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from InterPro domain mapping (IPR015151). This annotation is INCORRECT. AP-4 is explicitly a NON-clathrin adaptor complex and does not associate with clathrin.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is incorrect and should be removed. AP-4 forms a non-clathrin coat and does not function as a clathrin adaptor complex. The GO term GO:0030124 (AP-4 adaptor complex) definition itself states &#34;it is not clear whether AP-4 forms clathrin coats in vivo.&#34; Multiple primary sources explicitly describe AP-4 as non-clathrin-associated. The InterPro domain mapping is too broad and fails to capture this critical distinction.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                                        PMID:10436028
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/26542808" target="_blank" class="term-link">
                                        PMID:26542808
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The heterotetrameric (œµ-Œ≤4-Œº4-œÉ4) complex adaptor protein 4 (AP-4) is a component of a non-clathrin coat involved in protein sorting at the trans-Golgi network (TGN).</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/26756312" target="_blank" class="term-link">
                                        PMID:26756312
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The adaptor protein 4 (AP4) complex (œµ/Œ≤4/Œº4/œÉ4 subunits) forms a non-clathrin coat on vesicles departing the trans-Golgi network.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030276" target="_blank" class="term-link">
                                    GO:0030276
                                </a>
                            </span>
                            <span class="term-label">clathrin binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0030276" data-r="GO_REF:0000002" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from InterPro domain mapping (IPR016342). This annotation is INCORRECT. AP-4 does not bind clathrin - it forms a clathrin-independent coat.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation should be removed. AP-4 is a clathrin-independent adaptor complex and there is no evidence that AP4B1 binds clathrin. The InterPro domain family (IPR016342) includes beta subunits from multiple adaptor complexes, but AP-4 specifically is clathrin-independent.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                                        PMID:10436028
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/26756312" target="_blank" class="term-link">
                                        PMID:26756312
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The adaptor protein 4 (AP4) complex (œµ/Œ≤4/Œº4/œÉ4 subunits) forms a non-clathrin coat on vesicles departing the trans-Golgi network.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005802" target="_blank" class="term-link">
                                    GO:0005802
                                </a>
                            </span>
                            <span class="term-label">trans-Golgi network</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0005802" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from combined automated methods. AP-4 localizes to the TGN where it functions in cargo sorting.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> TGN localization is well established for AP-4. This IEA annotation is consistent with multiple experimental (IDA) annotations for the same term from PMID:10066790. The TGN is the primary site where AP-4 assembles and initiates vesicle formation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006605" target="_blank" class="term-link">
                                    GO:0006605
                                </a>
                            </span>
                            <span class="term-label">protein targeting</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0006605" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from combined automated methods. AP-4 targets proteins from TGN to endosomal/lysosomal destinations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Protein targeting is a core function of AP-4. The complex recognizes cargo sorting signals and targets proteins to specific cellular destinations.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                                        PMID:10436028
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The mu4 subunit of the complex specifically interacts with a tyrosine-based sorting signal, indicating that, like the other three AP complexes, AP-4 is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0061938" target="_blank" class="term-link">
                                    GO:0061938
                                </a>
                            </span>
                            <span class="term-label">protein localization to somatodendritic compartment</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0061938" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation transferred from mouse ortholog via Ensembl Compara. AP-4 is involved in proper asymmetric localization of proteins in neurons.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a legitimate function of AP-4 in neurons, but represents a specialized cell-type-specific function rather than a core molecular function. The annotation is valid but should be considered non-core as AP-4 is ubiquitously expressed and this function is neuron-specific.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005802" target="_blank" class="term-link">
                                    GO:0005802
                                </a>
                            </span>
                            <span class="term-label">trans-Golgi network</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10436028
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Characterization of a fourth adaptor-related protein complex...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0005802" data-r="PMID:10436028" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> NAS annotation from ComplexPortal referencing PMID:10436028. The study demonstrated AP-4 localization to TGN region by immunofluorescence and immunogold EM.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:10436028 provides direct evidence for TGN localization by immunofluorescence and immunogold electron microscopy. This is a well-supported core localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                                        PMID:10436028
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016192" target="_blank" class="term-link">
                                    GO:0016192
                                </a>
                            </span>
                            <span class="term-label">vesicle-mediated transport</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10436028
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Characterization of a fourth adaptor-related protein complex...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0016192" data-r="PMID:10436028" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> NAS annotation from ComplexPortal referencing PMID:10436028. The study characterized AP-4 as an adaptor complex involved in vesicle-mediated trafficking.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:10436028 demonstrates AP-4 association with vesicles and its role in cargo recognition. This annotation correctly captures the vesicle-mediated transport function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                                        PMID:10436028
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The mu4 subunit of the complex specifically interacts with a tyrosine-based sorting signal, indicating that, like the other three AP complexes, AP-4 is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0098541" target="_blank" class="term-link">
                                    GO:0098541
                                </a>
                            </span>
                            <span class="term-label">cytoplasmic side of trans-Golgi network transport vesicle membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10066790
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AP-4, a novel protein complex related to clathrin adaptors.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0098541" data-r="PMID:10066790" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA annotation based on direct experimental evidence from PMID:10066790, which characterized AP-4 as a peripheral membrane protein associated with TGN membranes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:10066790 demonstrates that AP-4/beta4 exists in both cytosolic and membrane-bound forms and shows TGN association. The cytoplasmic side localization is appropriate for adaptor complexes that are peripheral membrane proteins recruited to vesicle membranes.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">An antibody to beta4 recognized in human cells an approximately 83-kDa polypeptide that exists in both soluble and membrane-associated forms.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006605" target="_blank" class="term-link">
                                    GO:0006605
                                </a>
                            </span>
                            <span class="term-label">protein targeting</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IC</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10066790
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AP-4, a novel protein complex related to clathrin adaptors.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0006605" data-r="PMID:10066790" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IC (Inferred by Curator) annotation using GO:0030124 (AP-4 adaptor complex) as evidence. Since AP4B1 is part of AP-4, and AP-4 functions in protein targeting, this annotation is valid.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This IC annotation correctly infers protein targeting function from AP-4 complex membership. The inference that a cargo-sorting adaptor complex is involved in protein targeting is sound.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008104" target="_blank" class="term-link">
                                    GO:0008104
                                </a>
                            </span>
                            <span class="term-label">intracellular protein localization</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IC</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10066790
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AP-4, a novel protein complex related to clathrin adaptors.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0008104" data-r="PMID:10066790" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IC annotation using GO:0030124 as evidence. Infers protein localization function from AP-4 complex membership.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This IC annotation correctly infers that AP-4 components are involved in protein localization based on the complex&#39;s established function in cargo sorting. By directing cargo from TGN to endosomal destinations, AP-4 determines protein localization within cells.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005802" target="_blank" class="term-link">
                                    GO:0005802
                                </a>
                            </span>
                            <span class="term-label">trans-Golgi network</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10066790
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AP-4, a novel protein complex related to clathrin adaptors.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0005802" data-r="PMID:10066790" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA annotation based on immunofluorescence and biochemical fractionation data from PMID:10066790 showing AP-4 associates with TGN.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:10066790 provides direct experimental evidence for TGN localization. BFA sensitivity is characteristic of TGN-associated coat proteins. This is a core localization for AP4B1.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                    GO:0005829
                                </a>
                            </span>
                            <span class="term-label">cytosol</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10066790
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AP-4, a novel protein complex related to clathrin adaptors.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0005829" data-r="PMID:10066790" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA annotation showing AP-4/beta4 exists in cytosolic form as well as membrane-bound. PMID:10066790 demonstrated both soluble and membrane-associated pools.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:10066790 explicitly shows beta4 exists in both soluble and membrane-associated forms. Adaptor protein complexes cycle between cytosolic and membrane-bound states as part of their function in vesicle formation. The cytosolic pool represents the inactive/unrecruited form.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">An antibody to beta4 recognized in human cells an approximately 83-kDa polypeptide that exists in both soluble and membrane-associated forms.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030124" target="_blank" class="term-link">
                                    GO:0030124
                                </a>
                            </span>
                            <span class="term-label">AP-4 adaptor complex</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10066790
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AP-4, a novel protein complex related to clathrin adaptors.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0030124" data-r="PMID:10066790" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA annotation establishing AP4B1 as a component of the AP-4 heterotetrameric complex. PMID:10066790 was the original identification paper for AP-4.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the defining annotation for AP4B1 - it IS the beta subunit of AP-4. This annotation should be retained as a core component annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Gel filtration, sedimentation velocity, and immunoprecipitation experiments revealed that beta4 is a component of a multisubunit complex (AP-4) that also contains the sigma4 polypeptide and two additional adaptor subunit homologs named mu4 (mu-ARP2) and epsilon.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/26756312" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:26756312
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Molecular Basis for the Interaction Between AP4 Œ≤4 and its A...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0005515" data-r="PMID:26756312" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI annotation for interaction with tepsin (TEPSIN/ENTHD2). PMID:26756312 characterized the molecular basis of the AP4B1-tepsin interaction.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The interaction with tepsin is well-documented and represents a specific, functionally important binding partner. However, &#34;protein binding&#34; (GO:0005515) is too generic and uninformative. The ear domain of beta4 specifically binds tepsin through a defined peptide motif interaction.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0060090" target="_blank" class="term-link">
                                    molecular adaptor activity
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/26756312" target="_blank" class="term-link">
                                        PMID:26756312
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We show that tepsin harbors a hydrophobic sequence, LFxG[M/L]x[L/V], in its unstructured C-terminus, which binds directly and specifically to the C-terminal Œ≤4 appendage domain.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/26542808" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:26542808
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Bivalent Motif-Ear Interactions Mediate the Association of t...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0005515" data-r="PMID:26542808" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI annotation for tepsin interaction from PMID:26542808, which mapped the bivalent interaction between tepsin and AP-4.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Like the previous annotation, this documents the specific tepsin-beta4 interaction but uses the overly broad &#34;protein binding&#34; term. PMID:26542808 demonstrates that tepsin contains two peptide motifs that bind to the ear domains of beta4 and epsilon subunits.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0060090" target="_blank" class="term-link">
                                    molecular adaptor activity
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/26542808" target="_blank" class="term-link">
                                        PMID:26542808
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Using a variety of protein interaction assays, we found that tepsin comprises two phylogenetically conserved peptide motifs, [GS]LFXG[ML]X[LV] and S[AV]F[SA]FLN, within its C-terminal unstructured region, which interact with the C-terminal ear (or appendage) domains of the Œ≤4 and œµ subunits of AP-4, respectively.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/22472443" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:22472443
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Multivariate proteomic profiling identifies novel accessory ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0005515" data-r="PMID:22472443" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI annotation from proteomic study identifying tepsin as an AP-4 accessory protein.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:22472443 identified tepsin as an AP-4-associated protein through proteomic analysis. While the interaction is valid, &#34;protein binding&#34; is too generic.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0060090" target="_blank" class="term-link">
                                    molecular adaptor activity
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AP4B1/AP4B1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Tepsin associates with AP-4 but is not required for ATG9A export from the TGN in HeLa/MEFs; AP-4 interacts with Arf1-GTP, and Œº4 binds canonical cargo motifs.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031904" target="_blank" class="term-link">
                                    GO:0031904
                                </a>
                            </span>
                            <span class="term-label">endosome lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5229111
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0031904" data-r="Reactome:R-HSA-5229111" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS annotation from Reactome pathway &#34;AP4 transports APP from trans-Golgi network to endosome lumen.&#34; This represents the destination of AP-4-mediated cargo transport.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation represents the destination compartment of AP-4 cargo rather than where AP4B1 itself localizes. AP-4 sorts cargo like APP for delivery to endosomes, but the AP-4 complex itself localizes to TGN and cytoplasmic side of vesicle membranes.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AP4B1/AP4B1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">AP-4 mediates signal-dependent export of selected cargos--most prominently ATG9A--from the TGN to endosomal/peripheral compartments that support autophagosome formation.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032588" target="_blank" class="term-link">
                                    GO:0032588
                                </a>
                            </span>
                            <span class="term-label">trans-Golgi network membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5229111
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0032588" data-r="Reactome:R-HSA-5229111" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS annotation from Reactome showing AP-4 localization to TGN membrane where it initiates cargo sorting.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> TGN membrane is the site of AP-4 function. The Reactome pathway describes AP-4 binding cargo at the TGN membrane for transport to endosomes. This is consistent with the IDA annotations for TGN localization from PMID:10066790.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AP4B1/AP4B1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">AP-4 localizes to the TGN (perinuclear), forms AP-4-derived vesicles, and facilitates cargo delivery to early/late endosomes and pre-autophagosomal structures (PAS).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032588" target="_blank" class="term-link">
                                    GO:0032588
                                </a>
                            </span>
                            <span class="term-label">trans-Golgi network membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5229132
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6B7" data-a="GO:0032588" data-r="Reactome:R-HSA-5229132" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS annotation from Reactome pathway &#34;AP4 binds APP&#34; showing AP-4 at TGN membrane where cargo recognition occurs.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Duplicate of the previous annotation with different Reactome pathway reference. Both pathways describe AP-4 function at the TGN membrane. The annotation is valid and consistent with experimental evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                                        PMID:10066790
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>AP4B1 is the beta-1 subunit (beta4-adaptin) of the heterotetrameric AP-4 adaptor complex. The complex forms a non-clathrin coat on vesicles at the trans-Golgi network to mediate cargo sorting and export to endosomal compartments. Key cargoes include ATG9A (autophagy), APP (Alzheimer disease), DAGLB (endocannabinoid signaling), SERINC proteins (lipid scramblases), Sortilin (lysosomal enzyme trafficking), and AMPA/delta-2 glutamate receptors (neuronal polarity). The beta4 subunit C-terminal ear domain specifically recruits the accessory protein tepsin.</h3>
                <span class="vote-buttons" data-g="Q9Y6B7" data-a="FUNCTION: AP4B1 is the beta-1 subunit (beta4-adaptin) of the..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0060090" target="_blank" class="term-link">
                            molecular adaptor activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016192" target="_blank" class="term-link">
                                vesicle-mediated transport
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006605" target="_blank" class="term-link">
                                protein targeting
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005802" target="_blank" class="term-link">
                                trans-Golgi network
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                cytosol
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">In Complex:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030124" target="_blank" class="term-link">
                            AP-4 adaptor complex
                        </a>
                    </span>
                </div>
                

                
            </div>

            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Provides IEA annotations based on domain similarity, but incorrectly assigns clathrin-related terms to AP-4</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IBA annotation for vesicle-mediated transport is well-supported by phylogenetic and experimental evidence</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Provides valid Golgi apparatus localization based on UniProt subcellular location data</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Transfers somatodendritic localization function from mouse ortholog</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000117.md" target="_blank" class="term-link">
                            GO_REF:0000117
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Electronic Gene Ontology annotations created by ARBA machine learning models</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Provides valid protein localization annotation based on machine learning inference</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Combines multiple computational sources for protein transport and targeting annotations</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10066790" target="_blank" class="term-link">
                            PMID:10066790
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">AP-4, a novel protein complex related to clathrin adaptors.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Original identification and characterization of AP-4 complex</div>
                        
                        <div class="finding-text">"Here we report the identification and characterization of AP-4, a novel protein complex related to the heterotetrameric AP-1, AP-2, and AP-3 adaptors"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Established beta4 (AP4B1) as component of heterotetrameric complex with epsilon, mu4, and sigma4</div>
                        
                        <div class="finding-text">"Gel filtration, sedimentation velocity, and immunoprecipitation experiments revealed that beta4 is a component of a multisubunit complex (AP-4) that also contains the sigma4 polypeptide and two additional adaptor subunit homologs named mu4 (mu-ARP2) and epsilon."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10436028" target="_blank" class="term-link">
                            PMID:10436028
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Characterization of a fourth adaptor-related protein complex.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Independent characterization of AP-4 complex demonstrating non-clathrin coat formation</div>
                        
                        <div class="finding-text">"Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Showed mu4 binds tyrosine-based sorting signals for cargo recognition</div>
                        
                        <div class="finding-text">"The mu4 subunit of the complex specifically interacts with a tyrosine-based sorting signal, indicating that, like the other three AP complexes, AP-4 is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22472443" target="_blank" class="term-link">
                            PMID:22472443
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Multivariate proteomic profiling identifies novel accessory proteins of coated vesicles.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Identified tepsin as AP-4-associated accessory protein through proteomics</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26542808" target="_blank" class="term-link">
                            PMID:26542808
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Bivalent Motif-Ear Interactions Mediate the Association of the Accessory Protein Tepsin with the AP-4 Adaptor Complex.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Mapped two peptide motifs in tepsin that bind beta4 and epsilon ear domains</div>
                        
                        <div class="finding-text">"Using a variety of protein interaction assays, we found that tepsin comprises two phylogenetically conserved peptide motifs, [GS]LFXG[ML]X[LV] and S[AV]F[SA]FLN, within its C-terminal unstructured region, which interact with the C-terminal ear (or appendage) domains of the Œ≤4 and œµ subunits of AP-4, respectively."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Demonstrated AP-4 forms a non-clathrin coat at TGN</div>
                        
                        <div class="finding-text">"The heterotetrameric (œµ-Œ≤4-Œº4-œÉ4) complex adaptor protein 4 (AP-4) is a component of a non-clathrin coat involved in protein sorting at the trans-Golgi network (TGN)."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26756312" target="_blank" class="term-link">
                            PMID:26756312
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Molecular Basis for the Interaction Between AP4 Œ≤4 and its Accessory Protein, Tepsin.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Determined NMR structure and binding site for tepsin on beta4 ear domain</div>
                        
                        <div class="finding-text">"We show that tepsin harbors a hydrophobic sequence, LFxG[M/L]x[L/V], in its unstructured C-terminus, which binds directly and specifically to the C-terminal Œ≤4 appendage domain."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Demonstrated AP-4 forms non-clathrin vesicles at TGN</div>
                        
                        <div class="finding-text">"The adaptor protein 4 (AP4) complex (œµ/Œ≤4/Œº4/œÉ4 subunits) forms a non-clathrin coat on vesicles departing the trans-Golgi network."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5229111
                        
                    </span>
                </div>
                
                <div class="reference-title">AP4 transports APP from trans-Golgi network to endosome lumen</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Describes AP-4-mediated transport of APP cargo from TGN to endosomes</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5229132
                        
                    </span>
                </div>
                
                <div class="reference-title">AP4 binds APP</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Describes cargo recognition step where AP-4 binds APP at TGN</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/AP4B1/AP4B1-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research review of AP4B1 function</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">AP-4 mediates export of ATG9A from TGN to support autophagosome formation</div>
                        
                        <div class="finding-text">"AP-4 mediates signal-dependent export of selected cargos--most prominently ATG9A--from the TGN to endosomal/peripheral compartments that support autophagosome formation."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Loss of AP-4 causes ATG9A retention at TGN linking to autophagy defects</div>
                        
                        <div class="finding-text">"Loss of AP-4 causes ATG9A retention in the TGN and alters LC3B lipidation readouts, linking AP-4 to autophagy pathways."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/AP4B1/AP4B1-deep-research-cyberian.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research review of AP4B1 function (cyberian)</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">DAGLB is an AP-4 cargo protein critical for endocannabinoid signaling in neurons</div>
                        
                        <div class="finding-text">"A landmark 2022 study by Davies et al. identified DAGLB as an AP-4 cargo protein with significant implications for neuronal development [davies-2022-daglb-endocannabinoid-abstract]. DAGLB is a serine lipase that hydrolyzes diacylglycerol (DAG) to generate 2-arachidonoylglycerol (2-AG), the most abundant endocannabinoid in the brain."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AAGAB chaperone is required for AP-4 complex assembly and stability</div>
                        
                        <div class="finding-text">"Mattera et al. demonstrated that AAGAB directly binds to the Œµ and œÉ4 subunits of AP-4 and stabilizes both endogenous and recombinant AP-4 subunits by preventing their proteasomal degradation [mattera-2022-aagab-chaperone-abstract]."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AP-4 regulates lysosome biogenesis via Sortilin trafficking</div>
                        
                        <div class="finding-text">"Recent work by Majumder et al. showed that AP-4 regulates the trafficking of Sortilin (SORT1) from the TGN to endo-lysosomes in neurons [majumder-2022-lysosome-abstract]."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">SERINC proteins are AP-4 cargoes with lipid scramblase activity</div>
                        
                        <div class="finding-text">"Proteomic studies identified these multipass transmembrane proteins as AP-4 cargoes [davies-2018-ap4-vesicles-abstract]. Both proteins colocalize with ATG9A and exhibit altered localization in AP-4-deficient cells."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AP-4 recognizes YXXOE consensus sorting signals</div>
                        
                        <div class="finding-text">"AP-4 recognizes a distinct type of tyrosine-based sorting signal with the consensus sequence YXX√òE, where √ò represents a bulky hydrophobic residue [burgos-2010-app-sorting-abstract][mattera-2017-atg9a-export-abstract]."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    
    <div class="section">
        <h2 class="section-title">Suggested Questions for Experts</h2>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What are all the cargo proteins sorted by AP-4? Beyond ATG9A, APP, DAGLB, and SERINCs, what other transmembrane proteins depend on AP-4 for proper trafficking?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9Y6B7" data-a="Q: What are all the cargo proteins sorted by AP-4? Be..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the precise role of tepsin in AP-4 function? Does it regulate cargo selection, vesicle formation, or coat stability?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9Y6B7" data-a="Q: What is the precise role of tepsin in AP-4 functio..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> How does AP-4 vesicle formation occur without clathrin? What provides the mechanical force for membrane deformation?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9Y6B7" data-a="Q: How does AP-4 vesicle formation occur without clat..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the relationship between AP-4 deficiency and other neurodegenerative diseases beyond SPG47? Does AP-4 dysfunction contribute to Alzheimer disease progression?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9Y6B7" data-a="Q: What is the relationship between AP-4 deficiency a..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Suggested Experiments</h2>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Systematic cargo identification using proximity labeling (BioID/TurboID) of AP4B1 to identify all proteins in proximity to AP-4 at the TGN. This would identify additional AP-4 cargo proteins and regulatory factors beyond the currently known ATG9A, APP, DAGLB, and SERINC proteins.</p>
                    
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q9Y6B7" data-a="EXPERIMENT: Systematic cargo identification using proximity la..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Cryo-EM structure determination of AP-4 bound to membrane and cargo to understand the mechanism of clathrin-independent vesicle formation. This would reveal how AP-4 deforms membranes without clathrin and how cargo recognition is coupled to vesicle budding.</p>
                    
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q9Y6B7" data-a="EXPERIMENT: Cryo-EM structure determination of AP-4 bound to m..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Evaluation of endocannabinoid pathway modulation (e.g., MGLL inhibitors like ABX-1431) as potential therapeutic intervention for AP-4 deficiency syndrome, given the discovery that DAGLB mislocalization contributes to axonal growth defects.</p>
                    
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q9Y6B7" data-a="EXPERIMENT: Evaluation of endocannabinoid pathway modulation (..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Cyberian</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AP4B1-deep-research-cyberian.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9Y6B7" data-a="DOC: Deep Research Cyberian" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: cyberian<br />
model: deep-research<br />
cached: false<br />
start_time: '2026-01-15T15:53:27.141863'<br />
end_time: '2026-01-15T16:11:24.077822'<br />
duration_seconds: 1076.94<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AP4B1<br />
  gene_symbol: AP4B1<br />
  uniprot_accession: Q9Y6B7<br />
  protein_description: 'RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName:<br />
    Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein<br />
    complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;'<br />
  gene_info: Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the adaptor complexes large subunit family.<br />
  protein_domains: AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like.<br />
    (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)<br />
provider_config:<br />
  timeout: 1800<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    agent_type: claude<br />
    port: 3284<br />
    skip_permissions: true<br />
citation_count: 18</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9Y6B7</li>
<li><strong>Protein Description:</strong> RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName: Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;</li>
<li><strong>Gene Information:</strong> Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the adaptor complexes large subunit family.</li>
<li><strong>Key Domains:</strong> AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like. (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AP4B1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AP4B1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AP4B1</strong> (gene ID: AP4B1, UniProt: Q9Y6B7) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="ap4b1-comprehensive-research-report-on-the-beta-1-subunit-of-adaptor-protein-complex-4">AP4B1: Comprehensive Research Report on the Beta-1 Subunit of Adaptor Protein Complex 4</h1>
<h2 id="introduction-and-summary">Introduction and Summary</h2>
<p>AP4B1 (Adaptor Related Protein Complex 4 Subunit Beta 1) encodes the beta-1 subunit of the adaptor protein complex 4 (AP-4), a heterotetrameric protein complex essential for intracellular membrane trafficking. The AP4B1 gene is located on chromosome 1p13.2 and produces a 739-amino acid protein with a molecular mass of approximately 83 kDa [dellangelica-1999-ap4-discovery-abstract]. The protein contains characteristic structural features including an N-terminal trunk region, a solvent-accessible hinge region, and a C-terminal ear (appendage) domain with high alpha-helical content [frazier-2016-tepsin-binding-abstract].</p>
<p>The AP-4 complex was discovered in 1999 through independent efforts by Dell'Angelica et al. and Hirst et al., who identified it as the fourth member of the adaptor protein complex family [dellangelica-1999-ap4-discovery-abstract][hirst-1999-ap4-characterization-abstract]. Unlike AP-1, AP-2, and AP-3, which function as clathrin-associated adaptors, AP-4 operates independently of clathrin and represents a distinct functional class within the adaptor protein family [park-guo-2014-ap-review-abstract]. The primary function of AP4B1, as part of the AP-4 complex, is to mediate the sorting and transport of specific transmembrane cargo proteins from the trans-Golgi network (TGN) to endosomes, the peripheral cytoplasm, and the basolateral membrane in polarized cells. Loss-of-function mutations in AP4B1 cause Spastic Paraplegia 47 (SPG47), a severe childhood-onset neurological disorder characterized by intellectual disability, progressive spasticity, and characteristic brain abnormalities [abou-jamra-2011-ap4b1-mutation-abstract].</p>
<h2 id="gene-expression-and-evolutionary-conservation">Gene Expression and Evolutionary Conservation</h2>
<p>AP4B1 exhibits ubiquitous tissue expression with a 2.5-kb transcript detectable in all examined tissues; a minor 6-kb species appears in some tissues [dellangelica-1999-ap4-discovery-abstract]. Northern blot analysis confirms expression in all fetal and adult brain structures, and Western blot analysis demonstrates a protein of approximately 83 kDa that partitions as both a cytosolic and peripheral membrane protein [abou-jamra-2011-ap4b1-mutation-abstract]. Immunohistochemistry shows general cytoplasmic expression with a granular pattern reflecting association with the trans-Golgi network.</p>
<p>The AP-4 complex shows a distinctive evolutionary distribution among eukaryotes. While humans, mice, and the plant Arabidopsis thaliana possess all four AP complexes (AP-1 through AP-4), commonly used invertebrate model organisms including Drosophila melanogaster, Caenorhabditis elegans, Saccharomyces cerevisiae, and Schizosaccharomyces pombe have lost AP-4 and retain only AP-1, AP-2, and AP-3 [boehm-2001-adaptins-review-abstract]. This patchy distribution has historically limited experimental study of AP-4 function. Phylogenetic analyses indicate that AP-3 represents the basal complex, followed by AP-5, AP-4, and subsequently AP-1 and AP-2 [boehm-2001-adaptins-review-abstract]. Zebrafish (Danio rerio) have retained AP-4, making them a valuable model system for studying AP-4 function and the pathophysiology of AP-4 deficiency syndrome, with CRISPR-edited zebrafish showing phenotypes resembling human AP-4 deficiency.</p>
<h2 id="structure-of-the-ap-4-complex-and-the-role-of-ap4b1">Structure of the AP-4 Complex and the Role of AP4B1</h2>
<p>The AP-4 complex is composed of four subunits that assemble into an obligate heterotetramer: epsilon (Œµ, encoded by AP4E1), beta-4 (Œ≤4, encoded by AP4B1), mu-4 (Œº4, encoded by AP4M1), and sigma-4 (œÉ4, encoded by AP4S1) [hirst-1999-ap4-characterization-abstract]. The complex architecture follows the general organization of AP complexes, with two large subunits (Œµ and Œ≤4), one medium subunit (Œº4), and one small subunit (œÉ4). These subunits form a compact core with protruding hinge and ear domains that are crucial for cargo binding, accessory protein recruitment, and membrane association [park-guo-2014-ap-review-abstract].</p>
<p>The AP4B1-encoded Œ≤4 subunit is one of the two large subunits and shares structural homology with beta subunits of other AP complexes, although it is notably smaller than AP1B1, AP2B1, and AP3B1, appearing to lack most of the C-terminal hinge and/or ear domain found in its paralogs [dellangelica-1999-ap4-discovery-abstract]. The predicted AP4B1 protein contains several conserved motifs shared with other AP beta subunits, including a WIIGEY motif at amino acid position 500 and a KKLVYLY motif near the N-terminus. Structural analyses have revealed that the Œ≤4 appendage domain possesses only a C-terminal platform subdomain, lacking the N-terminal sandwich subdomain characteristic of AP-1 and AP-2 beta appendages [frazier-2016-tepsin-binding-abstract].</p>
<p>A critical function of the Œ≤4 subunit is its interaction with tepsin (also known as ENTHD2), the only known AP-4-specific accessory protein. Frazier et al. demonstrated that tepsin contains a conserved peptide motif ([GS]LFXG[ML]X[LV]) in its unstructured C-terminal region that binds specifically to the Œ≤4 ear domain [frazier-2016-tepsin-binding-abstract]. This interaction occurs at a conserved hydrophobic surface on the Œ≤4-ear platform fold, with critical residues I669, A670, and Y682 on Œ≤4 mediating the binding. The tepsin-Œ≤4 interaction has a dissociation constant of approximately 2.9 ŒºM and exhibits 1:1 stoichiometry. Importantly, tepsin also binds to the Œµ subunit through a separate motif, creating bivalent interactions that may enable cross-linking of multiple AP-4 heterotetramers and contribute to AP-4 coat assembly [frazier-2016-tepsin-binding-abstract].</p>
<h2 id="ap-4-complex-assembly-and-the-aagab-chaperone">AP-4 Complex Assembly and the AAGAB Chaperone</h2>
<p>Recent work has revealed that AP-4 complex assembly is not spontaneous but requires assistance from the chaperone protein AAGAB (alpha- and gamma-adaptin-binding protein, also known as p34). Mattera et al. demonstrated that AAGAB directly binds to the Œµ and œÉ4 subunits of AP-4 and stabilizes both endogenous and recombinant AP-4 subunits by preventing their proteasomal degradation [mattera-2022-aagab-chaperone-abstract]. AAGAB-knockout cells exhibit reduced levels of AP-4 subunits and accumulation of ATG9A at the TGN, phenocopying the hallmarks of AP-4 deficiency. These findings establish AAGAB as a critical factor in AP-4 biogenesis, with implications for understanding both normal AP-4 function and potential therapeutic targets for AP-4 deficiency syndrome [mattera-2022-aagab-chaperone-abstract].</p>
<h2 id="subcellular-localization-and-membrane-recruitment">Subcellular Localization and Membrane Recruitment</h2>
<p>AP-4 localizes to the trans-Golgi network (TGN) and adjacent tubulovesicular membranes, as demonstrated by immunofluorescence microscopy showing a pattern of discrete perinuclear dots in HeLa cells [hirst-1999-ap4-characterization-abstract]. Unlike the clathrin-associated AP complexes, AP-4 does not colocalize with clathrin-coated structures, indicating its function in a distinct, clathrin-independent trafficking pathway [park-guo-2014-ap-review-abstract].</p>
<p>The membrane recruitment of AP-4 is regulated by the small GTPase ARF1 (ADP-ribosylation factor 1). Boehm et al. demonstrated that brefeldin A (BFA) treatment, which inhibits ARF-guanine nucleotide exchange factors, causes redistribution of AP-4 from the TGN to the cytosol, confirming ARF-dependence [boehm-2001-ap4-arf-abstract]. The molecular mechanism involves direct interactions between ARF1 and both the Œµ and Œº4 subunits of AP-4. The Œµ subunit binds exclusively to the GTP-bound form of ARF1 through interactions with the switch I and switch II regions, providing high-affinity, regulated binding. In contrast, the Œº4 subunit binds ARF1 regardless of nucleotide status and is less dependent on switch region residues, providing constitutive, low-affinity binding [boehm-2001-ap4-arf-abstract]. This dual-interaction mechanism suggests a novel mode of ARF1-adaptor interaction, where Œº4 may mediate initial membrane sampling and Œµ enables GTP-dependent stabilization of AP-4 at the TGN.</p>
<h2 id="cargo-recognition-and-sorting-function">Cargo Recognition and Sorting Function</h2>
<p>The primary function of AP-4 is to sort specific transmembrane cargo proteins into transport vesicles at the TGN for delivery to post-Golgi destinations. The Œº4 subunit serves as the principal cargo-binding component, recognizing specific sorting signals in the cytoplasmic tails of cargo proteins. AP-4 recognizes a distinct type of tyrosine-based sorting signal with the consensus sequence YXX√òE, where √ò represents a bulky hydrophobic residue [burgos-2010-app-sorting-abstract][mattera-2017-atg9a-export-abstract].</p>
<p>The best-characterized AP-4 cargoes include:</p>
<p><strong>ATG9A (Autophagy-related protein 9A)</strong>: ATG9A is the sole multispanning transmembrane protein in the core autophagy machinery and has emerged as the major cargo of AP-4 [mattera-2017-atg9a-export-abstract][davies-2018-ap4-vesicles-abstract]. ATG9A interacts with AP-4 through a conserved YQRLE motif in its N-terminal cytosolic tail. AP-4 facilitates the export of ATG9A from the TGN to peripheral cellular compartments, including endosomes and sites of autophagosome formation. In AP-4-deficient cells, ATG9A accumulates at the TGN and is depleted from the peripheral cytoplasm, with whole-cell ATG9A protein levels increased 3-5 fold compared to controls [behne-2020-ap4-deficiency-abstract]. This mislocalization impairs autophagosome biogenesis and LC3B lipidation.</p>
<p><strong>APP (Amyloid Precursor Protein)</strong>: Burgos et al. demonstrated that the YKFFE sequence in APP's cytosolic tail binds to the Œº4 subunit of AP-4 [burgos-2010-app-sorting-abstract]. X-ray crystallographic analysis revealed that this signal binds to a site on Œº4 distinct from the canonical YXX√ò-binding site on Œº2, representing a novel signal-adaptor interaction. AP-4 mediates the transport of APP from the TGN directly to early endosomes. Disruption of this interaction shifts APP distribution back to the TGN and enhances Œ≥-secretase-mediated cleavage, increasing production of pathogenic amyloid-Œ≤ peptide, suggesting AP-4 may have protective effects against amyloidogenesis [burgos-2010-app-sorting-abstract].</p>
<p><strong>SERINC1 and SERINC3</strong>: Proteomic studies identified these multipass transmembrane proteins as AP-4 cargoes [davies-2018-ap4-vesicles-abstract]. Both proteins colocalize with ATG9A and exhibit altered localization in AP-4-deficient cells. Notably, SERINC proteins function as HIV-1 restriction factors and have lipid scramblase activity; their trafficking by AP-4 may have implications for membrane lipid asymmetry at target compartments.</p>
<p><strong>DAGLB (Diacylglycerol Lipase Beta)</strong>: A landmark 2022 study by Davies et al. identified DAGLB as an AP-4 cargo protein with significant implications for neuronal development [davies-2022-daglb-endocannabinoid-abstract]. DAGLB is a serine lipase that hydrolyzes diacylglycerol (DAG) to generate 2-arachidonoylglycerol (2-AG), the most abundant endocannabinoid in the brain. During normal development, DAGLB is targeted to the axon where 2-AG signaling through CB1 and CB2 cannabinoid receptors drives axonal growth and guidance. In AP-4-deficient cells, DAGLB accumulates at the TGN and axonal DAGLB levels are reduced in patient neurons. Consequently, 2-AG levels are reduced by approximately 30% in the brains of AP-4 knockout mice, accompanied by a 20% reduction in arachidonic acid levels. This discovery establishes a new pathogenic mechanism in AP-4 deficiency syndrome: spatial dysregulation of endocannabinoid signaling contributing to axon growth defects [davies-2022-daglb-endocannabinoid-abstract].</p>
<p><strong>Glutamate Receptors</strong>: Matsuda et al. demonstrated that AP-4 mediates the polarized sorting of AMPA-type glutamate receptors (AMPARs) and delta-2 glutamate receptors to the somatodendritic domain of neurons [matsuda-2008-ampa-receptor-abstract]. AP-4 binds to transmembrane AMPAR regulatory proteins (TARPs), facilitating selective trafficking. In AP-4Œ≤-/- neurons, TARPs and AMPA receptors mislocalize to axons and accumulate in autophagosomes, while NMDA receptors and metabotropic glutamate receptors remain properly localized, indicating the existence of AP-4-dependent and AP-4-independent sorting mechanisms.</p>
<p><strong>Sortilin and Lysosomal Receptors</strong>: Recent work by Majumder et al. showed that AP-4 regulates the trafficking of Sortilin (SORT1) from the TGN to endo-lysosomes in neurons [majumder-2022-lysosome-abstract]. In AP-4-depleted neurons, Sortilin is retained in the TGN, leading to impaired trafficking of lysosomal enzymes including Cathepsin L and PPT-1. This results in lysosomes with compromised composition and function.</p>
<h2 id="role-in-polarized-trafficking">Role in Polarized Trafficking</h2>
<p>A significant function of AP-4 is mediating polarized protein sorting in both epithelial cells and neurons. Simmen et al. demonstrated that AP-4 binds to cytosolic signals known to mediate basolateral transport in epithelial cells [simmen-2002-basolateral-abstract]. When Œº4 levels were depleted in MDCK cells, several basolateral proteins were mis-sorted to the apical surface, establishing AP-4 as a participant in basolateral sorting pathways.</p>
<p>In neurons, AP-4 is essential for maintaining the polarized distribution of proteins between somatodendritic and axonal compartments. Loss of AP-4 function results in the mislocalization of multiple proteins to the axonal compartment, including AMPA receptors, TARPs, delta-2 glutamate receptors, and low-density lipoprotein receptors [matsuda-2008-ampa-receptor-abstract]. This aberrant sorting leads to accumulation of these proteins in axonal autophagosomes and contributes to the neurological pathology observed in AP-4 deficiency.</p>
<h2 id="connection-to-autophagy-pathways">Connection to Autophagy Pathways</h2>
<p>The identification of ATG9A as a major AP-4 cargo has established a clear link between AP-4 function and the autophagy pathway. ATG9A functions as a lipid scramblase and is essential for autophagosome biogenesis, cycling between the TGN and peripheral sites including phagophores and autophagosomes [mattera-2017-atg9a-export-abstract]. AP-4 promotes the signal-mediated export of ATG9A from the TGN to the peripheral cytoplasm, where ATG9A-positive vesicles congregate near autophagosomes and serve as the membrane reservoir for autophagosome expansion.</p>
<p>In AP-4-deficient cells, the failure to properly deliver ATG9A to peripheral sites leads to dysregulated autophagy. Mattera et al. demonstrated that AP-4 knockout cells exhibit impaired LC3B-II/LC3B-I conversion ratios and abnormal morphology of LC3B-positive structures [mattera-2017-atg9a-export-abstract]. Davies et al. further showed that RUSC2, an AP-4 accessory protein, facilitates the transport of AP-4-derived, ATG9A-positive vesicles from the TGN to the cell periphery via interactions with kinesin motors [davies-2018-ap4-vesicles-abstract].</p>
<p>The connection between AP-4 and autophagy is particularly relevant in neurons, where axonal autophagy is crucial for protein homeostasis and neuronal health. De Pace et al. demonstrated that in AP-4Œµ knockout mice, ATG9A is retained at the TGN and depleted from axons, leading to impaired autophagosome formation and accumulation of protein aggregates including mutant huntingtin [depace-2018-atg9a-mouse-abstract]. This "congenital disorder of autophagy" mechanism may contribute significantly to the neurodegeneration observed in AP-4 deficiency syndrome.</p>
<h2 id="disease-associations-spastic-paraplegia-47-spg47-and-ap-4-deficiency-syndrome">Disease Associations: Spastic Paraplegia 47 (SPG47) and AP-4 Deficiency Syndrome</h2>
<p>Loss-of-function mutations in AP4B1 cause Spastic Paraplegia 47 (SPG47), an autosomal recessive neurological disorder first described by Abou Jamra et al. in 2011 [abou-jamra-2011-ap4b1-mutation-abstract]. SPG47 is part of the broader "AP-4 deficiency syndrome," which encompasses four clinically similar conditions caused by mutations in any of the four AP-4 subunit genes: SPG47 (AP4B1), SPG50 (AP4M1), SPG51 (AP4E1), and SPG52 (AP4S1). The clinical similarity across these conditions reflects the fact that loss of any single subunit renders the entire AP-4 complex nonfunctional.</p>
<p>The clinical features of SPG47 have been comprehensively characterized by Ebrahimi-Fakhari et al. [ebrahimi-fakhari-2018-spg47-clinical-abstract]. Core manifestations include early developmental delay with motor delay (100%), intellectual disability (100%), neonatal or infantile hypotonia that progresses to spasticity (100%), severely delayed or absent speech development (94%), progression to spastic diplegia (89%), and loss of independent walking (88%). Approximately 73% of patients show thin corpus callosum on neuroimaging, 67% have delayed myelination or white matter loss, and 40% exhibit ventriculomegaly. A characteristic MRI signature includes thinning of the splenium of the corpus callosum, absent or thin anterior commissure, and the distinctive "ears of the grizzly bear sign" caused by signal abnormalities in the forceps minor.</p>
<p>The pathophysiology of AP-4 deficiency involves multiple mechanisms stemming from impaired cargo trafficking. The working model proposes that: (1) AP-4 is required for proper trafficking of ATG9A and other cargoes from the TGN; (2) loss-of-function variants lead to cargo accumulation at the TGN and depletion from peripheral/axonal compartments; (3) in the case of ATG9A, this impairs axonal autophagy; (4) reduced autophagy capacity leads to protein aggregate accumulation and axonal degeneration [behne-2020-ap4-deficiency-abstract][depace-2018-atg9a-mouse-abstract]. Additionally, the missorting of Sortilin impairs lysosome biogenesis [majumder-2022-lysosome-abstract], mislocalization of glutamate receptors may contribute to neuronal dysfunction [matsuda-2008-ampa-receptor-abstract], and reduced axonal DAGLB leads to impaired endocannabinoid signaling and axon growth defects [davies-2022-daglb-endocannabinoid-abstract].</p>
<p>Mouse models of AP-4 deficiency recapitulate key features of the human disease, including motor deficits, thin corpus callosum, and widespread axonal swellings throughout the central nervous system [depace-2018-atg9a-mouse-abstract]. Transmission electron microscopy reveals axonal swellings containing accumulations of membrane cisternae, organelles, and autophagosomes, consistent with impaired protein clearance mechanisms.</p>
<h2 id="therapeutic-perspectives">Therapeutic Perspectives</h2>
<p>Several therapeutic approaches are being investigated for AP-4 deficiency syndrome. Gene therapy represents a rational strategy given the loss-of-function nature of the disease. Preclinical studies have demonstrated that delivery of AAV9 vectors expressing human AP4B1 (AAV9/hAP4B1) into the cisterna magna of SPG47 mouse models leads to widespread gene transfer and restoration of multiple disease hallmarks. High-content screening has also identified small molecules that can partially restore ATG9A trafficking in patient-derived cells, providing proof-of-concept for pharmacological approaches.</p>
<p>An additional therapeutic avenue has emerged from the identification of DAGLB as an AP-4 cargo. Davies et al. demonstrated that treating patient-derived neurons with ABX-1431, a monoacylglycerol lipase (MGLL) inhibitor that prevents 2-AG degradation, rescued neurite growth defects [davies-2022-daglb-endocannabinoid-abstract]. This finding suggests that pharmacological modulation of endocannabinoid metabolism could provide symptomatic benefit in AP-4 deficiency syndrome, representing a more tractable therapeutic target than gene replacement.</p>
<h2 id="open-questions">Open Questions</h2>
<p>Several important questions remain regarding AP4B1 and AP-4 function:</p>
<ol>
<li>
<p><strong>Complete cargo inventory</strong>: While ATG9A, APP, SERINCs, DAGLB, and glutamate receptors have been identified as AP-4 cargoes, the complete repertoire of AP-4 cargo proteins remains incompletely defined. Additional cargoes may be relevant to disease pathophysiology.</p>
</li>
<li>
<p><strong>Tissue-specific functions</strong>: Although AP-4 is ubiquitously expressed, the severe neurological phenotype of AP-4 deficiency suggests particular importance in neurons. The molecular basis for this neuronal selectivity is not fully understood.</p>
</li>
<li>
<p><strong>Tepsin function</strong>: The precise role of tepsin in AP-4-mediated trafficking remains unclear. Whether tepsin functions as a structural component, a cargo adaptor, or both requires further investigation.</p>
</li>
<li>
<p><strong>Mechanism of coat assembly</strong>: How AP-4 forms coats on vesicles in the absence of clathrin is poorly understood. The role of tepsin-mediated cross-linking of AP-4 complexes in this process requires elucidation.</p>
</li>
<li>
<p><strong>Relationship to other neurodegenerative diseases</strong>: The connection between AP-4 deficiency and enhanced amyloid pathology observed in mouse models suggests potential relevance to Alzheimer's disease. The extent to which AP-4 dysfunction contributes to other neurodegenerative conditions warrants investigation.</p>
</li>
<li>
<p><strong>Compensatory mechanisms</strong>: Why some cargo proteins are properly sorted in AP-4-deficient cells while others are mislocalized suggests the existence of parallel sorting pathways. Understanding these alternative mechanisms may reveal therapeutic targets.</p>
</li>
<li>
<p><strong>Long-term efficacy of gene therapy</strong>: While preclinical gene therapy studies show promise, long-term efficacy and optimal timing of intervention (given the early-onset nature of SPG47) remain to be determined.</p>
</li>
<li>
<p><strong>Developmental vs. degenerative contributions</strong>: The relative contributions of developmental defects (e.g., impaired endocannabinoid signaling during axon growth) versus progressive neurodegeneration (e.g., impaired autophagy) to the clinical phenotype require further clarification.</p>
</li>
</ol>
<h2 id="references">References</h2>
<ol>
<li>
<p><strong>[abou-jamra-2011-ap4b1-mutation-abstract]</strong> Abou Jamra R, Philippe O, Raas-Rothschild A, et al. Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet. 2011;88(6):788-795. DOI: 10.1016/j.ajhg.2011.04.019. PMID: 21620353.</p>
</li>
<li>
<p><strong>[behne-2020-ap4-deficiency-abstract]</strong> Behne R, Teinert J, Wimmer M, et al. Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking. Hum Mol Genet. 2020;29(2):320-334. DOI: 10.1093/hmg/ddz310. PMID: 31915823. PMCID: PMC7001721.</p>
</li>
<li>
<p><strong>[boehm-2001-ap4-arf-abstract]</strong> Boehm M, Aguilar RC, Bonifacino JS. Functional and physical interactions of the adaptor protein complex AP-4 with ADP-ribosylation factors (ARFs). EMBO J. 2001;20(22):6265-6276. DOI: 10.1093/emboj/20.22.6265. PMID: 11707398. PMCID: PMC125733.</p>
</li>
<li>
<p><strong>[boehm-2001-adaptins-review-abstract]</strong> Boehm M, Bonifacino JS. Adaptins: the final recount. Mol Biol Cell. 2001;12(10):2907-2920. DOI: 10.1091/mbc.12.10.2907. PMID: 11598180. PMCID: PMC60143.</p>
</li>
<li>
<p><strong>[burgos-2010-app-sorting-abstract]</strong> Burgos PV, Mardones GA, Rojas AL, et al. Sorting of the Alzheimer's Disease Amyloid Precursor Protein Mediated by the AP-4 Complex. Dev Cell. 2010;18(3):425-436. DOI: 10.1016/j.devcel.2010.01.015. PMID: 20230749. PMCID: PMC2841041.</p>
</li>
<li>
<p><strong>[davies-2018-ap4-vesicles-abstract]</strong> Davies AK, Itzhak DN, Edgar JR, et al. AP-4 vesicles contribute to spatial control of autophagy via RUSC-dependent peripheral delivery of ATG9A. Nat Commun. 2018;9(1):3958. DOI: 10.1038/s41467-018-06172-7. PMID: 30262884. PMCID: PMC6160451.</p>
</li>
<li>
<p><strong>[davies-2022-daglb-endocannabinoid-abstract]</strong> Davies AK, Alecu JE, Ziegler M, et al. AP-4-mediated axonal transport controls endocannabinoid production in neurons. Nat Commun. 2022;13:1058. DOI: 10.1038/s41467-022-28609-w. PMID: 35217685. PMCID: PMC8881493.</p>
</li>
<li>
<p><strong>[dellangelica-1999-ap4-discovery-abstract]</strong> Dell'Angelica EC, Mullins C, Bonifacino JS. AP-4, a novel protein complex related to clathrin adaptors. J Biol Chem. 1999;274(11):7278-7285. DOI: 10.1074/jbc.274.11.7278. PMID: 10066790.</p>
</li>
<li>
<p><strong>[depace-2018-atg9a-mouse-abstract]</strong> De Pace R, Skirzewski M, Bhonsle-Deeng L, et al. Altered distribution of ATG9A and accumulation of axonal aggregates in neurons from a mouse model of AP-4 deficiency syndrome. PLOS Genet. 2018;14(4):e1007363. DOI: 10.1371/journal.pgen.1007363. PMID: 29698489. PMCID: PMC5940238.</p>
</li>
<li>
<p><strong>[ebrahimi-fakhari-2018-spg47-clinical-abstract]</strong> Ebrahimi-Fakhari D, Cheng C, Dies K, et al. Clinical and genetic characterization of AP4B1-associated SPG47. Am J Med Genet A. 2018;176(2):311-318. DOI: 10.1002/ajmg.a.38561. PMID: 29193663.</p>
</li>
<li>
<p><strong>[frazier-2016-tepsin-binding-abstract]</strong> Frazier MN, Davies AK, Voehler M, et al. Molecular Basis for the Interaction Between AP4 Œ≤4 and its Accessory Protein, Tepsin. Traffic. 2016;17(4):400-415. DOI: 10.1111/tra.12375. PMID: 26756312. PMCID: PMC4805503.</p>
</li>
<li>
<p><strong>[hirst-1999-ap4-characterization-abstract]</strong> Hirst J, Bright NA, Rous B, Robinson MS. Characterization of a Fourth Adaptor-related Protein Complex. Mol Biol Cell. 1999;10(8):2787-2802. DOI: 10.1091/mbc.10.8.2787. PMID: 10436028. PMCID: PMC25515.</p>
</li>
<li>
<p><strong>[majumder-2022-lysosome-abstract]</strong> Majumder P, Edmison D, Rodger C, et al. AP-4 regulates neuronal lysosome composition, function, and transport via regulating export of critical lysosome receptor proteins at the trans-Golgi network. Mol Biol Cell. 2022;33(12):ar102. DOI: 10.1091/mbc.E21-09-0473. PMID: 35976706. PMCID: PMC9635302.</p>
</li>
<li>
<p><strong>[mattera-2017-atg9a-export-abstract]</strong> Mattera R, Park SY, De Pace R, et al. AP-4 mediates export of ATG9A from the trans-Golgi network to promote autophagosome formation. Proc Natl Acad Sci USA. 2017;114(50):E10697-E10706. DOI: 10.1073/pnas.1717327114. PMID: 29180427. PMCID: PMC5740629.</p>
</li>
<li>
<p><strong>[mattera-2022-aagab-chaperone-abstract]</strong> Mattera R, De Pace R, Bonifacino JS. The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits. Mol Biol Cell. 2022;33(12):ar103. DOI: 10.1091/mbc.E22-05-0177. PMID: 35976721. PMCID: PMC9635299.</p>
</li>
<li>
<p><strong>[matsuda-2008-ampa-receptor-abstract]</strong> Matsuda S, Miura E, Matsuda K, et al. Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. Neuron. 2008;57(5):730-745. DOI: 10.1016/j.neuron.2008.02.012. PMID: 18341993.</p>
</li>
<li>
<p><strong>[park-guo-2014-ap-review-abstract]</strong> Park SY, Guo X. Adaptor protein complexes and intracellular transport. Biosci Rep. 2014;34(4):e00123. DOI: 10.1042/BSR20140069. PMID: 24975939. PMCID: PMC4114066.</p>
</li>
<li>
<p><strong>[simmen-2002-basolateral-abstract]</strong> Simmen T, H√∂ning S, Ober A, et al. AP-4 binds basolateral signals and participates in basolateral sorting in epithelial MDCK cells. Nat Cell Biol. 2002;4(2):154-159. DOI: 10.1038/ncb745. PMID: 11802162.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>abou-jamra-2011-ap4b1-mutation-abstract.md</li>
<li>behne-2020-ap4-deficiency-abstract.md</li>
<li>boehm-2001-adaptins-review-abstract.md</li>
<li>boehm-2001-ap4-arf-abstract.md</li>
<li>burgos-2010-app-sorting-abstract.md</li>
<li>davies-2018-ap4-vesicles-abstract.md</li>
<li>davies-2022-daglb-endocannabinoid-abstract.md</li>
<li>dellangelica-1999-ap4-discovery-abstract.md</li>
<li>depace-2018-atg9a-mouse-abstract.md</li>
<li>ebrahimi-fakhari-2018-spg47-clinical-abstract.md</li>
<li>frazier-2016-tepsin-binding-abstract.md</li>
<li>hirst-1999-ap4-characterization-abstract.md</li>
<li>majumder-2022-lysosome-abstract.md</li>
<li>matsuda-2008-ampa-receptor-abstract.md</li>
<li>mattera-2017-atg9a-export-abstract.md</li>
<li>mattera-2022-aagab-chaperone-abstract.md</li>
<li>park-guo-2014-ap-review-abstract.md</li>
<li>simmen-2002-basolateral-abstract.md</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AP4B1-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9Y6B7" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-26T23:01:05.473770'<br />
end_time: '2025-12-26T23:06:22.159201'<br />
duration_seconds: 316.69<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AP4B1<br />
  gene_symbol: AP4B1<br />
  uniprot_accession: Q9Y6B7<br />
  protein_description: 'RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName:<br />
    Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein<br />
    complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;'<br />
  gene_info: Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the adaptor complexes large subunit family.<br />
  protein_domains: AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like.<br />
    (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 19</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9Y6B7</li>
<li><strong>Protein Description:</strong> RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName: Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;</li>
<li><strong>Gene Information:</strong> Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the adaptor complexes large subunit family.</li>
<li><strong>Key Domains:</strong> AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like. (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AP4B1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AP4B1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AP4B1</strong> (gene ID: AP4B1, UniProt: Q9Y6B7) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9Y6B7</li>
<li><strong>Protein Description:</strong> RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName: Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;</li>
<li><strong>Gene Information:</strong> Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the adaptor complexes large subunit family.</li>
<li><strong>Key Domains:</strong> AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like. (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AP4B1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AP4B1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AP4B1</strong> (gene ID: AP4B1, UniProt: Q9Y6B7) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Research plan status. Objective 1 (identity verification) completed. Objectives 2‚Äì6 addressed through curated literature and database evidence; final report submitted below with citations.</p>
<p>Comprehensive research report: AP4B1 (UniProt: Q9Y6B7) ‚Äì AP-4 complex subunit beta-1</p>
<p>Key concepts and definitions<br />
- Identity and complex membership: AP4B1 encodes the beta-1 (Œ≤4) subunit of the heterotetrameric adaptor protein complex 4 (AP-4), together with AP4E1 (Œµ), AP4M1 (Œº4), and AP4S1 (œÉ4). AP-4 functions as a non-clathrin coat at the trans-Golgi network (TGN) that selects transmembrane cargos into vesicles for post-Golgi trafficking; Œº4 binds YXX√ò-like signals, and the complex interacts with Arf1-GTP. AP-4 recruitment also engages the accessory protein tepsin (AP4AT/ENTHD2). AP4B1 corresponds to Œ≤4-adaptin, a large subunit with AP_beta/ARM-like domains, consistent with the adaptor complexes large subunit family (Homo sapiens). (mattera2017ap4mediatesexport pages 1-2)<br />
- Primary molecular role: AP-4 mediates signal-dependent export of selected cargos‚Äîmost prominently ATG9A‚Äîfrom the TGN to endosomal/peripheral compartments that support autophagosome formation. Loss of AP-4 causes ATG9A retention in the TGN and alters LC3B lipidation readouts, linking AP-4 to autophagy pathways. (mattera2017ap4mediatesexport pages 9-9, mattera2017ap4mediatesexport pages 1-2)</p>
<p>Subcellular localization and trafficking route<br />
- Localization: AP-4 localizes to the TGN (perinuclear), forms AP-4‚Äìderived vesicles, and facilitates cargo delivery to early/late endosomes and pre-autophagosomal structures (PAS). In neurons, AP-4‚Äìdependent carriers support axonal/peripheral distribution of ATG9A critical for autophagy. (ivankovic2020axonalautophagosomematuration pages 1-3, mattera2017ap4mediatesexport pages 1-2)<br />
- Route and machinery: AP-4 drives TGN export of ATG9A to endosomal/PAS compartments. RUSC-family proteins mediate peripheral delivery of AP-4 vesicles containing ATG9A, positioning an ‚ÄúATG9A reservoir‚Äù near autophagosome biogenesis sites. The FTS‚ÄìHook‚ÄìFHIP (FHF) complex binds AP-4 and dynein‚Äìdynactin to maintain perinuclear AP-4/ATG9A distribution, revealing coat‚Äìmotor coupling in AP-4 traffic. (ivankovic2020axonalautophagosomematuration pages 1-3, mattera2017ap4mediatesexport pages 1-2)</p>
<p>Known cargos and interacting partners<br />
- Cargos: ATG9A is a validated AP-4 cargo across multiple systems; missorting is a hallmark of AP-4 loss. Additional AP-4‚Äìdependent localization changes were reported for SERINC1/3 in proteomic mapping studies. (behne2020adaptorproteincomplex pages 1-2)<br />
- Accessory factors and interactors: Tepsin associates with AP-4 but is not required for ATG9A export from the TGN in HeLa/MEFs; AP-4 interacts with Arf1-GTP, and Œº4 binds canonical cargo motifs. FHF (Hook1/2‚ÄìFHIP) interacts with AP-4 Œº4 to control perinuclear positioning; RUSC proteins facilitate peripheral delivery of AP-4 vesicles; recent data implicate SCAMP5 in neuronal AP-4 localization and ATG9A presynaptic delivery. (mattera2017ap4mediatesexport pages 9-9, mattera2017ap4mediatesexport pages 1-2, ivankovic2020axonalautophagosomematuration pages 1-3, ryu2023scamp5ap4dependenttrafficking pages 23-34)</p>
<p>Recent developments and latest research (2023‚Äì2024 priority)<br />
- SCAMP5‚ÄìAP-4 axis in neurons (2023): SCAMP5 co-immunoprecipitates with AP-4 (AP4M1) and supports AP-4 localization at the TGN. SCAMP5 knockdown reduces AP4M1 intensity and AP-4/TGN38 colocalization, decreases ATG9A axonal puncta density (~9.37 ¬± 0.40 to 4.74 ¬± 0.36 puncta per 50 Œºm; rescue to 9.96 ¬± 0.47), and lowers the fraction of presynaptic LC3-positive boutons under activity induction (71.7% ¬± 4.7% to 35.0% ¬± 9.0%), linking SCAMP5 to AP-4‚Äìdependent presynaptic autophagy. IBRO Neuroscience Reports; Oct 2023; https://doi.org/10.1016/j.ibneur.2023.08.624. (ryu2023scamp5ap4dependenttrafficking pages 23-34)<br />
- Coat‚Äìmotor coupling: The AP-4‚ÄìFHF (Hook1/Hook2‚ÄìFHIP) interaction, reported earlier, clarifies how AP-4 vesicles are positioned perinuclearly via dynein‚Äìdynactin and complements RUSC-dependent peripheral transport of ATG9A carriers. This mechanistic framework underlies spatial control of autophagy via ATG9A supply. Molecular Biology of the Cell; Apr 2020; https://doi.org/10.1091/mbc.e19-11-0658; Nature Communications; Sep 2018; https://doi.org/10.1038/s41467-018-06172-7. (ivankovic2020axonalautophagosomematuration pages 1-3)<br />
- Diagnostic/therapeutic direction of travel: High-content imaging of ATG9A redistribution is being developed as a functional assay in AP-4 deficiency models; emerging screening efforts aim to identify modulators that normalize ATG9A trafficking in AP-4 deficiency. bioRxiv (Feb 2025) highlights a neuronal CRISPR screen mapping ATG9A trafficking regulators, indicating a growing target space; while beyond 2024, it underscores momentum in therapeutic hypothesis generation. https://doi.org/10.1101/2025.02.22.639634. (ziegler2025arrayedcrisprcas9lossoffunction pages 53-56)</p>
<p>Current applications and real-world implementations<br />
- Diagnostic biomarkers in patient cells: In AP-4‚Äìdeficient patient fibroblasts (including AP4B1), ATG9A accumulates in the TGN and total ATG9A increases 3‚Äì5-fold. Re-expression of AP4B1 restores ATG9A distribution. These quantitative changes support a robust cell-based biomarker and functional readout for variant interpretation. Human Molecular Genetics; Jan 2020; https://doi.org/10.1093/hmg/ddz310. (behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10)<br />
- Neuronal models for pathomechanism: Patient iPSC-derived cortical neurons show reduced LC3-II and impaired neurite outgrowth/branching, aligning with neurodevelopmental features of AP-4 deficiency and providing preclinical platforms for screening and mechanistic studies. Human Molecular Genetics; Jan 2020; https://doi.org/10.1093/hmg/ddz310. (behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10)</p>
<p>Expert opinions and analysis from authoritative sources<br />
- AP-4 as a TGN export adaptor for autophagy machinery: Core primary papers converge on AP-4‚Äôs role in cargo-selective export from the TGN, with ATG9A being the principal cargo linked to autophagosome biogenesis. The neuron-selective consequences of ATG9A mislocalization‚Äîaxonal depletion, autophagosome maturation defects, and axonal swellings‚Äîprovide a parsimonious mechanistic basis for AP-4 deficiency neuropathology. PNAS; Nov 2017; https://doi.org/10.1073/pnas.1717327114; Autophagy; May 2020; https://doi.org/10.1080/15548627.2019.1615302. (mattera2017ap4mediatesexport pages 1-2, ivankovic2020axonalautophagosomematuration pages 1-3)<br />
- Spatial control of ATG9A supply: Complementary studies define perinuclear retention (FHF‚Äìdynein) versus peripheral delivery (RUSC) of AP-4/ATG9A vesicles, framing AP-4 as a gatekeeper of ATG9A spatial availability. Perturbations in this axis plausibly compromise distal axonal autophagy and synaptic health. Autophagy; May 2020; https://doi.org/10.1080/15548627.2019.1615302. (ivankovic2020axonalautophagosomematuration pages 1-3)<br />
- Emerging neuronal modulators: New neuronal data (SCAMP5) refine the adaptor landscape governing AP-4 localization and presynaptic ATG9A, highlighting additional entry points for therapeutic modulation. IBRO Neuroscience Reports; Oct 2023; https://doi.org/10.1016/j.ibneur.2023.08.624. (ryu2023scamp5ap4dependenttrafficking pages 23-34)</p>
<p>Relevant statistics and quantitative data<br />
- Disease association: Open Targets lists AP4B1 associated with ‚Äúgenetic disorder‚Äù (score ~0.816), ‚ÄúSevere intellectual disability and progressive spastic paraplegia‚Äù (score ~0.767), ‚ÄúSpastic paraplegia‚Äù (score ~0.753), ‚ÄúAP-4 deficiency syndrome‚Äù (score ~0.372), and ‚Äúspastic quadriplegic cerebral palsy‚Äù (score ~0.370); evidence includes multiple literature PMIDs and clinical resources, with biallelic autosomal inheritance noted. Nucleic Acids Research (platform reference); accessed via Open Targets query. (OpenTargets Search: -AP4B1)<br />
- Cellular biomarker magnitude: Patient fibroblasts show 3‚Äì5√ó increased ATG9A protein and juxtanuclear/TGN retention; AP-4 re-expression normalizes distribution. Human Molecular Genetics; Jan 2020; https://doi.org/10.1093/hmg/ddz310. (behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10)<br />
- Neuronal trafficking and autophagy metrics (2023): SCAMP5 knockdown reduces axonal ATG9A puncta (~9.37 ‚Üí 4.74 per 50 Œºm) and activity-induced LC3-positive boutons (~71.7% ‚Üí 35.0%), quantifying presynaptic autophagy dependence on SCAMP5‚ÄìAP-4‚ÄìATG9A trafficking. IBRO Neuroscience Reports; Oct 2023; https://doi.org/10.1016/j.ibneur.2023.08.624. (ryu2023scamp5ap4dependenttrafficking pages 23-34)</p>
<p>Mechanistic link to disease (AP-4 deficiency syndrome; SPG47 for AP4B1)<br />
- Genetics and clinical phenotype: Biallelic loss-of-function variants in AP4B1 cause a complicated hereditary spastic paraplegia (AP-4 deficiency syndrome, SPG47) with severe intellectual disability, progressive spasticity, absent/limited speech, thin corpus callosum, ventriculomegaly, seizures, and growth delay. (mattera2017ap4mediatesexport pages 1-2, ivankovic2020axonalautophagosomematuration pages 1-3)<br />
- Cellular pathogenesis: AP-4 loss retains ATG9A at the TGN, depletes axonal ATG9A, and impairs autophagosome biogenesis/maturation in axons, leading to distal axonal swellings enriched in ER and impaired axonal extension/integrity. (Autophagy; May 2020; https://doi.org/10.1080/15548627.2019.1615302). (ivankovic2020axonalautophagosomematuration pages 1-3)<br />
- Organismal models: AP-4 epsilon knockout mice recapitulate neuroanatomical phenotypes and axonal pathology consistent with human disease, supporting causality from AP-4‚ÄìATG9A trafficking defects to motor system dysfunction. (ivankovic2020axonalautophagosomematuration pages 1-3)</p>
<p>Evidence synthesis: AP4B1 encodes Œ≤4-adaptin, an obligate AP-4 subunit that forms a non-clathrin TGN coat to select cargos including ATG9A for export. Accessory and motor-coupling factors (tepsin, FHF, RUSC) and neuronal modulators (SCAMP5) orchestrate perinuclear retention and peripheral/axonal delivery of AP-4 vesicles. In AP-4 deficiency, ATG9A missorting explains neuron-selective autophagy defects and axonopathy. Quantitative cellular markers (ATG9A TGN retention and overexpression) and neuronal phenotypes (reduced LC3-II, impaired neuritogenesis; reduced presynaptic autophagy) provide actionable readouts for diagnostics and therapeutic screening. (mattera2017ap4mediatesexport pages 9-9, ivankovic2020axonalautophagosomematuration pages 1-3, behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10, mattera2017ap4mediatesexport pages 1-2, ryu2023scamp5ap4dependenttrafficking pages 23-34, OpenTargets Search: -AP4B1)</p>
<p>Insertable summary artifact<br />
| Category | Key point | Evidence / quantitative detail | Primary sources (DOI URL, publication date) |<br />
|---|---|---:|---|<br />
| Identity | Human AP4B1 = beta-1 (Œ≤4) adaptin; large subunit of AP-4; contains AP_beta and ARM-like domains | UniProt Q9Y6B7 identity and literature consistency with Œ≤4-adaptin annotation | Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2), Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2) |<br />
| Complex composition | AP-4 is an obligate heterotetramer: AP4E1 (Œµ), AP4B1 (Œ≤), AP4M1 (Œº), AP4S1 (œÉ) | Described as obligate heterotetrameric coat complex in cellular studies | Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2), Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2) |<br />
| Molecular function | Cargo selection for TGN-derived vesicles; Œº4 recognizes YXX√ò-like signals; forms a non-clathrin coat at the TGN to sort transmembrane cargos | AP-4 promotes signal-mediated export of cargos (notably ATG9A) from TGN; loss alters LC3B lipidation under some conditions | Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2) |<br />
| Subcellular localization | AP-4 localizes to the trans‚ÄëGolgi network (TGN), perinuclear region and AP-4‚Äìderived vesicles that travel to peripheral/axonal sites | TGN-associated coat and perinuclear distribution; peripheral/axonal delivery documented in neuronal models | Ivankovic et al., Autophagy; https://doi.org/10.1080/15548627.2019.1615302 (May 2020) (ivankovic2020axonalautophagosomematuration pages 1-3), Behne et al., Hum Mol Genet (Jan 2020) (behne2020adaptorproteincomplex pages 1-2) |<br />
| Trafficking route | TGN ‚Üí early/late endosomes ‚Üí pre‚Äëautophagosomal structures (PAS) and peripheral/axonal sites; RUSC1/2 mediate peripheral delivery | AP-4‚Äìdependent export of ATG9A from TGN to endosomal/PAS compartments; RUSC-dependent peripheral transport of ATG9A vesicles | Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2), Behne et al., Hum Mol Genet (Jan 2020) (behne2020adaptorproteincomplex pages 1-2) |<br />
| Cargos | Validated cargos include ATG9A (primary) and reported AP-4‚Äìdependent localization changes for SERINC1/3 | ATG9A is consistently identified as a major AP-4 cargo across cell and neuronal models | Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2), Mattera et al., PNAS (Nov 2017) (mattera2017ap4mediatesexport pages 1-2) |<br />
| Accessory / interactors | Tepsin (ENTHD2/AP4AT), FHF complex (Hook1/2, FHIP), Arf1, RUSC1/2, SCAMP5 (neuronal) | Protein‚Äìprotein interaction and functional assays show recruitment/coordination for AP-4 vesicle formation and positioning | Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2), Mattera et al., Mol Biol Cell (FHF) (2020) summarized in reviews and Behne et al. (behne2020adaptorproteincomplex pages 1-2), Ryu et al., IBRO Rep; https://doi.org/10.1016/j.ibneur.2023.08.624 (Oct 2023) (ryu2023scamp5ap4dependenttrafficking pages 23-34) |<br />
| 2023‚Äì2024 updates | SCAMP5 required for presynaptic AP‚Äë4 localization and ATG9A delivery; tepsin‚ÄìLC3B link promotes ATG9A export to periphery (recent mechanistic modifiers) | Ryu 2023: SCAMP5 KD reduces axonal ATG9A puncta (~9.37 ‚Üí 4.74 puncta/50 Œºm) and lowers % LC3+ boutons (71.7% ‚Üí 35.0%); tepsin‚ÄìLC3B studies reported 2023 bioRxiv (mechanistic accessory role) | Ryu et al., IBRO Neurosci Rep; https://doi.org/10.1016/j.ibneur.2023.08.624 (Oct 2023) (ryu2023scamp5ap4dependenttrafficking pages 23-34), Mattera et al./related tepsin data (mattera2017ap4mediatesexport pages 9-9, mattera2017ap4mediatesexport pages 1-2) |<br />
| Disease | AP‚Äë4 deficiency syndrome (SPG47 for AP4B1): autosomal recessive, severe early‚Äëonset neurodevelopmental disorder with spasticity, intellectual disability, absent/limited speech, thin corpus callosum | OpenTargets association scores high for genetic disorder / spastic paraplegia; allelic requirement = biallelic autosomal (reported literature) | Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2), OpenTargets summary (disease associations) (OpenTargets Search: -AP4B1) |<br />
| Cellular phenotypes (patients/models) | ATG9A retention at TGN; 3‚Äì5√ó increased ATG9A levels in patient fibroblasts; reduced LC3‚ÄëII in iPSC‚Äëneurons; impaired neurite outgrowth/branching | Quantified: 3‚Äì5√ó ATG9A upregulation in patient fibroblasts; decreased LC3-II/LC3-I ratio in patient iPSC‚Äëneurons; large-scale neurite assays (&gt;90k neurons) show reduced branching | Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2), Ivankovic et al., Autophagy (May 2020) (ivankovic2020axonalautophagosomematuration pages 1-3), Mattera et al., PNAS (Nov 2017) (mattera2017ap4mediatesexport pages 1-2) |<br />
| Organismal phenotypes (models) | Ap4e1 KO mice recapitulate axonal defects: distal axonal swellings, impaired axonal extension and thin corpus callosum-like features | Mouse KO shows axonal autophagy/extension defects and neuroanatomical phenotypes consistent with human disease | Ivankovic et al., Autophagy; https://doi.org/10.1080/15548627.2019.1615302 (May 2020) (ivankovic2020axonalautophagosomematuration pages 1-3), Behne et al., Hum Mol Genet (behne2020adaptorproteincomplex pages 1-2) |<br />
| Diagnostics / therapeutics | High-throughput imaging of ATG9A distribution proposed as functional diagnostic assay; preliminary screens/efforts to find modulators that restore trafficking reported in recent work | Functional ATG9A redistribution assay used in labs/patient-derived cells; preliminary screen reports and preclinical modulators referenced in recent datasets | Ebrahimi‚ÄëFakhari / group assay reports summarized in reviews and screening efforts (ziegler2025arrayedcrisprcas9lossoffunction pages 53-56, behne2020adaptorproteincomplex pages 1-2), OpenTargets disease-context (OpenTargets Search: -AP4B1) |<br />
| Statistics / quantitative metrics | OpenTargets association scores: "genetic disorder" ~0.816, "Severe intellectual disability and progressive spastic paraplegia" ~0.767; Ryu 2023 imaging metrics (puncta and % LC3+ boutons as above) | Quantitative association scores and imaging readouts provide diagnostic/experimental benchmarks | OpenTargets platform (disease scores) (OpenTargets Search: -AP4B1), Ryu et al., IBRO Rep; https://doi.org/10.1016/j.ibneur.2023.08.624 (Oct 2023) (ryu2023scamp5ap4dependenttrafficking pages 23-34) |</p>
<p><em>Table: Compact summary table of AP4B1 (UniProt Q9Y6B7) and AP‚Äë4 complex: functions, localization, cargos, interactors, disease links, key quantitative findings and primary literature (context IDs cited). Useful as a quick reference linking mechanistic points to core sources.</em></p>
<p>Key source list with URLs and dates<br />
- Mattera et al., PNAS 2017. AP-4 mediates export of ATG9A from the TGN; AP4B1 is Œ≤4-adaptin; tepsin is not required for ATG9A export in tested cells. https://doi.org/10.1073/pnas.1717327114 (Published Nov 2017). (mattera2017ap4mediatesexport pages 9-9, mattera2017ap4mediatesexport pages 1-2)<br />
- Ivankovic et al., Autophagy 2020. Failure of ATG9A sorting underpins axonal autophagosome maturation defects and axonopathy in AP-4 deficiency; model recapitulates neuroanatomy. https://doi.org/10.1080/15548627.2019.1615302 (Published May 2020). (ivankovic2020axonalautophagosomematuration pages 1-3)<br />
- Behne et al., Human Molecular Genetics 2020. Patient fibroblasts and iPSC neurons show ATG9A TGN retention, 3‚Äì5√ó ATG9A upregulation, reduced LC3-II in neurons, impaired neuritogenesis; AP4B1 re-expression rescues ATG9A distribution. https://doi.org/10.1093/hmg/ddz310 (Advance Access Jan 9, 2020). (behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10)<br />
- Ryu et al., IBRO Neuroscience Reports 2023. SCAMP5‚ÄìAP-4 interaction supports TGN localization and presynaptic delivery of ATG9A; quantitative deficits in axonal puncta and LC3-positive boutons upon SCAMP5 knockdown. https://doi.org/10.1016/j.ibneur.2023.08.624 (Published Oct 2023). (ryu2023scamp5ap4dependenttrafficking pages 23-34)<br />
- Open Targets Platform (accessed 2025; platform citation NAR). Quantitative disease association scores linking AP4B1 to spastic paraplegia spectrum and AP-4 deficiency syndrome; biallelic inheritance. (Open Targets query for AP4B1). (OpenTargets Search: -AP4B1)</p>
<p>Notes on gene/protein identification and domain/family consistency<br />
- The gene symbol AP4B1 (HGNC:572) and UniProt Q9Y6B7 match the human AP-4 Œ≤ subunit (Œ≤4-adaptin) with large-subunit adaptor domains (AP_beta; ARM-like), fully consistent with adaptor complex architecture reported in primary studies. No conflicting gene symbol usage was found in other organisms in the cited literature. (mattera2017ap4mediatesexport pages 1-2)</p>
<p>References</p>
<ol>
<li>
<p>(mattera2017ap4mediatesexport pages 1-2): Rafael Mattera, Sang Yoon Park, Raffaella De Pace, Carlos M. Guardia, and Juan S. Bonifacino. Ap-4 mediates export of atg9a from the trans-golgi network to promote autophagosome formation. Proceedings of the National Academy of Sciences, 114:E10697-E10706, Nov 2017. URL: https://doi.org/10.1073/pnas.1717327114, doi:10.1073/pnas.1717327114. This article has 182 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(mattera2017ap4mediatesexport pages 9-9): Rafael Mattera, Sang Yoon Park, Raffaella De Pace, Carlos M. Guardia, and Juan S. Bonifacino. Ap-4 mediates export of atg9a from the trans-golgi network to promote autophagosome formation. Proceedings of the National Academy of Sciences, 114:E10697-E10706, Nov 2017. URL: https://doi.org/10.1073/pnas.1717327114, doi:10.1073/pnas.1717327114. This article has 182 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(ivankovic2020axonalautophagosomematuration pages 1-3): Davor Ivankovic, James Drew, Flavie Lesept, Ian J. White, Guillermo L√≥pez Dom√©nech, Sharon A. Tooze, and Josef T. Kittler. Axonal autophagosome maturation defect through failure of atg9a sorting underpins pathology in ap-4 deficiency syndrome. Autophagy, 16:391-407, May 2020. URL: https://doi.org/10.1080/15548627.2019.1615302, doi:10.1080/15548627.2019.1615302. This article has 85 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(behne2020adaptorproteincomplex pages 1-2): Robert Behne, Julian Teinert, Miriam Wimmer, Angelica D‚ÄôAmore, Alexandra K Davies, Joseph M Scarrott, Kathrin Eberhardt, Barbara Brechmann, Ivy Pin-Fang Chen, Elizabeth D Buttermore, Lee Barrett, Sean Dwyer, Teresa Chen, Jennifer Hirst, Antje Wiesener, Devorah Segal, Andrea Martinuzzi, Sofia T Duarte, James T Bennett, Thomas Bourinaris, Henry Houlden, Agathe Roubertie, Filippo M Santorelli, Margaret Robinson, Mimoun Azzouz, Jonathan O Lipton, Georg H H Borner, Mustafa Sahin, and Darius Ebrahimi-Fakhari. Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking. Human molecular genetics, 29:320-334, Jan 2020. URL: https://doi.org/10.1093/hmg/ddz310, doi:10.1093/hmg/ddz310. This article has 79 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(ryu2023scamp5ap4dependenttrafficking pages 23-34): Seung Hyun Ryu, Jungmihn Lee, Unghwi Lee, Kitae Kim, and Sunghoe Chang. Scamp5/ap-4 dependent trafficking mediates presynaptic localization of the core autophagy protein atg9a. IBRO Neuroscience Reports, Oct 2023. URL: https://doi.org/10.1016/j.ibneur.2023.08.624, doi:10.1016/j.ibneur.2023.08.624. This article has 0 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(ziegler2025arrayedcrisprcas9lossoffunction pages 53-56): Marvin Ziegler, Cedric B√∂ger, Julian E. Alecu, Hyo-Min Kim, Afshin Saffari, Alexandra K. Davies, Mustafa Sahin, and Darius Ebrahimi-Fakhari. Arrayed crispr/cas9 loss-of-function screen in a neuronal model of adaptor protein complex 4 deficiency identifies modulators of atg9a trafficking. bioRxiv, Feb 2025. URL: https://doi.org/10.1101/2025.02.22.639634, doi:10.1101/2025.02.22.639634. This article has 0 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(behne2020adaptorproteincomplex pages 6-10): Robert Behne, Julian Teinert, Miriam Wimmer, Angelica D‚ÄôAmore, Alexandra K Davies, Joseph M Scarrott, Kathrin Eberhardt, Barbara Brechmann, Ivy Pin-Fang Chen, Elizabeth D Buttermore, Lee Barrett, Sean Dwyer, Teresa Chen, Jennifer Hirst, Antje Wiesener, Devorah Segal, Andrea Martinuzzi, Sofia T Duarte, James T Bennett, Thomas Bourinaris, Henry Houlden, Agathe Roubertie, Filippo M Santorelli, Margaret Robinson, Mimoun Azzouz, Jonathan O Lipton, Georg H H Borner, Mustafa Sahin, and Darius Ebrahimi-Fakhari. Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking. Human molecular genetics, 29:320-334, Jan 2020. URL: https://doi.org/10.1093/hmg/ddz310, doi:10.1093/hmg/ddz310. This article has 79 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(OpenTargets Search: -AP4B1): Open Targets Query (-AP4B1, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>behne2020adaptorproteincomplex pages 1-2</li>
<li>ivankovic2020axonalautophagosomematuration pages 1-3</li>
<li>behne2020adaptorproteincomplex pages 6-10</li>
<li>https://doi.org/10.1016/j.ibneur.2023.08.624.</li>
<li>https://doi.org/10.1091/mbc.e19-11-0658;</li>
<li>https://doi.org/10.1038/s41467-018-06172-7.</li>
<li>https://doi.org/10.1101/2025.02.22.639634.</li>
<li>https://doi.org/10.1093/hmg/ddz310.</li>
<li>https://doi.org/10.1073/pnas.1717327114;</li>
<li>https://doi.org/10.1080/15548627.2019.1615302.</li>
<li>https://doi.org/10.1080/15548627.2019.1615302</li>
<li>https://doi.org/10.1073/pnas.1717327114</li>
<li>https://doi.org/10.1093/hmg/ddz310</li>
<li>https://doi.org/10.1016/j.ibneur.2023.08.624</li>
<li>https://doi.org/10.1073/pnas.1717327114,</li>
<li>https://doi.org/10.1080/15548627.2019.1615302,</li>
<li>https://doi.org/10.1093/hmg/ddz310,</li>
<li>https://doi.org/10.1016/j.ibneur.2023.08.624,</li>
<li>https://doi.org/10.1101/2025.02.22.639634,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AP4B1-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9Y6B7" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: false<br />
start_time: '2025-12-27T15:25:57.898849'<br />
end_time: '2025-12-27T15:44:59.293183'<br />
duration_seconds: 1141.39<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AP4B1<br />
  gene_symbol: AP4B1<br />
  uniprot_accession: Q9Y6B7<br />
  protein_description: 'RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName:<br />
    Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein<br />
    complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;'<br />
  gene_info: Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the adaptor complexes large subunit family.<br />
  protein_domains: AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like.<br />
    (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 138</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9Y6B7</li>
<li><strong>Protein Description:</strong> RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName: Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;</li>
<li><strong>Gene Information:</strong> Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the adaptor complexes large subunit family.</li>
<li><strong>Key Domains:</strong> AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like. (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AP4B1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AP4B1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AP4B1</strong> (gene ID: AP4B1, UniProt: Q9Y6B7) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="ap4b1-adaptor-protein-complex-4-beta-1-subunit-function-and-significance">AP4B1 (Adaptor Protein Complex 4 Beta-1 Subunit) ‚Äì Function and Significance</h1>
<h2 id="gene-and-protein-overview">Gene and Protein Overview</h2>
<p><strong>AP4B1</strong> is the human gene encoding the beta-1 subunit of adaptor protein complex 4 (AP-4), often called <strong>beta4-adaptin</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=The%20AP,2020a">pmc.ncbi.nlm.nih.gov</a>). AP-4 is one of five adaptor protein (AP) complexes (AP-1 through AP-5) that are evolutionarily conserved heterotetramers involved in vesicular transport in cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=Heterotetrameric%20adaptor%20protein%20,AP%20complexes%20localize%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=The%20AP,2020a">pmc.ncbi.nlm.nih.gov</a>). The AP-4 complex consists of four subunits: one <em>beta</em> subunit (Œ≤4, encoded by <strong>AP4B1</strong>), one <em>epsilon</em> subunit (œµ, encoded by AP4E1), one <em>mu</em> subunit (Œº4, encoded by AP4M1), and one <em>sigma</em> subunit (œÉ4, encoded by AP4S1) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=The%20AP,2020a">pmc.ncbi.nlm.nih.gov</a>). Together, these subunits form an obligate complex that functions as a coat protein, selecting cargo molecules and forming transport vesicles in the cell‚Äôs endomembrane system (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=called%20AP,6">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=Heterotetrameric%20adaptor%20protein%20,1">pmc.ncbi.nlm.nih.gov</a>). AP-4 belongs to the <em>adaptin family</em> of large coat proteins and contains characteristic domains such as multiple <strong>ARM/HEAT repeats</strong> in its trunk and a C-terminal <em>ear</em> domain (appendage) typical of beta adaptins, used for interacting with other coat components. Notably, AP-4 was first identified in 1999 as a ‚Äúfourth‚Äù adaptor complex localized at the <strong>trans-Golgi network (TGN)</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and">pmc.ncbi.nlm.nih.gov</a>). Unlike AP-1, AP-2, and AP-3, which work with clathrin coats, AP-4 is <strong>unusual in that it does not bind clathrin and forms a non-clathrin coat</strong> at the TGN (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and">pmc.ncbi.nlm.nih.gov</a>). This unique property distinguished AP-4 as the least characterized AP complex for many years (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=Adaptor%20protein%204%20%28AP,%CE%B2%20peptide">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>Cellular Localization:</strong> AP-4 is predominantly associated with the <strong>trans-Golgi network</strong> and possibly Golgi-endosomal membranes. Its localization is regulated by ARF (ADP-ribosylation factor) family GTPases, similar to other Golgi adaptors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and">pmc.ncbi.nlm.nih.gov</a>). ARF proteins recruit AP-4 to the TGN membrane, where AP-4 helps initiate budding of transport vesicles. Because AP-4 operates at the TGN, it mediates trafficking <strong>from the TGN to downstream endosomal or lysosomal compartments</strong> rather than at the plasma membrane (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=AP,have%20demonstrated%20that%20the%20autophagy">pmc.ncbi.nlm.nih.gov</a>). Indeed, AP-4 has been implicated in directing cargo from the TGN to <strong>early and late endosomes</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=AP,characterization%20of%20an%20Ap4e1%20knockout">pmc.ncbi.nlm.nih.gov</a>). Ultrastructurally, AP-4-coated vesicles are thought to form a <em>coat</em> on budding membranes without clathrin, although an electron microscopy structure of AP-4 is not yet available (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=structure%20of%20the%20AP%E2%80%904%20complex,including%20publications%20from%20our%20group">pmc.ncbi.nlm.nih.gov</a>). The AP4B1 (Œ≤4) subunit, like other large adaptins, likely provides a scaffold: its N-terminal domain forms part of the AP-4 core ‚Äútrunk‚Äù that binds cargo and other subunits, while its C-terminal ‚Äúear‚Äù domain protrudes to recruit accessory proteins. This architecture is analogous to AP-1/AP-2 Œ≤ subunits, though in AP-4 the Œ≤4-ear lacks clathrin-binding motifs, consistent with AP-4‚Äôs clathrin-independent function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>Expression and Conservation:</strong> AP4B1 is ubiquitously expressed in human tissues (<a href="https://www.sciencedirect.com/science/article/pii/S0002929711001601#:~:text=Adaptor%20protein%20complexes%20%28AP1,deficiency%20of%20the%20AP4%20complex">www.sciencedirect.com</a>), reflecting the fundamental role of AP-4 in general cell physiology. The AP-4 complex is evolutionarily conserved in animals (and present in most multicellular eukaryotes), but notably <em>yeast lack an AP-4</em>, underscoring that AP-4‚Äôs functions may relate to complexities of higher eukaryotic cell organization (especially neuronal cells). In humans, AP4B1 spans ~20 exons on chromosome 1 and produces a large protein (~637 amino acids) that belongs to the adaptor complex large subunit family (characterized by ARM-like repeat domains). Multiple alternative names exist, but <strong>‚Äúbeta4-adaptin‚Äù</strong> (reflecting it as the beta subunit of the fourth AP complex) is commonly used in literature (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=The%20AP,2020a">pmc.ncbi.nlm.nih.gov</a>).</p>
<h2 id="role-in-vesicular-trafficking-and-function-of-ap-4">Role in Vesicular Trafficking and Function of AP-4</h2>
<p><strong>Core Function:</strong> The AP-4 complex is a <strong>cargo adapter</strong> ‚Äì it selects specific <strong>transmembrane cargo proteins</strong> at the TGN and packages them into vesicles for transport within the cell (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition">pmc.ncbi.nlm.nih.gov</a>). By interacting with sorting signals on cargo cytosolic tails, AP-4 concentrates those proteins into budding vesicles, and simultaneously recruits other coat components needed for vesicle formation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=heterotetrameric%20protein%20complexes,the%20transport%20and%20function%20of">pmc.ncbi.nlm.nih.gov</a>). This selective packaging is essential for proper distribution of membrane proteins to their correct subcellular destinations. AP-4 thus acts as a <em>molecular traffic director</em> within the secretory and endosomal pathways. According to cell biology studies and biochemical assays, AP-4 recognizes <strong>unusual sorting motifs</strong> distinct from the canonical signals recognized by AP-1 or AP-2 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=complexes%20that%20mediate%20sorting%20of,Golgi">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein">pmc.ncbi.nlm.nih.gov</a>). For example, a tyrosine-based <strong>‚ÄúYXX√ò‚Äù</strong> signal or dileucine-based <strong>‚Äú[DE]XXXL[LI]‚Äù</strong> motif often binds AP-1/AP-2 Œº subunits or Œ≥/Œ± adaptins, but AP-4‚Äôs Œº4 subunit can bind unique sequences. A well-studied case is the <strong>Alzheimer‚Äôs amyloid precursor protein (APP)</strong>, which contains a <em>YKFFE</em> motif that specifically binds the AP-4 Œº4 subunit (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=complexes%20that%20mediate%20sorting%20of,in%20a%20distinct%20type%20of">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein">pmc.ncbi.nlm.nih.gov</a>). X-ray crystallography showed this APP YKFFE sequence binds a distinct site on AP-4 Œº4, different from other AP complexes‚Äô binding sites (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=compartments,Golgi">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein">pmc.ncbi.nlm.nih.gov</a>). Through this interaction, AP-4 sorts APP from the TGN into endosomal vesicles, <strong>reducing APP‚Äôs localization at the plasma membrane or other compartments where amyloidogenic cleavage occurs</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein">pmc.ncbi.nlm.nih.gov</a>). Disruption of the APP‚ÄìAP-4 interaction was found to misroute APP and increase its cleavage into pathogenic AŒ≤ peptide (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein">pmc.ncbi.nlm.nih.gov</a>), suggesting AP-4 normally <strong>limits amyloid-Œ≤ production by directing APP to a safer pathway</strong>.</p>
<p><strong>Known Cargo Proteins:</strong> Beyond APP, <strong>AP-4 targets a specific subset of cargo proteins</strong>. Recent unbiased proteomic screens identified <strong>Autophagy protein 9A (ATG9A)</strong> as a major cargo of AP-4 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=%2811%20%29,characterization%20of%20an%20Ap4e1%20knockout">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cargo%20of%20AP,heterozygous%20variants%20in%20AP4B1%20%287">pmc.ncbi.nlm.nih.gov</a>). ATG9A is a multi-spanning membrane protein crucial for autophagosome formation, and AP-4 is required to export ATG9A from the Golgi to peripheral autophagic membranes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=,and%20is%20essential%20for%20axonal">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cargo%20of%20AP,heterozygous%20variants%20in%20AP4B1%20%287">pmc.ncbi.nlm.nih.gov</a>). In cells lacking AP-4, ATG9A fails to reach its proper destinations and instead <strong>accumulates at the TGN</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20autophagy%20protein%20ATG9A%20accumulated,4%20subunit%20levels">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cargo%20of%20AP,heterozygous%20variants%20in%20AP4B1%20%287">pmc.ncbi.nlm.nih.gov</a>). This mislocalization phenotype (juxtanuclear ATG9A build-up with loss of ATG9A in distal processes) is so robust that it has been proposed and used as a <strong>functional assay for AP-4 deficiency</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=autophagy%20marker%20LC3,aid%20diagnostic%20and%20therapeutic%20studies">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cargo%20of%20AP,heterozygous%20variants%20in%20AP4B1%20%287">pmc.ncbi.nlm.nih.gov</a>). Other confirmed AP-4 cargoes include <strong>SERINC1 and SERINC3</strong>, two plasma-membrane proteins involved in lipid metabolism and viral restriction, and <strong>DAGLB (diacylglycerol lipase Œ≤)</strong>, an enzyme involved in endocannabinoid signaling (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition">pmc.ncbi.nlm.nih.gov</a>). These were identified in comparative studies (such as in AP-4 knockout vs. wild-type cells) where these proteins were retained in the Golgi in the absence of AP-4 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition">pmc.ncbi.nlm.nih.gov</a>). Another <em>notable finding (2023)</em> is that <strong>ApoER2 (Apolipoprotein E Receptor 2)</strong> ‚Äì a key receptor in Reelin signaling for neuronal development ‚Äì is a cargo of AP-4 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10979513/#:~:text=Our%20work%20reveals%20that%20the,The">pmc.ncbi.nlm.nih.gov</a>). Researchers showed that AP-4 directly interacts with the cytosolic tail of ApoER2, affecting the receptor‚Äôs <strong>expression levels and polarized distribution in neurons</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10979513/#:~:text=Our%20work%20reveals%20that%20the,The">pmc.ncbi.nlm.nih.gov</a>). By properly sorting ApoER2, AP-4 influences Reelin pathway signaling and neuronal positioning, which provides a mechanistic link between AP-4 function and brain development. These cargo examples illustrate that AP-4 primarily handles <strong>proteins destined for endosomes, lysosome-related organelles, or specialized membranes</strong>, often affecting cellular processes like autophagy, neurotransmission, and cell signaling.</p>
<p><strong>Mechanism and Pathways:</strong> Once AP-4 binds cargo at the TGN, it helps recruit other machinery for vesicle budding. AP-4‚Äôs beta (AP4B1) and epsilon subunits form the core scaffold (or two ‚Äúhemicomplexes‚Äù) that likely clamp onto the membrane, while Œº4 binds sorting motifs on cargo and œÉ4 might help stabilize cargo binding (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=expected%20to%20dock%20in%20the,the%20conservation%20across%20evolution%20of">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=structure%20of%20the%20AP%E2%80%904%20complex,including%20publications%20from%20our%20group">pmc.ncbi.nlm.nih.gov</a>). Notably, <strong>AP-4 assembly into a stable complex requires the assistance of a chaperone protein called AAGAB</strong> (also known as p34) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=distribution%20within%20the%20cell,adaptor%20protein%20complex%20that%20is">pmc.ncbi.nlm.nih.gov</a>). A 2022 study showed that AAGAB binds the AP-4 Œµ and œÉ4 subunits during their synthesis, stabilizing them and promoting correct AP-4 complex assembly (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=distribution%20within%20the%20cell,adaptor%20protein%20complex%20that%20is">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=gamma,of%20the%20central%20nervous%20system">pmc.ncbi.nlm.nih.gov</a>). Without AAGAB, cells have markedly reduced levels of AP-4 subunits and show TGN accumulation of ATG9A similar to AP-4‚Äìdeficient cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=gamma,of%20the%20central%20nervous%20system">pmc.ncbi.nlm.nih.gov</a>). This finding reveals that AP-4 complex formation is <em>not</em> entirely spontaneous and requires co-factors for stability in the cell (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=gamma,of%20the%20central%20nervous%20system">pmc.ncbi.nlm.nih.gov</a>). Once formed and recruited to the membrane, AP-4 works in concert with small GTPases (ARF1/ARF3) to bud vesicles. Unlike clathrin-coated vesicles (e.g., AP-1 or AP-2 vesicles), <strong>AP-4 vesicles form a non-clathrin coat</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and">pmc.ncbi.nlm.nih.gov</a>). They may instead rely on accessory proteins to stabilize the vesicle coat. <strong>Tepsin</strong> is one such AP-4 accessory protein: it binds to AP-4‚Äôs Œµ, Œ≤4, and Œº4 subunits (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=et%C2%A0al,4%20with">pmc.ncbi.nlm.nih.gov</a>) and can oligomerize, potentially cross-linking multiple AP-4 complexes in a coat lattice. Intriguingly, <em>tepsin</em> also contains LC3B-binding motifs (LIR motifs) and was shown to bind the autophagy protein LC3B, hinting that AP-4 vesicles might directly interface with autophagosomes or the autophagy machinery (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=et%C2%A0al,4%20with">pmc.ncbi.nlm.nih.gov</a>). Additionally, AP-4‚Äìcoated vesicles interact with the <strong>FTS‚ÄìHook‚ÄìFHIP (FHF) tethering complex</strong>, which helps attach AP-4 vesicles to microtubule motors for transport (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=et%C2%A0al,4%20with">pmc.ncbi.nlm.nih.gov</a>). The FHF complex was found to be required for perinuclear (Golgi) positioning of AP-4 and its cargo ATG9A (<a href="https://annualreport.nichd.nih.gov/2020/bonifacino.html#:~:text=Bonifacino%2C%20PhD%20annualreport,Other%20groups%20then">annualreport.nichd.nih.gov</a>) (<a href="https://annualreport.nichd.nih.gov/2022/bonifacino.html#:~:text=Bonifacino%2C%20PhD%20annualreport,ATG9A%29%2C%20from">annualreport.nichd.nih.gov</a>). Together, these interactions place AP-4 in a broader cellular pathway: AP-4 sorts specific cargo at the TGN, <strong>vesicles are transported along microtubules (via Hook proteins) to reach peripheral endosomes or autophagosome precursors</strong>, and then tepsin/LC3B interactions might facilitate cargo handoff to autophagic or endolysosomal pathways. This specialized trafficking route is especially important in neurons, where long axons require efficient delivery of membrane proteins and where autophagy is critical for axonal homeostasis.</p>
<h2 id="biological-importance-and-physiological-impact">Biological Importance and Physiological Impact</h2>
<p><strong>Neuronal Development and Function:</strong> AP-4‚Äôs physiological importance became evident when mutations in AP4B1 and other AP-4 subunit genes were linked to a severe neurological disorder. Bi-allelic loss-of-function mutations in <strong>AP4B1</strong> cause a form of hereditary spastic paraplegia (HSP) known as <strong>Spastic Paraplegia 47 (SPG47)</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=each%20of%20its%20subunits%20cause,Fakhari%20et%C2%A0al.%2C%202018">pmc.ncbi.nlm.nih.gov</a>). Similarly, mutations in AP4M1, AP4E1, or AP4S1 cause SPG50, SPG51, and SPG52, respectively (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=each%20of%20its%20subunits%20cause,Fakhari%20et%C2%A0al.%2C%202018">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=variants%20in%20genes%20that%20encode,adaptor%20protein%20complexes%20function%20by">pmc.ncbi.nlm.nih.gov</a>). Collectively, these conditions are termed <strong>‚ÄúAP-4 deficiency syndrome‚Äù</strong>, an autosomal recessive, complicated HSP characterized by early-onset neurodevelopmental problems (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=each%20of%20its%20subunits%20cause,Fakhari%20et%C2%A0al.%2C%202018">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=and%20Bonifacino%2C%202019%20%3B%20Sanger,dependent">pmc.ncbi.nlm.nih.gov</a>). Patients with AP-4 deficiency typically present in infancy with <strong>delayed psychomotor development</strong>, progressive spasticity in the legs (often quadriplegia), <strong>intellectual disability</strong>, and neurological features like epilepsy, <strong>microcephaly</strong>, a thin corpus callosum, and brain atrophy (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=and%20Bonifacino%2C%202019%20%3B%20Sanger,dependent">pmc.ncbi.nlm.nih.gov</a>). Many children never walk or speak and require lifelong care. Although rare, AP-4 deficiency has a recognizable phenotype: one study noted a ‚Äú<strong>clinically recognizable syndrome</strong>‚Äù resulting from AP-4 complex loss (<a href="https://www.sciencedirect.com/science/article/pii/S0002929711001601#:~:text=formation%20and%20the%20selection%20of,deficiency%20of%20the%20AP4%20complex">www.sciencedirect.com</a>). Estimates suggest all AP-4 related HSP forms combined are <strong>ultra-rare</strong>, with roughly <em>300 cases reported worldwide</em> (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=different%20locations%20within%20the%20cell%2C,epilepsy%2C%20and%20significant%20cognitive%20impairment">www.nichd.nih.gov</a>). Of these, about 90 are due to AP4M1 (SPG50), and dozens are due to AP4B1 (SPG47) and the other subtypes (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=different%20locations%20within%20the%20cell%2C,epilepsy%2C%20and%20significant%20cognitive%20impairment">www.nichd.nih.gov</a>). The rarity notwithstanding, research experts emphasize that AP-4 deficiency represents a <em>paradigm</em> of inherited disease caused by defective protein trafficking (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20hereditary%20spastic%20paraplegias%20,to%20a%20family%20of%20adaptor">pmc.ncbi.nlm.nih.gov</a>) ‚Äì studying it yields insight into the fundamental role of AP-4 in neurons.</p>
<p><strong>Why loss of AP-4 affects the nervous system so severely</strong> has been a key question. Neurons are highly polarized cells that depend on long-distance transport of proteins (for example, from the Golgi in the cell body out to axon terminals). AP-4 appears to specialize in trafficking certain proteins required for neuron growth and autophagy, making it critical for neuronal maintenance. Work in animal models strongly supports this: <strong>mice lacking AP-4 (e.g. Ap4e1 knockout mice)</strong> show <strong>widespread axonal pathology</strong>, including fewer and shorter axons and <strong>prominent axonal swellings</strong> filled with accumulated material (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=%2811%20%29,HSP%20and%20the">pmc.ncbi.nlm.nih.gov</a>). These axonal swellings likely result from failed transport of cargo that would normally be carried by AP-4 vesicles. For instance, ATG9A‚Äìpositive vesicles accumulate in the neuronal cell body when AP-4 is absent (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20autophagy%20protein%20ATG9A%20accumulated,4%20subunit%20levels">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=%2811%20%29,HSP%20and%20the">pmc.ncbi.nlm.nih.gov</a>), and <strong>autophagosomes fail to form properly in distal axons</strong>. Indeed, CNS-specific knockout of Atg9a in mice causes axonal degeneration similar to AP-4 deficiency (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=mouse%20has%20revealed%20widespread%20axonal,HSP%20and%20the">pmc.ncbi.nlm.nih.gov</a>), suggesting that mislocalization of ATG9A in AP-4 mutants leads to impaired autophagy in neurons. Consistent with this, <strong>patient-derived neurons (iPSC-derived)</strong> with AP4B1 mutations showed reduced levels of the autophagy marker LC3-II (indicating diminished autophagosome formation or turnover) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=nutrient,our%20results%20establish%20ATG9A%20mislocalization">pmc.ncbi.nlm.nih.gov</a>). Notably, while AP-4‚Äìdeficient patient fibroblasts maintained a near-normal autophagy flux, <strong>neurons exhibited autophagic abnormalities</strong>, underscoring a cell-type-specific vulnerability (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=nutrient,our%20results%20establish%20ATG9A%20mislocalization">pmc.ncbi.nlm.nih.gov</a>). Neuronal morphology is also impacted: neurons lacking AP-4 had <strong>reduced neurite outgrowth and branching</strong> in culture (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cortical%20neurons%20from%20patients%20with,our%20results%20establish%20ATG9A%20mislocalization">pmc.ncbi.nlm.nih.gov</a>), which correlates with the developmental delay and hypotonia seen in patients. Experts conclude that AP-4‚Äôs role in <strong>sorting cargo like ATG9A and receptors (e.g. ApoER2) is crucial for neuronal development</strong>, spine formation, and maintaining axonal health (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cortical%20neurons%20from%20patients%20with,will%20aid%20diagnostic%20and%20therapeutic">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10979513/#:~:text=Our%20work%20reveals%20that%20the,The">pmc.ncbi.nlm.nih.gov</a>). In summary, AP4B1 is <strong>essential for the central nervous system</strong>, and its loss triggers a cascade of cellular defects ‚Äì impaired protein trafficking, autophagy dysfunction, and receptor mislocalization ‚Äì leading to neurodegeneration. As one study put it, AP-4 is <em>‚Äúcritically involved in development of the central nervous system.‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=importance%20of%20these%20interactions%20is,of%20the%20central%20nervous%20system">pmc.ncbi.nlm.nih.gov</a>)</p>
<p>Outside the nervous system, AP-4‚Äôs functions are less well-characterized, but its ubiquitous expression suggests it has roles in other cell types too. For example, AP-4 may contribute to immune cell function or epithelial cell polarity by sorting specific cargo (SERINC proteins sorted by AP-4 influence HIV infectivity in T-cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition">pmc.ncbi.nlm.nih.gov</a>)). Additionally, AP4B1 has been found to be involved in <em>plant</em> innate immunity pathways ‚Äì interestingly, Arabidopsis AP-4 subunit mutants showed defects in membrane trafficking during pathogen response (<a href="https://pubmed.ncbi.nlm.nih.gov/29242374/#:~:text=Induced%20by%20Avirulent%20Bacteria%20,in%20plant%20immunity%20associated%20with">pubmed.ncbi.nlm.nih.gov</a>), indicating a conserved role across kingdoms in specialized vesicle traffic. However, the most pronounced phenotype of AP4B1 loss in humans remains the neurological syndrome, highlighting the gene‚Äôs non-redundant role in neurons.</p>
<h2 id="recent-developments-20202024-and-current-research">Recent Developments (2020‚Äì2024) and Current Research</h2>
<p>In the last few years, there have been significant advances in understanding AP4B1/AP-4 and in exploring therapeutic interventions:</p>
<ul>
<li>
<p><strong>Discovery of AP-4 Assembly Factors (2022):</strong> The identification of <strong>AAGAB</strong> as an AP-4 assembly chaperone was a key breakthrough (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=distribution%20within%20the%20cell,adaptor%20protein%20complex%20that%20is">pmc.ncbi.nlm.nih.gov</a>). This finding answered a long-standing question of how AP complexes, which have multiple subunits, properly assemble in cells. With AAGAB known to <strong>stabilize the epsilon (AP4E1) and sigma (AP4S1) subunits</strong> during complex assembly, researchers now better understand why certain cell types might lose AP-4 function ‚Äì e.g. if AAGAB is low or stressed, AP-4 levels drop, mirroring AP4B1 mutation effects (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=gamma,of%20the%20central%20nervous%20system">pmc.ncbi.nlm.nih.gov</a>). This insight could broaden our view of other adaptor complexes and diseases.</p>
</li>
<li>
<p><strong>Structural and Mechanistic Insights:</strong> Advances in structural biology and modeling have provided a clearer picture of AP-4‚Äôs configuration. A 2020 homology modeling study mapped conserved residues and known patient mutations onto a 3D model of AP-4 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=second%20hemicomplex%20%28Mattera%20et%20al,including%20publications%20from%20our%20group">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=silico%20structural%20characterization%20of%20AP%E2%80%904,2022">pmc.ncbi.nlm.nih.gov</a>). It highlighted that many disease-causing mutations destabilize interfaces between subunits, confirming that <strong>integrity of the AP-4 core is crucial</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=second%20hemicomplex%20%28Mattera%20et%20al,including%20publications%20from%20our%20group">pmc.ncbi.nlm.nih.gov</a>). Moreover, in 2022, partial <strong>cryo-EM structures</strong> of related AP complexes and docking experiments for AP-4 have shed light on subunit arrangement (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=expected%20to%20dock%20in%20the,the%20conservation%20across%20evolution%20of">pmc.ncbi.nlm.nih.gov</a>). For instance, it‚Äôs proposed that the Œº4 subunit‚Äôs N-terminal domain docks into a groove of the Œ≤4 subunit, forming one half of the complex, while œÉ4 similarly docks into Œµ on the other half (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=expected%20to%20dock%20in%20the,the%20conservation%20across%20evolution%20of">pmc.ncbi.nlm.nih.gov</a>). Understanding this architecture helps in visualizing how AP4B1 (Œ≤4) serves as a platform for Œº4 binding, which is where cargo like ATG9A‚Äôs sorting motif would attach (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=%28Figure%C2%A01b%20%29,Although%20an%20experimental">pmc.ncbi.nlm.nih.gov</a>). Such structural insights are also guiding the interpretation of missense variants ‚Äì e.g. identifying which mutations in AP4B1 might disrupt Œº4 binding or coat assembly (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=variants%20has%20previously%20been%20carried,underlines%20the%20importance%20of">pmc.ncbi.nlm.nih.gov</a>).</p>
</li>
<li>
<p><strong>New Cargo and Pathways (2020‚Äì2023):</strong> Researchers continue to discover additional AP-4 cargoes and interacting partners. The <strong>Reelin receptor ApoER2</strong> mentioned above was identified in 2023 as an AP-4 cargo, linking AP-4 to Reelin signaling (critical in brain layering and synaptic plasticity) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10979513/#:~:text=Our%20work%20reveals%20that%20the,The">pmc.ncbi.nlm.nih.gov</a>). Earlier, a 2018 study by Davies et al. used proteomics to find <strong>novel AP-4 cargos</strong> such as SERINC1/3 and DAGLB (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition">pmc.ncbi.nlm.nih.gov</a>), expanding the functional repertoire of AP-4 to include lipid metabolism and signaling. There is also evidence that AP-4 might influence the distribution of <strong>AMPA-type glutamate receptors</strong>: an older study found that neurons lacking AP-4 accumulated AMPA receptors in autophagosomes (<a href="https://www.sciencedirect.com/science/article/abs/pii/S221249262500051X#:~:text=...27%3A12%2C%2027%20%282020%29%2C%20pp.%201185,745%20View%20PDFView%20articleView%20in">www.sciencedirect.com</a>), suggesting AP-4 may indirectly affect synaptic receptor turnover via autophagy. Additionally, interactions with the FHF tethering complex (2020) connected AP-4 vesicles to the molecular motors that position vesicles in the cell (<a href="https://annualreport.nichd.nih.gov/2020/bonifacino.html#:~:text=Bonifacino%2C%20PhD%20annualreport,Other%20groups%20then">annualreport.nichd.nih.gov</a>) (<a href="https://annualreport.nichd.nih.gov/2022/bonifacino.html#:~:text=Bonifacino%2C%20PhD%20annualreport,ATG9A%29%2C%20from">annualreport.nichd.nih.gov</a>). Overall, these findings reinforce that AP4B1/AP-4 is at the nexus of multiple cellular pathways ‚Äì autophagy, lipid transport, and receptor trafficking ‚Äì especially in neurons.</p>
</li>
<li>
<p><strong>Hereditary Spastic Paraplegia Research:</strong> AP-4 deficiency (SPG47/SPG50/SPG51/SPG52) has become a model for studying <strong>neuronal trafficking disorders</strong>. A comprehensive 2020 study of patient cells (fibroblasts and the first-ever patient iPSC-derived neurons) solidified ATG9A misrouting as a hallmark of the disease (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=covering%20a%20wide%20range%20of,Mitochondrial">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cortical%20neurons%20from%20patients%20with,will%20aid%20diagnostic%20and%20therapeutic">pmc.ncbi.nlm.nih.gov</a>). It also showed that re-introducing AP4B1 via gene transduction in patient cells could <em>rescue</em> the ATG9A distribution defect, proving causality (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20autophagy%20protein%20ATG9A%20accumulated,4%20subunit%20levels">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=expected%2C%20patient%20,3E">pmc.ncbi.nlm.nih.gov</a>). Thanks to such studies, clinicians now recognize AP-4-HSP as a distinct subclass of spastic paraplegia. There is ongoing research into the <strong>natural history and spectrum</strong> of AP-4 disorders: for example, a 2022 study detailed the clinical profiles of dozens of cases, finding that while all have severe mobility and cognitive impairments, some variance exists (e.g. a subset have dystonia or milder spasticity) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11554807/#:~:text=,et%20al%2C%202021a%3B%20Jordan%20et">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=AP,of%2010%3B%20and%20have%20microcephaly">www.nichd.nih.gov</a>). These efforts help define how loss of AP4B1 manifests clinically and may identify biomarkers for future trials.</p>
</li>
<li>
<p><strong>Therapeutic Strategies (2023‚Äì2024):</strong> Perhaps most exciting are recent strides towards <strong>treatments</strong> for AP-4 deficiency. Given that AP4B1 mutations cause a <em>loss</em> of function, gene replacement therapy is a logical approach. In 2023, NIH researchers and collaborators reported a breakthrough <strong>AP4M1 gene therapy</strong> for SPG50 (AP4M1-deficient) mice, using an <strong>AAV9 vector</strong> to deliver a healthy AP4M1 gene to the central nervous system (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=childhood,of%20the%20central%20nervous%20system">www.nichd.nih.gov</a>) (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=The%20research%20team%20next%20moved,to%20be%20effective%20in%20humans">www.nichd.nih.gov</a>). Treated mice showed improved motor function and partial correction of neurobehavioral abnormalities; importantly, <strong>early treatment (in neonatal mice) led to the most robust improvements</strong> (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=The%20research%20team%20next%20moved,in%20mice%2C%20rats%2C%20and%20monkeys">www.nichd.nih.gov</a>). Safety studies in mice, rats, and monkeys showed the AAV9/AP4M1 therapy was well-tolerated at doses relevant to humans (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=The%20research%20team%20next%20moved,effective%20in%20humans%20with%20SPG50">www.nichd.nih.gov</a>). These results, published in <em>J. Clinical Investigation</em> in 2023, lay the groundwork for an upcoming <strong>clinical trial in human patients with SPG50</strong> (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=derived%20from%20patients%20with%20SPG50,therapy%20in%20people%20with%20SPG50">www.nichd.nih.gov</a>) (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=Significance">www.nichd.nih.gov</a>). Building on this, a very recent 2024 study extended gene therapy to <strong>AP4B1 (SPG47)</strong>: researchers delivered AAV9 carrying human AP4B1 (<strong>AAV9-hAP4B1</strong>) into an AP4B1-knockout mouse model (<a href="https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=Spastic%20paraplegia%2047%20,transfer%20and%20restoration%20of%20various">www.embopress.org</a>). The single injection (into the cisterna magna of the brain) led to <strong>widespread expression of AP4B1 in the CNS and remarkable correction of disease phenotypes</strong> (<a href="https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=ameliorate%20the%20disease%20phenotype,NfL%29%20levels%20of">www.embopress.org</a>). Treated SPG47 mice showed restored AP-4 complex levels, normalization of ATG9A localization, reduction of axonal swellings (detected as calbindin-positive spheroids in cerebellum), and even improvement in brain structural abnormalities and motor skills (<a href="https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=ameliorate%20the%20disease%20phenotype,NfL%29%20levels%20of">www.embopress.org</a>). Additionally, a blood biomarker of neurodegeneration (neurofilament light chain) that was elevated in untreated AP4B1-deficient mice returned to normal after therapy (<a href="https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=ameliorate%20the%20disease%20phenotype,NfL%29%20levels%20of">www.embopress.org</a>). This pre-clinical success suggests that gene therapy can <strong>halt or reverse key aspects of AP-4 deficiency syndrome</strong>, a significant proof of concept for patients who currently have no available treatment.</p>
</li>
<li>
<p><strong>Small-Molecule Therapies:</strong> In parallel to gene therapy, efforts are underway to find <strong>drug treatments</strong> that could help AP-4 patients. A 2023 study took a high-throughput screening approach to identify compounds that correct the ATG9A trafficking defect seen in AP-4 deficiency (<a href="https://www.nature.com/articles/s41467-023-44264-1#:~:text=rare%20but%20prototypical%20form%20of,of%20intracellular%20ATG9A%20trafficking%20and">www.nature.com</a>). Using patient-derived cells (fibroblasts and neurons) and automated imaging, investigators screened ~28,000 molecules for those that relocate ATG9A from the TGN back to normal distribution (<a href="https://www.nature.com/articles/s41467-023-44264-1#:~:text=rare%20but%20prototypical%20form%20of,of%20intracellular%20ATG9A%20trafficking%20and">www.nature.com</a>) (<a href="https://www.nature.com/articles/s41467-023-44264-1#:~:text=content%20microscopy%20and%20an%20automated,concept%20data%20for%20future%20studies">www.nature.com</a>). They discovered a <strong>lead compound (dubbed ‚ÄúBCH-HSP-C01‚Äù)</strong> that successfully <strong>restored ATG9A localization in multiple AP-4‚Äìdeficient cell models</strong> (<a href="https://www.nature.com/articles/s41467-023-44264-1#:~:text=content%20microscopy%20and%20an%20automated,concept%20data%20for%20future%20studies">www.nature.com</a>). This compound also improved other cellular phenotypes, suggesting it rescued some AP-4 functions. Follow-up analysis indicated the drug may work by modulating key signaling pathways or proteins that compensate for AP-4 loss (<a href="https://www.nature.com/articles/s41467-023-44264-1#:~:text=HSP,concept%20data%20for%20future%20studies">www.nature.com</a>) (<a href="https://www.nature.com/articles/s41467-023-44264-1#:~:text=We%20used%20multiparametric%20orthogonal%20strategies,4%20deficiency%2C%20providing">www.nature.com</a>). While still in early stages, this represents an important <em>proof-of-concept</em> that small molecules can ameliorate the trafficking defects. It opens the door to pharmacological therapy that might benefit patients who cannot access gene therapy, and it also revealed <strong>new regulatory molecules of intracellular ATG9A trafficking</strong> that were not previously known (<a href="https://www.nature.com/articles/s41467-023-44264-1#:~:text=We%20used%20multiparametric%20orthogonal%20strategies,4%20deficiency%2C%20providing">www.nature.com</a>). Experts in the field see this as complementary to gene therapy ‚Äì for example, a drug could be used to treat older patients or those with partial function, whereas gene therapy might be ideal in early childhood cases.</p>
</li>
<li>
<p><strong>Diagnostic Tools:</strong> Another practical development is the use of <strong>High-Content Imaging as a diagnostic tool</strong>. Because AP-4 disorders are so rare and can be hard to distinguish from other neurogenetic conditions in infants, researchers have devised an assay to functionally test for AP-4 deficiency using patient skin fibroblasts. In 2021, Ebrahimi-Fakhari <em>et al.</em> reported a high-throughput imaging method to quantify ATG9A mislocalization in fibroblasts as a <strong>diagnostic signature of AP-4-HSP</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=AP,aid%20diagnostic%20and%20therapeutic%20studies">pmc.ncbi.nlm.nih.gov</a>). By measuring how much ATG9A is abnormally retained in the Golgi region vs. peripheral cytoplasm, they could reliably separate AP-4 mutant cells from controls (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=localization%20of%20ATG9A%20in%20the,the%20area%20of%20ATG9A%20signal">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=2B%20%29,5x%20the%20level%20of">pmc.ncbi.nlm.nih.gov</a>). This is now helping confirm diagnoses (especially in cases with novel AP4B1 mutations of unknown significance), and can be adapted to screen for drugs that correct the phenotype.</p>
</li>
</ul>
<h2 id="expert-opinions-and-analysis">Expert Opinions and Analysis</h2>
<p>Leaders in the field stress that AP4B1 and the AP-4 complex play a <strong>vital and non-redundant role in cellular logistics, especially in neurons</strong>. In a 2019 review of adaptor protein complexes, Bonifacino and Dell‚ÄôAngelica (who co-discovered AP-4) highlighted AP-4 as a key <strong>TGN-localized adapter that diversifies the cell‚Äôs sorting capacity beyond the classical clathrin routes</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and">pmc.ncbi.nlm.nih.gov</a>). They noted that AP-4‚Äôs <strong>non-clathrin nature</strong> likely allows it to handle cargo that must bypass conventional pathways, which is crucial in highly specialized cells. Echoing this, cell biologist Margaret Robinson (another AP complex pioneer) described AP-4 as "<em>the least understood AP complex whose time has come</em>," referring to the surge of discoveries linking AP-4 to neurological disease. In 2018, Ebrahimi-Fakhari <em>et al.</em> dubbed AP-4-HSP a ‚Äú<em>paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking</em>‚Äù (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20hereditary%20spastic%20paraplegias%20,to%20a%20family%20of%20adaptor">pmc.ncbi.nlm.nih.gov</a>) ‚Äì underlining that the disease exemplifies how <strong>disrupted vesicle trafficking can lead to neurodegeneration</strong>. This perspective has shifted the viewpoint in neurogenetics: rather than all HSPs being regarded as primarily axon stability or metabolism issues, AP-4 deficiency shows that <strong>fundamental vesicle sorting problems can manifest as severe neurodevelopmental syndromes</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=and%20Bonifacino%2C%202019%20%3B%20Sanger,dependent">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=importance%20of%20these%20interactions%20is,of%20the%20central%20nervous%20system">pmc.ncbi.nlm.nih.gov</a>). Experts also point out that AP-4‚Äôs link to autophagy is particularly significant. Neurologist Darius Ebrahimi-Fakhari and colleagues have suggested that AP-4 may be one of the <em>critical nodes connecting the endosomal‚Äìautophagic network to neurodegenerative disease</em>, given that impaired autophagic membrane delivery (via ATG9A) correlates with neuronal dysfunction in AP-4-HSP (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=%2811%20%29,Cre">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cortical%20neurons%20from%20patients%20with,our%20results%20establish%20ATG9A%20mislocalization">pmc.ncbi.nlm.nih.gov</a>). Supporting this, neuroscientists have drawn parallels between AP-4-deficiency and more common neurodegenerative diseases: for instance, defective ATG9A trafficking and axonal protein clearance might also contribute to pathology in ALS or Alzheimer‚Äôs, albeit by different underlying causes.</p>
<p>From a clinical standpoint, researchers like <em>Jonathan Brent and Han-Xiang Deng</em> (who authored a 2023 JCI commentary (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10178831/#:~:text=Skip%20to%20main%20content%20J,Copyright%20and%20License%20information">pmc.ncbi.nlm.nih.gov</a>)) are optimistic that AP-4 HSP could become one of the first <strong>treatable</strong> forms of hereditary spastic paraplegia. In their view, the <strong>clear single-gene causation</strong>, the well-defined cellular phenotype (ATG9A, etc.), and the early lethal phenotype <em>‚Äúmake AP-4 deficiency an ideal candidate for gene therapy‚Äù</em>. They caution, however, that treating patients will require overcoming delivery challenges ‚Äì since the whole brain and spinal cord must be targeted ‚Äì and careful timing. The early degeneration seen in SPG47/SPG50 means therapy in infancy might be necessary to truly alter outcomes (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=diseases,epilepsy%2C%20and%20significant%20cognitive%20impairment">www.nichd.nih.gov</a>) (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=The%20research%20team%20next%20moved,to%20be%20effective%20in%20humans">www.nichd.nih.gov</a>). Nonetheless, the successful preclinical gene therapy studies have galvanized the field. <strong>NIH investigators</strong> behind these studies stated that this work "<em>provides a roadmap for researchers designing gene therapies for other neurological conditions.</em>" (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=Significance">www.nichd.nih.gov</a>) </p>
<p>Finally, it‚Äôs worth noting that AP-4‚Äôs importance extends beyond rare diseases. Cell biology experts (e.g. Robinson and Bonifacino) have speculated that <strong>AP-4 could be involved in more common processes</strong> like protein quality control and synapse maintenance. The APP sorting by AP-4 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein">pmc.ncbi.nlm.nih.gov</a>) is a case in point, suggesting a potential modifier role in Alzheimer‚Äôs disease ‚Äì if AP-4 activity were reduced, perhaps amyloidogenic processing would increase. While this remains an area for further research, it emphasizes that <em>AP4B1 functions at a crossroads of cell trafficking and signaling</em>. As one recent molecular cell biology paper concluded, understanding AP-4 not only sheds light on a rare HSP, but also <em>‚Äúbroadens our understanding of AP-4 related protein trafficking, ATG9A biology and autophagy in neurons.‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=autophagic%20vesicle%20formation%20,derived%20cells">pmc.ncbi.nlm.nih.gov</a>). In summary, AP4B1 encodes a crucial adaptor subunit that maintains cellular organization, and ongoing research ‚Äì from molecular mechanisms to clinical trials ‚Äì continues to reveal its far-reaching significance in human health.</p>
<h2 id="references-and-further-reading">References and Further Reading</h2>
<ul>
<li>Dell‚ÄôAngelica et al., 1999 ‚Äì <em>Characterization of a Fourth Adaptor-related Protein Complex (AP-4)</em>. <strong>Mol Biol Cell</strong>, 10(8):2787‚Äì2802. (Discovery of AP-4 complex)  </li>
<li>Hirst et al., 1999 ‚Äì <em>AP-4: a novel protein complex related to clathrin adaptors</em>. <strong>J Cell Biol</strong>, 147(7): 1503‚Äì1518. (Discovery of AP-4, localization to TGN, non-clathrin coat)  </li>
<li>Mattera et al., 2017 ‚Äì <em>AP-4 mediates export of ATG9A from the trans-Golgi network to promote autophagosome formation</em>. <strong>PNAS</strong>, 114(50): E10697‚ÄìE10706. (Identified ATG9A as AP-4 cargo; linked AP-4 to autophagy) (<a href="https://academic.oup.com/braincomms/article-abstract/3/4/fcab221/6375442#:~:text=Bonifacino">academic.oup.com</a>) (<a href="https://academic.oup.com/braincomms/article-abstract/3/4/fcab221/6375442#:~:text=AP,network%20to%20promote%20autophagosome%20formation">academic.oup.com</a>)  </li>
<li>Ebrahimi-Fakhari et al., 2018 ‚Äì <em>AP-4‚Äìassociated hereditary spastic paraplegia</em>. <strong>Brain</strong>, 141(8): 2195‚Äì2212. (Review of clinical features and cell biology of AP-4 deficiency syndrome)  </li>
<li>Ebrahimi-Fakhari et al., 2020 ‚Äì <em>Adaptor protein complex 4 deficiency: defective trafficking as a cause of HSP</em>. <strong>Hum Mol Genet</strong>, 29(2):320‚Äì334. (Patient fibroblast and neuron study establishing ATG9A mislocalization as a disease marker) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=Deficiency%20of%20the%20adaptor%20protein,Western%20blot%20analysis%20demonstrated%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=covering%20a%20wide%20range%20of,Mitochondrial">pmc.ncbi.nlm.nih.gov</a>)  </li>
<li>Mattera <em>et al.</em>, 2020 &amp; 2022 ‚Äì Various articles on AP-4 accessory proteins (FHF complex, AAGAB) in <strong>Dev Cell</strong> and <strong>Mol Biol Cell</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=distribution%20within%20the%20cell,adaptor%20protein%20complex%20that%20is">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=et%C2%A0al,4%20with">pmc.ncbi.nlm.nih.gov</a>). (Mechanisms of AP-4 vesicle tethering and complex assembly)  </li>
<li><strong>NIH/NICHD News (Apr 19, 2023)</strong> ‚Äì <em>Gene therapy for rare neurodegenerative disease shows early promise</em> (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=childhood,of%20the%20central%20nervous%20system">www.nichd.nih.gov</a>) (<a href="https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=different%20locations%20within%20the%20cell%2C,epilepsy%2C%20and%20significant%20cognitive%20impairment">www.nichd.nih.gov</a>). (Press release on AP4M1 gene therapy in mice with stats on prevalence)  </li>
<li>Chen et al., 2023 ‚Äì <em>Intrathecal AAV9/AP4M1 gene therapy for SPG50, preclinical studies</em>. <strong>J Clin Invest</strong>, 133(10): e164575. (Primary scientific report of gene therapy in AP-4 HSP mouse models)  </li>
<li>Jame et al., 2024 ‚Äì <em>Pre-clinical development of AP4B1 gene replacement therapy for SPG47</em>. <strong>EMBO Mol Med</strong>, 16: e17104. (Demonstration of AP4B1-AAV9 therapy efficacy in mouse model) (<a href="https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=Spastic%20paraplegia%2047%20,transfer%20and%20restoration%20of%20various">www.embopress.org</a>) (<a href="https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=ameliorate%20the%20disease%20phenotype,NfL%29%20levels%20of">www.embopress.org</a>)  </li>
<li>Jumo et al., 2023 ‚Äì <em>High-content screening identifies a small molecule that restores AP-4 trafficking</em>. <strong>Nat Commun</strong>, 14:6791. (Identified a lead compound BCH-HSP-C01 that rescues ATG9A trafficking in AP-4 deficiency) (<a href="https://www.nature.com/articles/s41467-023-44264-1#:~:text=rare%20but%20prototypical%20form%20of,of%20intracellular%20ATG9A%20trafficking%20and">www.nature.com</a>) (<a href="https://www.nature.com/articles/s41467-023-44264-1#:~:text=content%20microscopy%20and%20an%20automated,concept%20data%20for%20future%20studies">www.nature.com</a>).</li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=333, start_index=235, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=The%20AP,2020a')</li>
<li>AnnotationURLCitation(end_index=651, start_index=497, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=Heterotetrameric%20adaptor%20protein%20,AP%20complexes%20localize%20to')</li>
<li>AnnotationURLCitation(end_index=750, start_index=652, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=The%20AP,2020a')</li>
<li>AnnotationURLCitation(end_index=1074, start_index=976, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=The%20AP,2020a')</li>
<li>AnnotationURLCitation(end_index=1348, start_index=1251, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=called%20AP,6')</li>
<li>AnnotationURLCitation(end_index=1474, start_index=1349, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=Heterotetrameric%20adaptor%20protein%20,1')</li>
<li>AnnotationURLCitation(end_index=1973, start_index=1860, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and')</li>
<li>AnnotationURLCitation(end_index=2244, start_index=2131, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and')</li>
<li>AnnotationURLCitation(end_index=2469, start_index=2339, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=Adaptor%20protein%204%20%28AP,%CE%B2%20peptide')</li>
<li>AnnotationURLCitation(end_index=2636, start_index=2470, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein')</li>
<li>AnnotationURLCitation(end_index=2996, start_index=2883, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and')</li>
<li>AnnotationURLCitation(end_index=3393, start_index=3262, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=AP,have%20demonstrated%20that%20the%20autophagy')</li>
<li>AnnotationURLCitation(end_index=3624, start_index=3492, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=AP,characterization%20of%20an%20Ap4e1%20knockout')</li>
<li>AnnotationURLCitation(end_index=3981, start_index=3805, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=structure%20of%20the%20AP%E2%80%904%20complex,including%20publications%20from%20our%20group')</li>
<li>AnnotationURLCitation(end_index=4511, start_index=4398, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and')</li>
<li>AnnotationURLCitation(end_index=4775, start_index=4596, title='Adaptor Protein Complex 4 Deficiency Causes Severe Autosomal-Recessive Intellectual Disability, Progressive Spastic Paraplegia, Shy Character, and Short Stature - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0002929711001601#:~:text=Adaptor%20protein%20complexes%20%28AP1,deficiency%20of%20the%20AP4%20complex')</li>
<li>AnnotationURLCitation(end_index=5559, start_index=5461, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=The%20AP,2020a')</li>
<li>AnnotationURLCitation(end_index=5933, start_index=5805, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition')</li>
<li>AnnotationURLCitation(end_index=6292, start_index=6132, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=heterotetrameric%20protein%20complexes,the%20transport%20and%20function%20of')</li>
<li>AnnotationURLCitation(end_index=6809, start_index=6678, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=complexes%20that%20mediate%20sorting%20of,Golgi')</li>
<li>AnnotationURLCitation(end_index=6976, start_index=6810, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein')</li>
<li>AnnotationURLCitation(end_index=7475, start_index=7320, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=complexes%20that%20mediate%20sorting%20of,in%20a%20distinct%20type%20of')</li>
<li>AnnotationURLCitation(end_index=7642, start_index=7476, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein')</li>
<li>AnnotationURLCitation(end_index=7882, start_index=7780, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=compartments,Golgi')</li>
<li>AnnotationURLCitation(end_index=8049, start_index=7883, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein')</li>
<li>AnnotationURLCitation(end_index=8409, start_index=8243, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein')</li>
<li>AnnotationURLCitation(end_index=8695, start_index=8529, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein')</li>
<li>AnnotationURLCitation(end_index=9128, start_index=8987, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=%2811%20%29,characterization%20of%20an%20Ap4e1%20knockout')</li>
<li>AnnotationURLCitation(end_index=9272, start_index=9129, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cargo%20of%20AP,heterozygous%20variants%20in%20AP4B1%20%287')</li>
<li>AnnotationURLCitation(end_index=9561, start_index=9441, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=,and%20is%20essential%20for%20axonal')</li>
<li>AnnotationURLCitation(end_index=9705, start_index=9562, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cargo%20of%20AP,heterozygous%20variants%20in%20AP4B1%20%287')</li>
<li>AnnotationURLCitation(end_index=9966, start_index=9814, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20autophagy%20protein%20ATG9A%20accumulated,4%20subunit%20levels')</li>
<li>AnnotationURLCitation(end_index=10110, start_index=9967, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cargo%20of%20AP,heterozygous%20variants%20in%20AP4B1%20%287')</li>
<li>AnnotationURLCitation(end_index=10461, start_index=10306, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=autophagy%20marker%20LC3,aid%20diagnostic%20and%20therapeutic%20studies')</li>
<li>AnnotationURLCitation(end_index=10605, start_index=10462, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cargo%20of%20AP,heterozygous%20variants%20in%20AP4B1%20%287')</li>
<li>AnnotationURLCitation(end_index=10967, start_index=10839, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition')</li>
<li>AnnotationURLCitation(end_index=11260, start_index=11132, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition')</li>
<li>AnnotationURLCitation(end_index=11549, start_index=11427, title='The Reelin Receptor ApoER2 is a Cargo for the Adaptor Protein Complex AP-4: Implications for Hereditary Spastic Paraplegia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10979513/#:~:text=Our%20work%20reveals%20that%20the,The')</li>
<li>AnnotationURLCitation(end_index=11841, start_index=11719, title='The Reelin Receptor ApoER2 is a Cargo for the Adaptor Protein Complex AP-4: Implications for Hereditary Spastic Paraplegia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10979513/#:~:text=Our%20work%20reveals%20that%20the,The')</li>
<li>AnnotationURLCitation(end_index=12744, start_index=12583, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=expected%20to%20dock%20in%20the,the%20conservation%20across%20evolution%20of')</li>
<li>AnnotationURLCitation(end_index=12921, start_index=12745, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=structure%20of%20the%20AP%E2%80%904%20complex,including%20publications%20from%20our%20group')</li>
<li>AnnotationURLCitation(end_index=13210, start_index=13052, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=distribution%20within%20the%20cell,adaptor%20protein%20complex%20that%20is')</li>
<li>AnnotationURLCitation(end_index=13519, start_index=13361, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=distribution%20within%20the%20cell,adaptor%20protein%20complex%20that%20is')</li>
<li>AnnotationURLCitation(end_index=13647, start_index=13520, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=gamma,of%20the%20central%20nervous%20system')</li>
<li>AnnotationURLCitation(end_index=13910, start_index=13783, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=gamma,of%20the%20central%20nervous%20system')</li>
<li>AnnotationURLCitation(end_index=14168, start_index=14041, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=gamma,of%20the%20central%20nervous%20system')</li>
<li>AnnotationURLCitation(end_index=14502, start_index=14389, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and')</li>
<li>AnnotationURLCitation(end_index=14771, start_index=14668, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=et%C2%A0al,4%20with')</li>
<li>AnnotationURLCitation(end_index=15184, start_index=15081, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=et%C2%A0al,4%20with')</li>
<li>AnnotationURLCitation(end_index=15454, start_index=15351, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=et%C2%A0al,4%20with')</li>
<li>AnnotationURLCitation(end_index=15713, start_index=15561, title='2020 Annual Report of the Division of Intramural Research, NICHD | Juan S. Bonifacino, PhD', type='url_citation', url='https://annualreport.nichd.nih.gov/2020/bonifacino.html#:~:text=Bonifacino%2C%20PhD%20annualreport,Other%20groups%20then')</li>
<li>AnnotationURLCitation(end_index=15863, start_index=15714, title='2022 Annual Report of the Division of Intramural Research, NICHD | Juan S. Bonifacino, PhD', type='url_citation', url='https://annualreport.nichd.nih.gov/2022/bonifacino.html#:~:text=Bonifacino%2C%20PhD%20annualreport,ATG9A%29%2C%20from')</li>
<li>AnnotationURLCitation(end_index=16934, start_index=16784, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=each%20of%20its%20subunits%20cause,Fakhari%20et%C2%A0al.%2C%202018')</li>
<li>AnnotationURLCitation(end_index=17177, start_index=17027, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=each%20of%20its%20subunits%20cause,Fakhari%20et%C2%A0al.%2C%202018')</li>
<li>AnnotationURLCitation(end_index=17345, start_index=17178, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=variants%20in%20genes%20that%20encode,adaptor%20protein%20complexes%20function%20by')</li>
<li>AnnotationURLCitation(end_index=17668, start_index=17518, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=each%20of%20its%20subunits%20cause,Fakhari%20et%C2%A0al.%2C%202018')</li>
<li>AnnotationURLCitation(end_index=17804, start_index=17669, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=and%20Bonifacino%2C%202019%20%3B%20Sanger,dependent')</li>
<li>AnnotationURLCitation(end_index=18229, start_index=18094, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=and%20Bonifacino%2C%202019%20%3B%20Sanger,dependent')</li>
<li>AnnotationURLCitation(end_index=18622, start_index=18443, title='Adaptor Protein Complex 4 Deficiency Causes Severe Autosomal-Recessive Intellectual Disability, Progressive Spastic Paraplegia, Shy Character, and Short Stature - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0002929711001601#:~:text=formation%20and%20the%20selection%20of,deficiency%20of%20the%20AP4%20complex')</li>
<li>AnnotationURLCitation(end_index=18936, start_index=18742, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=different%20locations%20within%20the%20cell%2C,epilepsy%2C%20and%20significant%20cognitive%20impairment')</li>
<li>AnnotationURLCitation(end_index=19236, start_index=19042, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=different%20locations%20within%20the%20cell%2C,epilepsy%2C%20and%20significant%20cognitive%20impairment')</li>
<li>AnnotationURLCitation(end_index=19557, start_index=19399, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20hereditary%20spastic%20paraplegias%20,to%20a%20family%20of%20adaptor')</li>
<li>AnnotationURLCitation(end_index=20367, start_index=20256, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=%2811%20%29,HSP%20and%20the')</li>
<li>AnnotationURLCitation(end_index=20733, start_index=20581, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20autophagy%20protein%20ATG9A%20accumulated,4%20subunit%20levels')</li>
<li>AnnotationURLCitation(end_index=20845, start_index=20734, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=%2811%20%29,HSP%20and%20the')</li>
<li>AnnotationURLCitation(end_index=21154, start_index=21010, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=mouse%20has%20revealed%20widespread%20axonal,HSP%20and%20the')</li>
<li>AnnotationURLCitation(end_index=21596, start_index=21452, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=nutrient,our%20results%20establish%20ATG9A%20mislocalization')</li>
<li>AnnotationURLCitation(end_index=21929, start_index=21785, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=nutrient,our%20results%20establish%20ATG9A%20mislocalization')</li>
<li>AnnotationURLCitation(end_index=22228, start_index=22049, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cortical%20neurons%20from%20patients%20with,our%20results%20establish%20ATG9A%20mislocalization')</li>
<li>AnnotationURLCitation(end_index=22657, start_index=22486, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cortical%20neurons%20from%20patients%20with,will%20aid%20diagnostic%20and%20therapeutic')</li>
<li>AnnotationURLCitation(end_index=22780, start_index=22658, title='The Reelin Receptor ApoER2 is a Cargo for the Adaptor Protein Complex AP-4: Implications for Hereditary Spastic Paraplegia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10979513/#:~:text=Our%20work%20reveals%20that%20the,The')</li>
<li>AnnotationURLCitation(end_index=23281, start_index=23116, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=importance%20of%20these%20interactions%20is,of%20the%20central%20nervous%20system')</li>
<li>AnnotationURLCitation(end_index=23742, start_index=23614, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition')</li>
<li>AnnotationURLCitation(end_index=24104, start_index=23945, title='Involvement of Adapter Protein Complex 4 in Hypersensitive Cell Death Induced by Avirulent Bacteria - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/29242374/#:~:text=Induced%20by%20Avirulent%20Bacteria%20,in%20plant%20immunity%20associated%20with')</li>
<li>AnnotationURLCitation(end_index=24819, start_index=24661, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=distribution%20within%20the%20cell,adaptor%20protein%20complex%20that%20is')</li>
<li>AnnotationURLCitation(end_index=25349, start_index=25222, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=gamma,of%20the%20central%20nervous%20system')</li>
<li>AnnotationURLCitation(end_index=25856, start_index=25682, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=second%20hemicomplex%20%28Mattera%20et%20al,including%20publications%20from%20our%20group')</li>
<li>AnnotationURLCitation(end_index=26005, start_index=25857, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=silico%20structural%20characterization%20of%20AP%E2%80%904,2022')</li>
<li>AnnotationURLCitation(end_index=26331, start_index=26157, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=second%20hemicomplex%20%28Mattera%20et%20al,including%20publications%20from%20our%20group')</li>
<li>AnnotationURLCitation(end_index=26640, start_index=26479, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=expected%20to%20dock%20in%20the,the%20conservation%20across%20evolution%20of')</li>
<li>AnnotationURLCitation(end_index=26993, start_index=26832, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=expected%20to%20dock%20in%20the,the%20conservation%20across%20evolution%20of')</li>
<li>AnnotationURLCitation(end_index=27298, start_index=27161, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=%28Figure%C2%A01b%20%29,Although%20an%20experimental')</li>
<li>AnnotationURLCitation(end_index=27632, start_index=27468, title='Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11670165/#:~:text=variants%20has%20previously%20been%20carried,underlines%20the%20importance%20of')</li>
<li>AnnotationURLCitation(end_index=28056, start_index=27934, title='The Reelin Receptor ApoER2 is a Cargo for the Adaptor Protein Complex AP-4: Implications for Hereditary Spastic Paraplegia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10979513/#:~:text=Our%20work%20reveals%20that%20the,The')</li>
<li>AnnotationURLCitation(end_index=28299, start_index=28171, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=manner%20%28Boehm%20et%C2%A0al,In%20addition')</li>
<li>AnnotationURLCitation(end_index=28778, start_index=28584, title='The AP-4 accessory protein tepsin exhibits multivalent binding to LC3B - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S221249262500051X#:~:text=...27%3A12%2C%2027%20%282020%29%2C%20pp.%201185,745%20View%20PDFView%20articleView%20in')</li>
<li>AnnotationURLCitation(end_index=29160, start_index=29008, title='2020 Annual Report of the Division of Intramural Research, NICHD | Juan S. Bonifacino, PhD', type='url_citation', url='https://annualreport.nichd.nih.gov/2020/bonifacino.html#:~:text=Bonifacino%2C%20PhD%20annualreport,Other%20groups%20then')</li>
<li>AnnotationURLCitation(end_index=29310, start_index=29161, title='2022 Annual Report of the Division of Intramural Research, NICHD | Juan S. Bonifacino, PhD', type='url_citation', url='https://annualreport.nichd.nih.gov/2022/bonifacino.html#:~:text=Bonifacino%2C%20PhD%20annualreport,ATG9A%29%2C%20from')</li>
<li>AnnotationURLCitation(end_index=29938, start_index=29808, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=covering%20a%20wide%20range%20of,Mitochondrial')</li>
<li>AnnotationURLCitation(end_index=30110, start_index=29939, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cortical%20neurons%20from%20patients%20with,will%20aid%20diagnostic%20and%20therapeutic')</li>
<li>AnnotationURLCitation(end_index=30408, start_index=30256, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20autophagy%20protein%20ATG9A%20accumulated,4%20subunit%20levels')</li>
<li>AnnotationURLCitation(end_index=30520, start_index=30409, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=expected%2C%20patient%20,3E')</li>
<li>AnnotationURLCitation(end_index=31054, start_index=30933, title='Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11554807/#:~:text=,et%20al%2C%202021a%3B%20Jordan%20et')</li>
<li>AnnotationURLCitation(end_index=31187, start_index=31055, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=AP,of%2010%3B%20and%20have%20microcephaly')</li>
<li>AnnotationURLCitation(end_index=31881, start_index=31743, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=childhood,of%20the%20central%20nervous%20system')</li>
<li>AnnotationURLCitation(end_index=32043, start_index=31882, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=The%20research%20team%20next%20moved,to%20be%20effective%20in%20humans')</li>
<li>AnnotationURLCitation(end_index=32400, start_index=32234, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=The%20research%20team%20next%20moved,in%20mice%2C%20rats%2C%20and%20monkeys')</li>
<li>AnnotationURLCitation(end_index=32687, start_index=32521, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=The%20research%20team%20next%20moved,effective%20in%20humans%20with%20SPG50')</li>
<li>AnnotationURLCitation(end_index=33005, start_index=32837, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=derived%20from%20patients%20with%20SPG50,therapy%20in%20people%20with%20SPG50')</li>
<li>AnnotationURLCitation(end_index=33109, start_index=33006, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=Significance')</li>
<li>AnnotationURLCitation(end_index=33459, start_index=33299, title='Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47 | EMBO Molecular Medicine', type='url_citation', url='https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=Spastic%20paraplegia%2047%20,transfer%20and%20restoration%20of%20various')</li>
<li>AnnotationURLCitation(end_index=33769, start_index=33622, title='Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47 | EMBO Molecular Medicine', type='url_citation', url='https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=ameliorate%20the%20disease%20phenotype,NfL%29%20levels%20of')</li>
<li>AnnotationURLCitation(end_index=34171, start_index=34024, title='Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47 | EMBO Molecular Medicine', type='url_citation', url='https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=ameliorate%20the%20disease%20phenotype,NfL%29%20levels%20of')</li>
<li>AnnotationURLCitation(end_index=34486, start_index=34339, title='Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47 | EMBO Molecular Medicine', type='url_citation', url='https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=ameliorate%20the%20disease%20phenotype,NfL%29%20levels%20of')</li>
<li>AnnotationURLCitation(end_index=35141, start_index=34978, title='High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-023-44264-1#:~:text=rare%20but%20prototypical%20form%20of,of%20intracellular%20ATG9A%20trafficking%20and')</li>
<li>AnnotationURLCitation(end_index=35495, start_index=35332, title='High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-023-44264-1#:~:text=rare%20but%20prototypical%20form%20of,of%20intracellular%20ATG9A%20trafficking%20and')</li>
<li>AnnotationURLCitation(end_index=35658, start_index=35496, title='High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-023-44264-1#:~:text=content%20microscopy%20and%20an%20automated,concept%20data%20for%20future%20studies')</li>
<li>AnnotationURLCitation(end_index=35970, start_index=35808, title='High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-023-44264-1#:~:text=content%20microscopy%20and%20an%20automated,concept%20data%20for%20future%20studies')</li>
<li>AnnotationURLCitation(end_index=36318, start_index=36196, title='High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-023-44264-1#:~:text=HSP,concept%20data%20for%20future%20studies')</li>
<li>AnnotationURLCitation(end_index=36481, start_index=36319, title='High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-023-44264-1#:~:text=We%20used%20multiparametric%20orthogonal%20strategies,4%20deficiency%2C%20providing')</li>
<li>AnnotationURLCitation(end_index=37004, start_index=36842, title='High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-023-44264-1#:~:text=We%20used%20multiparametric%20orthogonal%20strategies,4%20deficiency%2C%20providing')</li>
<li>AnnotationURLCitation(end_index=37860, start_index=37727, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=AP,aid%20diagnostic%20and%20therapeutic%20studies')</li>
<li>AnnotationURLCitation(end_index=38173, start_index=38020, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=localization%20of%20ATG9A%20in%20the,the%20area%20of%20ATG9A%20signal')</li>
<li>AnnotationURLCitation(end_index=38288, start_index=38174, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=2B%20%29,5x%20the%20level%20of')</li>
<li>AnnotationURLCitation(end_index=38998, start_index=38885, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=the%20TGN%20in%20an%20ARF,and')</li>
<li>AnnotationURLCitation(end_index=39706, start_index=39548, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=The%20hereditary%20spastic%20paraplegias%20,to%20a%20family%20of%20adaptor')</li>
<li>AnnotationURLCitation(end_index=40221, start_index=40086, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=and%20Bonifacino%2C%202019%20%3B%20Sanger,dependent')</li>
<li>AnnotationURLCitation(end_index=40387, start_index=40222, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=importance%20of%20these%20interactions%20is,of%20the%20central%20nervous%20system')</li>
<li>AnnotationURLCitation(end_index=40865, start_index=40766, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=%2811%20%29,Cre')</li>
<li>AnnotationURLCitation(end_index=41045, start_index=40866, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=cortical%20neurons%20from%20patients%20with,our%20results%20establish%20ATG9A%20mislocalization')</li>
<li>AnnotationURLCitation(end_index=41610, start_index=41455, title='Paving a way to treat spastic paraplegia 50 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10178831/#:~:text=Skip%20to%20main%20content%20J,Copyright%20and%20License%20information')</li>
<li>AnnotationURLCitation(end_index=42357, start_index=42201, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=diseases,epilepsy%2C%20and%20significant%20cognitive%20impairment')</li>
<li>AnnotationURLCitation(end_index=42519, start_index=42358, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=The%20research%20team%20next%20moved,to%20be%20effective%20in%20humans')</li>
<li>AnnotationURLCitation(end_index=42876, start_index=42773, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=Significance')</li>
<li>AnnotationURLCitation(end_index=43328, start_index=43162, title='Sorting of the Alzheimer‚Äôs Disease Amyloid Precursor Protein Mediated by the AP-4 Complex - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/#:~:text=that%20the%20properties%20of%20the,amyloidogenic%20processing%20of%20the%20protein')</li>
<li>AnnotationURLCitation(end_index=43989, start_index=43854, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=autophagic%20vesicle%20formation%20,derived%20cells')</li>
<li>AnnotationURLCitation(end_index=44934, start_index=44821, title='High-throughput imaging of ATG9A distribution as a diagnostic functional assay for adaptor protein complex 4-associated hereditary spastic paraplegia | Brain Communications | Oxford Academic', type='url_citation', url='https://academic.oup.com/braincomms/article-abstract/3/4/fcab221/6375442#:~:text=Bonifacino')</li>
<li>AnnotationURLCitation(end_index=45091, start_index=44935, title='High-throughput imaging of ATG9A distribution as a diagnostic functional assay for adaptor protein complex 4-associated hereditary spastic paraplegia | Brain Communications | Oxford Academic', type='url_citation', url='https://academic.oup.com/braincomms/article-abstract/3/4/fcab221/6375442#:~:text=AP,network%20to%20promote%20autophagosome%20formation')</li>
<li>AnnotationURLCitation(end_index=45696, start_index=45526, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=Deficiency%20of%20the%20adaptor%20protein,Western%20blot%20analysis%20demonstrated%20a')</li>
<li>AnnotationURLCitation(end_index=45827, start_index=45697, title='Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7001721/#:~:text=covering%20a%20wide%20range%20of,Mitochondrial')</li>
<li>AnnotationURLCitation(end_index=46125, start_index=45967, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=distribution%20within%20the%20cell,adaptor%20protein%20complex%20that%20is')</li>
<li>AnnotationURLCitation(end_index=46229, start_index=46126, title='The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9635299/#:~:text=et%C2%A0al,4%20with')</li>
<li>AnnotationURLCitation(end_index=46539, start_index=46401, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=childhood,of%20the%20central%20nervous%20system')</li>
<li>AnnotationURLCitation(end_index=46734, start_index=46540, title='Science Update: Gene therapy for rare neurodegenerative disease shows early promise | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development', type='url_citation', url='https://www.nichd.nih.gov/newsroom/news/041923-gene-therapy#:~:text=different%20locations%20within%20the%20cell%2C,epilepsy%2C%20and%20significant%20cognitive%20impairment')</li>
<li>AnnotationURLCitation(end_index=47355, start_index=47195, title='Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47 | EMBO Molecular Medicine', type='url_citation', url='https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=Spastic%20paraplegia%2047%20,transfer%20and%20restoration%20of%20various')</li>
<li>AnnotationURLCitation(end_index=47503, start_index=47356, title='Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47 | EMBO Molecular Medicine', type='url_citation', url='https://www.embopress.org/doi/10.1038/s44321-024-00148-5#:~:text=ameliorate%20the%20disease%20phenotype,NfL%29%20levels%20of')</li>
<li>AnnotationURLCitation(end_index=47892, start_index=47729, title='High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-023-44264-1#:~:text=rare%20but%20prototypical%20form%20of,of%20intracellular%20ATG9A%20trafficking%20and')</li>
<li>AnnotationURLCitation(end_index=48055, start_index=47893, title='High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-023-44264-1#:~:text=content%20microscopy%20and%20an%20automated,concept%20data%20for%20future%20studies')</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AP4B1-deep-research-perplexity.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9Y6B7" data-a="DOC: Deep Research Perplexity" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-deep-research<br />
cached: false<br />
start_time: '2025-12-27T16:08:30.997539'<br />
end_time: '2025-12-27T16:10:18.024977'<br />
duration_seconds: 107.03<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AP4B1<br />
  gene_symbol: AP4B1<br />
  uniprot_accession: Q9Y6B7<br />
  protein_description: 'RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName:<br />
    Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein<br />
    complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;'<br />
  gene_info: Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the adaptor complexes large subunit family.<br />
  protein_domains: AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like.<br />
    (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: medium<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 49</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9Y6B7</li>
<li><strong>Protein Description:</strong> RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName: Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;</li>
<li><strong>Gene Information:</strong> Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the adaptor complexes large subunit family.</li>
<li><strong>Key Domains:</strong> AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like. (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AP4B1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AP4B1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AP4B1</strong> (gene ID: AP4B1, UniProt: Q9Y6B7) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p><think><br />
The user is asking for a comprehensive research report on the AP4B1 gene. Let me verify the gene identity first:</p>
<p>From the UniProt information provided:<br />
- UniProt Accession: Q9Y6B7<br />
- Protein: AP-4 complex subunit beta-1<br />
- Gene: AP4B1<br />
- Organism: Homo sapiens (Human)<br />
- Protein Family: Belongs to the adaptor complexes large subunit family</p>
<p>Looking at the search results provided, I can see extensive information about AP4B1 and AP-4 complex. This is the correct gene. The search results include information from:<br />
1. GeneCards (sources 1, 27, 57)<br />
2. UniProt (sources 16, 30, 34, 40)<br />
3. NCBI Gene (sources 4, 6, 37)<br />
4. Proteintech (source 2)<br />
5. Human Protein Atlas (source 3)<br />
6. PNAS (source 8)<br />
7. Rare Diseases (source 9)<br />
8. PubMed/PMC articles on AP-4 function, including:<br />
   - AP-4 and autophagy (sources 8, 11, 25, 26)<br />
   - AP-4-associated hereditary spastic paraplegia (sources 9, 12, 22)<br />
   - Cargo identification (sources 7, 10)<br />
   - Structural and functional studies (sources 17, 21, 24, 47)<br />
   - Gene therapy (source 51)<br />
   - And many more</p>
<p>The gene is well-characterized and I have plenty of high-quality source material. Let me structure a comprehensive report covering:</p>
<ol>
<li>Title and summary</li>
<li>Overview of AP4B1 and the AP-4 complex</li>
<li>Structural organization and subunit composition</li>
<li>Molecular function and cargo binding</li>
<li>Localization and cellular distribution</li>
<li>
<p>Biological processes and pathways</p>
</li>
<li>
<p>AP-4 cargo proteins and trafficking mechanisms</p>
</li>
<li>Autophagy and lysosomal regulation</li>
<li>Neuronal functions and polarized sorting</li>
<li>Clinical significance and disease associations</li>
<li>Recent research and therapeutic approaches</li>
<li>Conclusion</li>
</ol>
<p>I have sufficient material to construct a detailed, well-sourced report that covers the gene's structure, function, cellular roles, and clinical relevance. I'll proceed with writing the comprehensive analysis while ensuring proper citations throughout.<br />
</think></p>
<h1 id="ap4b1-adaptor-related-protein-complex-4-subunit-beta-1-comprehensive-molecular-and-functional-analysis">AP4B1 (Adaptor Related Protein Complex 4 Subunit Beta 1): Comprehensive Molecular and Functional Analysis</h1>
<h2 id="summary">Summary</h2>
<p>The AP4B1 gene encodes the beta-1 subunit (Œ≤4) of the adaptor protein complex 4 (AP-4), a heterotetrameric protein assembly that functions as a non-clathrin-associated coat component localized to the trans-Golgi network (TGN)[1][12]. This complex plays a critical role in the selective sorting and anterograde transport of transmembrane cargo proteins from the TGN toward peripheral endosomal and post-Golgi compartments[1][8][11]. The AP-4 complex, composed of Œµ, Œ≤4, Œº4, and œÉ4 subunits, recognizes specific tyrosine-based and other sorting signals present in the cytoplasmic domains of cargo proteins, enabling precise protein segregation into transport vesicles[1][14][50]. Beyond its canonical trafficking functions, AP-4 has emerged as a crucial regulator of autophagy through its control of ATG9A localization and distribution[8][25], and it functions prominently in neuronal protein sorting, including the polarized trafficking of glutamate receptors and other neuronal determinants[31][38]. Mutations in any of the four AP-4 subunit genes result in a severe neurodevelopmental disorder termed AP-4-deficiency syndrome or spastic paraplegia, underscoring the biological importance of this complex in central nervous system development and function[9][12][22].</p>
<h2 id="the-ap-4-complex-molecular-architecture-and-composition">The AP-4 Complex: Molecular Architecture and Composition</h2>
<h3 id="heterotetrameric-structure-and-subunit-organization">Heterotetrameric Structure and Subunit Organization</h3>
<p>The adaptor protein complex 4 (AP-4) represents the fourth member of the heterotetrameric adaptor protein family, which includes AP-1, AP-2, and AP-3, each serving distinct roles in vesicular transport at different cellular compartments[14][50]. Like its relatives, AP-4 comprises four distinct subunits: two large subunits designated the Œµ (epsilon) subunit and the Œ≤4 (beta-4) subunit, which together form the structural scaffold of the complex; one medium-sized Œº4 (mu-4) subunit responsible for recognition of cargo sorting signals; and one small œÉ4 (sigma-4) subunit[1][14][50]. The AP4B1 gene specifically encodes the Œ≤4 subunit, which has a predicted molecular mass of approximately 83 kilodaltons and consists of 739 amino acids[1][57].</p>
<p>The Œ≤4 subunit, like other Œ≤-adaptin family members, shares approximately 20% amino acid identity with its counterparts in AP-1, AP-2, and AP-3 complexes, with significant homology restricted to the N-terminal ~600 amino acid core domain[14][50]. This N-terminal domain maintains conserved motifs characteristic of adaptin family proteins and is critical for complex assembly and protein-protein interactions[14][47]. Notably, AP-4 demonstrates a distinctive structural feature: the Œ≤4 appendage domain, which forms the C-terminal projection of the Œ≤ subunit, lacks the inner subdomain present in the Œ≤-appendages of AP-1, AP-2, and AP-3[33][36]. Despite this structural divergence, the Œ≤4 appendage retains the capacity to interact with specific accessory proteins, most notably tepsin, an established partner of AP-4-coated vesicles[26][47].</p>
<h3 id="localization-to-the-trans-golgi-network">Localization to the Trans-Golgi Network</h3>
<p>Immunofluorescence microscopy and immunoelectron microscopy studies have established that AP-4 exhibits a distinctive perinuclear localization pattern, concentrating in approximately 10-20 discrete dots representative of the trans-Golgi network (TGN)[14][50]. This specific subcellular localization is achieved through the interaction of the Œµ subunit with the GTP-bound form of the small GTPase Arf1, a key regulator of adaptor protein recruitment to the TGN[8][11][18]. The preferential association of AP-4 with Arf1¬∑GTP at the TGN contrasts with the broader tissue distribution of AP-4 components, suggesting that while AP-4 subunits are expressed ubiquitously across all cell types, the functional complex exhibits compartmentalization at specific membrane sites where cargo selection and vesicle formation occur[1][50]. This localization pattern indicates that AP-4 participates in a specialized trafficking pathway that, despite its selective localization, is required in all cell types for proper protein homeostasis and function[50].</p>
<h2 id="molecular-function-and-cargo-recognition">Molecular Function and Cargo Recognition</h2>
<h3 id="tyrosine-based-sorting-signal-recognition">Tyrosine-Based Sorting Signal Recognition</h3>
<p>The Œº4 subunit of the AP-4 complex functions as the primary cargo recognition module, specifically recognizing sorting signals present in the cytoplasmic tails of transmembrane proteins destined for AP-4-dependent transport[1][14][50]. The Œº4 subunit exhibits binding capacity for tyrosine-based sorting signals conforming to the canonical YXX√∏ motif, where Y represents tyrosine, X represents any amino acid, and √∏ represents a bulky hydrophobic residue[1][53]. However, structural and biochemical studies have revealed that Œº4 displays unique specificity characteristics compared to its counterparts in other AP complexes, demonstrating a strong preference for non-canonical YXX√ò-type signals, particularly those fitting the Y(X)(FYL)(FL)E consensus sequence[21][53].</p>
<p>This unusual specificity has been structurally characterized through X-ray crystallographic analysis showing that the amyloid precursor protein (APP) sequence YKFFE binds to a distinct site on the Œº4 subunit that is located on the opposite face of the protein from the canonical YXX√∏-binding site occupied by other Œº subunits[21][24][53]. The binding interface between Œº4 and the APP YKFFE motif encompasses an area of approximately 431 ≈≤, comparable to canonical YXX√∏-binding interactions on other Œº subunits, but the location and chemical environment of this binding pocket confer selectivity for the specific YKFFE sequence[53]. This structural divergence enables AP-4 to recognize a distinct subset of cargo proteins not typically engaged by AP-1, AP-2, or AP-3, thereby enabling specialized sorting pathways[21][24].</p>
<h3 id="cargo-proteins-identified-through-multiple-complementary-approaches">Cargo Proteins Identified Through Multiple Complementary Approaches</h3>
<p>Recent proteomic investigations employing orthogonal mass spectrometry-based approaches have comprehensively identified the physiological cargo proteins transported by AP-4-derived vesicles[25][28]. Autophagy-related protein 9A (ATG9A) has emerged as the most extensively characterized AP-4 cargo, recognized through both direct biochemical interaction studies and functional validation demonstrating that disruption of AP-4 function results in accumulation of ATG9A within the TGN with concurrent depletion from peripheral compartments[8][11][25]. The ATG9A cytoplasmic tail contains a conserved YQRLE motif that mediates binding to the Œº4 subunit, and mutation of this sequence or depletion of Œº4 causes redistribution of ATG9A away from peripheral compartments and toward the TGN, impairing autophagosome biogenesis[8].</p>
<p>Beyond ATG9A, serine incorporator proteins SERINC1 and SERINC3 have been identified as AP-4-dependent cargo proteins through quantitative mass spectrometry profiling of vesicle fractions enriched from AP-4-depleted cells[25][28]. These multipass transmembrane proteins exhibit altered subcellular distribution when AP-4 is depleted, accumulating in perinuclear compartments and depleting from peripheral sites where they normally localize[25]. The amyloid precursor protein (APP), implicated in Alzheimer's disease pathology, represents another well-characterized AP-4 cargo, as the YKFFE sequence in its cytoplasmic tail interacts directly with Œº4, and disruption of this interaction impairs APP localization to endosomes and enhances Œ≥-secretase-mediated cleavage to the amyloidogenic amyloid-Œ≤ peptide[21][24]. Additional identified cargoes include diacylglycerol lipase-beta (DAGLB), Sortilin-1, and the ApoER2 lipoprotein receptor, each contributing to distinct cellular pathways regulated by AP-4-dependent sorting[52][56].</p>
<h2 id="accessory-proteins-and-coat-assembly">Accessory Proteins and Coat Assembly</h2>
<h3 id="tepsin-and-rusc-proteins-as-ap-4-partners">Tepsin and RUSC Proteins as AP-4 Partners</h3>
<p>The AP-4 complex functions not as an autonomous coat but rather as the catalytic core of a more expansive protein assembly that includes multiple accessory proteins essential for proper vesicle formation and cargo delivery[26][29][47]. Tepsin, an epsin family member discovered as the first identified AP-4 accessory protein, binds directly to the C-terminal Œ≤4 appendage domain through a conserved hydrophobic motif with the consensus sequence LFxG[M/L]x[L/V][47]. This interaction is critical for tepsin recruitment to AP-4-coated vesicles, and point mutations disrupting this binding interface dramatically reduce the capacity of tepsin to associate with AP-4 both in vitro and in cellular systems[47].</p>
<p>Recent functional studies have demonstrated that tepsin harbors a functional LC3-interacting region (LIR) motif in its N-terminal domain that enables direct interaction with lipidated LC3B, a core autophagosomal protein[26]. This interaction appears to couple AP-4 vesicle formation with autophagosome dynamics, suggesting a direct mechanistic link between AP-4-mediated cargo delivery and autophagosome biogenesis or maturation[26]. Tepsin depletion in cells results in partial accumulation of ATG9A at the TGN but causes distinct phenotypes compared to complete AP-4 depletion, indicating that tepsin has specialized functions beyond simply serving as a passive coat component, possibly participating in vesicle internalization or cargo delivery[26].</p>
<p>The RUSC (regulator of ubiquitin-like phagocytosis, suppressor of cytokine signaling) family proteins, specifically RUSC1 and RUSC2, have been identified as AP-4 accessory proteins through proximity-based biotin identification (BioID) and proteomic profiling[25][29]. These proteins display functional redundancy, as loss of both RUSC proteins produces more profound autophagy dysregulation than loss of either protein individually[25]. The RUSC proteins appear to coordinate anterograde transport of AP-4 cargo proteins including ATG9A, SERINC1, and SERINC3 toward the cell periphery, operating as crucial components of the AP-4 trafficking apparatus[25][29]. Additionally, the FHF (FTS, Hook, and FHIP) complex, comprising Hook1/Hook2 and associated proteins, participates in AP-4 vesicle dynamics, potentially mediating retrograde trafficking of AP-4-coated and ATG9A-containing vesicles[29].</p>
<h3 id="aagab-mediated-complex-assembly-and-stabilization">AAGAB-Mediated Complex Assembly and Stabilization</h3>
<p>Recent investigations have revealed that AP-4 complex assembly itself is not a spontaneous process but rather requires assistance from the adaptor-associated gamma-adaptin-binding protein (AAGAB, also termed p34)[58]. AAGAB binds directly to both the Œµ and œÉ4 subunits of AP-4, promoting their association and stabilizing the heterotetrameric complex[58]. This finding carries significant implications for understanding AP-4 biogenesis and dysfunction, as AAGAB-knockout cells exhibit reduced steady-state levels of AP-4 subunits accompanied by accumulation of ATG9A within the TGN, phenotypically resembling cells with mutations in individual AP-4 subunit genes[58]. The chaperone-like activity of AAGAB suggests that proper folding and oligomerization of AP-4 components represent rate-limiting steps in complex assembly, introducing an additional layer of regulation for AP-4-dependent trafficking pathways.</p>
<h2 id="cellular-localization-and-tissue-distribution">Cellular Localization and Tissue Distribution</h2>
<h3 id="subcellular-compartmentalization">Subcellular Compartmentalization</h3>
<p>Beyond its signature localization to the TGN, AP-4 exhibits a dynamic distribution pattern reflecting its role in anterograde vesicular transport from the trans-Golgi network to multiple downstream compartments[1][3]. Immunoelectron microscopy studies in polarized epithelial cells and other cell types have demonstrated that AP-4 resides on tubulo-vesicular structures of the Golgi complex, on individual transport vesicles dispersed throughout the cytoplasm, and on early endosomal membranes[32][44]. Notably, approximately 23% of Œº4-positive transport vesicles also contain clathrin heavy chain, indicating that while AP-4 is characteristically associated with non-clathrin-coated vesicles, it can transiently associate with clathrin-containing structures, particularly on endosomal membranes[32][44]. This localization pattern distinguishes AP-4-positive vesicles from those containing AP-1, which typically exhibit different morphological characteristics, suggesting that AP-4 and AP-1 function in parallel but distinct trafficking pathways operating at overlapping but not identical cellular sites[32][44].</p>
<p>The Human Protein Atlas provides complementary information regarding AP4B1 expression, indicating general cytoplasmic localization with a granular staining pattern consistent with association with punctate organelles, particularly the perinuclear region[3]. This granular pattern correlates with the documented concentration of AP-4 in 10-20 discrete TGN-derived compartments, providing microscopic evidence consistent with biochemical and ultrastructural studies[3][50]. The tissue expression analysis demonstrates that AP4B1 is expressed ubiquitously across fetal and adult tissues, with particularly prominent expression in brain structures, consistent with the severe neurological manifestations observed when AP-4 function is disrupted[38].</p>
<h2 id="biochemical-pathways-and-functional-roles">Biochemical Pathways and Functional Roles</h2>
<h3 id="regulation-of-autophagy-through-atg9a-export">Regulation of Autophagy Through ATG9A Export</h3>
<p>The discovery that AP-4 mediates the export of ATG9A from the trans-Golgi network to peripheral compartments, particularly pre-autophagosomal structures (PAS), has established autophagy regulation as a central function of this adaptor complex[8][11]. ATG9A represents a critical scramblase protein essential for autophagosome biogenesis, and its subcellular localization appears critical for the early stages of autophagosomal membrane formation and lipid expansion[8]. In wild-type cells, ATG9A localizes to the TGN, as well as to peripheral endosomal and autophagosomal compartments, where it is thought to deliver lipids or membrane to the expanding phagophore during autophagosome formation[8].</p>
<p>When AP-4 function is disrupted through genetic mutation or targeted depletion, ATG9A accumulates dramatically at the TGN and is depleted from peripheral compartments, representing the most consistent and striking phenotypic hallmark of AP-4 deficiency[8][11][19][25]. This mislocalization has functional consequences, as ATG9A-containing AP-4 vesicles are thought to cluster in close association with autophagosomes, functioning as a lipid or membrane reservoir for autophagosome biogenesis[8][25]. The impairment of ATG9A export results in decreased formation of lipidated LC3B-II, the membrane-associated form of the autophagy marker LC3, indicating reduced autophagosome formation or altered autophagy flux[8][11]. Proteomic and immunological studies in patient-derived cells and mouse models have confirmed that ATG9A accumulation occurs broadly across diverse cell types, suggesting this represents a fundamental and cell-autonomous consequence of AP-4 loss rather than a cell-type-specific artifact[19][25].</p>
<h3 id="neuronal-protein-sorting-and-polarized-trafficking">Neuronal Protein Sorting and Polarized Trafficking</h3>
<p>Neurons present particular challenges for protein sorting due to their specialized architecture, with distinct compartments including the axon, axon initial segment, somatodendrite, and synaptic terminal requiring selective protein targeting[31][38]. AP-4 has emerged as a critical regulator of polarized protein sorting in neurons, functioning in parallel with AP-1 to direct transmembrane proteins toward the somatodendritic domain[31]. Genetic deletion of the AP-4 Œ≤4 subunit in mice results in mislocalization of Œ±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and other glutamate receptors to axonal compartments rather than their normal somatodendritic localization[31][38]. AMPA receptors represent key components of synaptic transmission, mediating fast excitatory neurotransmission, and their inappropriate axonal localization would be expected to severely compromise neuronal physiology and synaptic function[31][38].</p>
<p>Beyond glutamate receptors, AP-4 functions in the proper subcellular distribution of additional neuronal determinants including transmembrane AMPA receptor regulatory proteins (TARPs), Œ¥2 glutamate receptors, SERINC1, SERINC3, and Sortilin-1[11][19][31][56]. These diverse cargoes indicate that AP-4-dependent sorting represents a broadly important mechanism for establishing and maintaining neuronal polarity, segregating proteins into appropriate subcellular compartments for proper neural network formation and synaptic plasticity[31][38]. The particular importance of AP-4 in neurons becomes evident when comparing the consequences of AP-4 loss across diverse cell types: while non-neuronal cells exhibit trafficking defects, the neurological consequences are disproportionately severe, suggesting that the neuronal cytoskeleton, the complexity of neuronal polarity, and the dependence of neurons on precise protein distribution create a special vulnerability to AP-4 disruption[31][38].</p>
<h3 id="lysosomal-biogenesis-and-endolysosomal-homeostasis">Lysosomal Biogenesis and Endolysosomal Homeostasis</h3>
<p>Recent investigations have revealed that AP-4 functions as a critical regulator of neuronal lysosome composition, function, and transport, operating through control of lysosomal receptor protein trafficking[56]. Sortilin-1, a key lysosomal receptor mediating cargo transport between the TGN and endolysosomal compartments, has been identified as an AP-4-dependent cargo protein[56]. When AP-4 function is disrupted, Sortilin-1 distribution becomes aberrant, causing reduced export from the TGN and impaired lysosomal protein recruitment[56]. Consequently, neurons lacking functional AP-4 exhibit lysosomes with altered protein composition, including reduced levels of specific lysosomal enzymes, and demonstrate compromised lysosomal function measured through proteolytic activity assays[56].</p>
<p>The functional consequences of this dysregulation extend to neuronal axons, where AP-4 loss causes accumulation of LAMP1-positive organelles (late endosomal and lysosomal compartments) together with JIP3, a neuronally enriched putative adaptor protein that regulates retrograde axonal transport[56]. This accumulation appears as characteristic axonal swellings in AP-4-deficient neurons, suggesting that impaired lysosomal transport and distributed maintenance of lysosomal function represent contributory defects in the pathophysiology of AP-4 deficiency[56]. The coupling of altered lysosomal transport, reduced lysosomal enzyme content, and accumulation of lysosomal structures in axons indicates that AP-4 regulation of lysosomal biogenesis and axonal distribution represents an important neurobiological function whose disruption contributes to the progressive neurological deterioration observed in AP-4-deficiency syndrome[56].</p>
<h3 id="basolateral-sorting-in-polarized-epithelial-cells">Basolateral Sorting in Polarized Epithelial Cells</h3>
<p>In addition to its neuronal functions, AP-4 participates in the polarized trafficking of proteins in epithelial cells, specifically functioning in basolateral protein sorting[20][31]. The basolateral membrane of polarized epithelial cells contains distinct protein populations segregated from the apical membrane through selective trafficking pathways, and AP-4 has been demonstrated to recognize multiple types of basolateral sorting signals[20]. This epithelial sorting function operates in parallel with AP-1 pathways, and evidence suggests that AP-4 may participate in specialized basolateral trafficking steps for selected cargo proteins[20]. The functional significance of AP-4 in epithelial cells appears less critical than in neurons, as epithelial cells often maintain viability despite AP-4 mutations, but the capability of AP-4 to recognize basolateral signals indicates that this adaptor complex has broad cellular functions beyond its better-characterized neuronal roles[31].</p>
<h2 id="disease-associations-and-clinical-manifestations">Disease Associations and Clinical Manifestations</h2>
<h3 id="ap-4-deficiency-syndrome-and-hereditary-spastic-paraplegia">AP-4-Deficiency Syndrome and Hereditary Spastic Paraplegia</h3>
<p>Mutations in any one of the four AP-4 subunit genes, including AP4B1, result in a complex form of hereditary spastic paraplegia collectively termed AP-4-deficiency syndrome or AP-4-associated hereditary spastic paraplegia (AP-4-HSP)[9][12][22]. The disease presentations associated with mutations in individual AP-4 subunits exhibit remarkable clinical similarity, with distinguishing features including the dominant-negative effects of specific mutations rather than variation in the basic disease phenotype[22]. Patients with AP4B1-associated disease manifest the condition known as spastic paraplegia type 47 (SPG47 or HSP-AP4B1), characterized by neonatal onset of hypotonia (low muscle tone) that progressively develops into spasticity (high muscle tone) of the lower extremities[9][12][22].</p>
<p>The clinical presentation typically includes global developmental delay manifesting in infancy, moderate to severe intellectual disability, severely impaired or absent speech development, and characteristic seizures including frequent febrile seizures[9][12][22]. Neuroimaging studies reveal diagnostic hallmarks including thinning of the corpus callosum, enlarged lateral ventricles, and delayed white matter myelination[9][12][19][22]. Physical examination demonstrates progressive spasticity beginning in the lower limbs leading to inability to walk independently, wheelchair dependence, and in some cases progression to tetraplegia affecting all four limbs[9][12][22]. Additional clinical features may include short stature, dystonia (involuntary muscle movements), and ataxia (impaired balance and coordination)[9][12][22].</p>
<p>The inheritance pattern is autosomal recessive, with affected individuals typically inheriting biallelic loss-of-function mutations[9][12][22]. Early reports focused primarily on families of consanguineous backgrounds carrying homozygous mutations; however, recognition of the disorder has expanded to include individuals from non-consanguineous families carrying compound heterozygous mutations[22]. This expanded ascertainment indicates that AP-4-deficiency syndrome likely represents an underdiagnosed condition, particularly in populations where genetic testing is less available, as the clinical presentation overlaps substantially with cerebral palsy, resulting in diagnostic misclassification[9][22].</p>
<h3 id="neuropathological-features-and-brain-morphology">Neuropathological Features and Brain Morphology</h3>
<p>Comprehensive neuropathological examination of brain tissue from AP-4-deficient individuals and animal models has revealed distinctive features reflecting the underlying cellular trafficking defects. The thin corpus callosum represents the most consistent finding, reflecting reduced white matter connectivity between hemispheres[12][19][22]. Histological studies in AP4B1-knockout mouse models have revealed characteristic accumulations of calbindin-positive spheroids in the deep cerebellar nuclei, located at sites of Purkinje cell axonal projections, indicating neurodegeneration or impaired neuronal maintenance in this cerebellar region[19]. The expansion of lateral ventricles reflects reduced white matter volume and altered brain architecture[19][22]. These anatomical changes appear established early during development, as evidence of ATG9A mislocalization and abnormal brain morphology has been documented in embryonic cortical neurons at stage E15.5, indicating that AP-4 dysfunction impairs developmental processes beginning in utero[19].</p>
<h3 id="biomarkers-and-disease-progression">Biomarkers and Disease Progression</h3>
<p>Recent therapeutic development efforts have identified plasma neurofilament light (NfL), a protein released during neurodegeneration, as a biomarker for AP-4-deficiency syndrome that correlates with disease burden and responds to therapeutic intervention[51]. The elevation of plasma NfL in AP-4-deficient individuals reflects ongoing neurodegeneration, providing an objective measure of disease progression and a potential endpoint for clinical trials evaluating therapeutic interventions[51]. The progressive nature of the disease, with early developmental delay and motor dysfunction evolving into increasingly severe spasticity and neurodegeneration, underscores the chronic pathological process initiated by loss of AP-4 function.</p>
<h2 id="structural-and-evolutionary-relationships">Structural and Evolutionary Relationships</h2>
<h3 id="phylogenetic-divergence-of-ap-4">Phylogenetic Divergence of AP-4</h3>
<p>The AP-4 complex represents a phylogenetically divergent member of the adaptor protein family, distinguishing itself from AP-1, AP-2, and AP-3 through both structural and functional characteristics[14][48][50]. Analysis of the amino acid sequences of AP-4 subunits reveals that while the N-terminal core domains (~600 amino acids) maintain conservation with corresponding domains in other AP complexes (sharing 20-40% identity), the peripheral domains, particularly the Œ≤4 appendage, exhibit substantial divergence[14][50]. The Œ≤4 appendage lacks the inner subdomain present in other Œ≤-adaptins, and this structural simplification reflects divergent functional requirements for AP-4 coat assembly and regulation[33][36][50].</p>
<p>This structural divergence carries functional implications, as the simplified Œ≤4 appendage exhibits restricted binding properties compared to Œ≤-appendages of AP-1 and AP-2[33][36]. While AP-1 and AP-2 Œ≤-appendages bind numerous accessory proteins from the cytosol, the Œ≤4 appendage exhibits selectivity, binding only tepsin among the cytosolic factors that bind other Œ≤-appendages[33][36][47]. This restricted accessory protein interaction profile, combined with the unique signal-binding specificities of the Œº4 subunit, indicates that AP-4 has undergone specialized evolution for selective recognition of particular cargo proteins and cooperation with distinct accessory factors, distinguishing it from the more broadly functional AP-1 and AP-2 complexes[31][48].</p>
<h2 id="recent-advances-and-therapeutic-perspectives">Recent Advances and Therapeutic Perspectives</h2>
<h3 id="gene-therapy-approaches-for-spg47">Gene Therapy Approaches for SPG47</h3>
<p>Recent preclinical investigations have demonstrated the feasibility of gene therapy approaches targeting AP4B1 mutations, offering potential therapeutic pathways for affected patients[51]. A single administration of adeno-associated virus serotype 9 (AAV9) expressing human AP4B1 cDNA delivered into the cisterna magna (the cerebrospinal fluid space surrounding the brain) achieved widespread gene transfer throughout the central nervous system and restored multiple hallmarks of AP-4 deficiency in a mouse model[51]. Treated animals demonstrated restoration of ATG9A localization, disappearance of calbindin-positive spheroids in the deep cerebellar nuclei, normalization of anatomical brain defects including corpus callosum thickness and ventricle volume, and significant improvement in motor function measured through rotarod performance[51].</p>
<p>Critically, the therapeutic intervention normalized plasma neurofilament light (NfL) levels, a biomarker of neurodegeneration, suggesting that restoring AP4B1 expression halts ongoing neurodegeneration[51]. Preclinical safety studies in non-human primates revealed no significant adverse events, supporting the translational feasibility of this approach[51]. These findings provide proof-of-concept for gene replacement as a viable therapeutic strategy and establish the foundation for clinical translation of AP4B1 gene therapy to human patients with SPG47.</p>
<h3 id="cellular-disease-models-and-patient-derived-studies">Cellular Disease Models and Patient-Derived Studies</h3>
<p>Complementary investigations utilizing patient-derived fibroblasts and induced pluripotent stem cell (iPSC)-derived neurons have confirmed that AP4B1 mutations result in loss of AP4B1 protein expression and characteristic mislocalization of ATG9A within the TGN[51][56]. Lentiviral-mediated expression of wild-type AP4B1 in patient fibroblasts dose-dependently increased AP4B1 levels, restored formation of the AP-4 complex as indicated by restoration of AP4E1 protein levels, and corrected ATG9A mislocalization[51]. Similar findings in iPSC-derived cortical neurons demonstrated that AP4B1 expression restoration corrects not only ATG9A trafficking but also normalizes lysosomal composition and function, indicating that restoring a single AP-4 subunit is sufficient to reconstitute functional AP-4 complex and correct multiple disease phenotypes[51][56].</p>
<h3 id="emerging-understanding-of-ap-4-as-a-therapeutic-target">Emerging Understanding of AP-4 as a Therapeutic Target</h3>
<p>The identification of specific cargo proteins and accessory proteins that depend on AP-4 for proper trafficking has opened avenues for downstream therapeutic approaches beyond gene replacement. Understanding the consequences of impaired ATG9A export, such as autophagy dysregulation, raises the possibility of therapeutic interventions targeting autophagy pathways to compensate for AP-4 loss or to address the cellular consequences of AP-4 dysfunction[8][11][25]. Similarly, the identification of AP-4-mediated lysosomal regulation provides insight into mechanisms contributing to neurodegeneration and suggests potential therapeutic targets for supporting neuronal survival in AP-4-deficiency syndrome[56]. The discovery that tepsin facilitates ATG9A trafficking through its LC3-interacting domain raises questions about whether targeting this interaction or enhancing tepsin function might provide therapeutic benefit[26].</p>
<h2 id="comparative-analysis-with-other-adaptor-protein-complexes">Comparative Analysis with Other Adaptor Protein Complexes</h2>
<h3 id="structural-and-functional-distinction-from-ap-1-and-ap-2">Structural and Functional Distinction from AP-1 and AP-2</h3>
<p>While AP-4 shares the fundamental heterotetrameric architecture characteristic of adaptor protein complexes, its structural organization differs in ways that reflect its specialized cellular functions[14][31][48][50]. The Œµ subunit of AP-4 contains a conserved N-terminal domain but possesses a putative hinge domain that is only moderately hydrophilic and enriched in proline and glycine residues, contrasting with the highly hydrophilic hinge domains characteristic of the Œ≥, Œ±, and Œ¥ subunits of AP-1, AP-2, and AP-3 respectively[14][50]. This difference in hinge region composition may influence the structural dynamics of the complex or its interaction with coat-building machinery.</p>
<p>Critically, AP-4 does not interact with clathrin in the manner characteristic of AP-1 and AP-2, which recruit clathrin triskelia through their appendage domains to form characteristic clathrin-coated vesicles[14][32]. Instead, AP-4 mediates formation of a non-clathrin-associated coat, representing an alternative mechanism for vesicle formation and cargo selection[8][11][14]. The absence of strong clathrin-binding capacity, combined with the presence of accessory proteins such as RUSC1/2, tepsin, and the FHF complex, suggests that AP-4 may utilize alternative membrane-deformation mechanisms compared to the clathrin-mediated approaches employed by other AP complexes[29][31].</p>
<h3 id="comparison-of-cargo-specificity">Comparison of Cargo Specificity</h3>
<p>The cargo specificity profiles of AP complexes reflect their distinct subcellular localizations and functional roles[31][53]. While AP-1 and AP-2 recognize broad classes of YXX√∏-containing cargo proteins distributed across the proteome, AP-4 exhibits more restrictive cargo selectivity, particularly demonstrating preferential recognition of non-canonical YXX√ò signals such as those present in APP family members[21][24][53]. This restricted cargo repertoire is consistent with AP-4 functioning in "specialized trafficking pathways" while maintaining ubiquitous expression, as opposed to AP-1 and AP-2 which function in more broadly utilized transport routes[50].</p>
<h2 id="conclusions-and-significance">Conclusions and Significance</h2>
<p>The AP4B1 gene product, the Œ≤4 subunit of the adaptor protein complex 4, represents a critical molecular component of cellular protein sorting machinery with specialized functions in autophagy regulation, neuronal protein distribution, lysosomal biogenesis, and epithelial cell polarization. Operating as a non-clathrin-associated coat at the trans-Golgi network, AP-4 selectively recognizes and sorts transmembrane cargo proteins including ATG9A, APP, SERINCs, and lysosomal receptors into transport vesicles for delivery to peripheral cellular compartments. The identification of AP-4-dependent cargo proteins has revealed that this adaptor complex couples vesicular transport to fundamental cellular processes including autophagy and lysosomal maintenance, explaining why disruption of AP-4 function impairs these essential homeostatic pathways.</p>
<p>The severe clinical consequences of AP4B1 mutations, manifesting as hereditary spastic paraplegia with intellectual disability, underscore the particular importance of this adaptor complex in neuronal development and function. The neurological specificity of AP-4 deficiency‚Äîdespite ubiquitous AP-4 expression‚Äîreflects the specialized demands of neuronal protein trafficking, particularly the complex polarized sorting required to maintain distinct axonal and somatodendritic compartments. Recent therapeutic advances, including successful preclinical demonstration of AAV-mediated AP4B1 gene replacement, provide hope for future clinical interventions that could halt or reverse the progressive neurodegeneration characteristic of this disorder. Continued investigation of AP-4 function, its cargo proteins, and its role in maintaining neuronal and cellular homeostasis will likely reveal additional therapeutic targets and deepen understanding of how defects in protein trafficking contribute to neurological disease[8][11][19][25][26][31][51][56].</p>
<h2 id="citations">Citations</h2>
<ol>
<li>https://www.genecards.org/cgi-bin/carddisp.pl?gene=AP4B1</li>
<li>https://www.ptglab.com/products/AP4B1-Antibody-16313-1-AP.htm</li>
<li>https://www.proteinatlas.org/ENSG00000134262-AP4B1/tissue</li>
<li>https://www.ncbi.nlm.nih.gov/gene/10717</li>
<li>https://www.biomatik.com/proteins/recombinant-human-adaptor-related-protein-complex-4-beta-1-ap4b1-cat-rpu58256/</li>
<li>https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=10717</li>
<li>https://pubmed.ncbi.nlm.nih.gov/27371946/</li>
<li>https://www.pnas.org/doi/10.1073/pnas.1717327114</li>
<li>https://rarediseases.org/rare-diseases/ap-4-associated-hereditary-spastic-paraplegia/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5013305/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/33084855/</li>
<li>https://www.ncbi.nlm.nih.gov/books/NBK535153/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/15916959/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC25515/</li>
<li>https://www.molbiolcell.org/doi/10.1091/mbc.9.6.1323</li>
<li>https://www.uniprot.org/uniprotkb/Q9Y6B7/entry</li>
<li>https://www.rcsb.org/structure/4mdr</li>
<li>https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.679046/pdf</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9825813/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/11802162/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2841041/</li>
<li>https://onlinelibrary.wiley.com/doi/abs/10.1002/ajmg.a.38561</li>
<li>https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0021181</li>
<li>https://pubmed.ncbi.nlm.nih.gov/20230749/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6160451/</li>
<li>https://www.molbiolcell.org/doi/10.1091/mbc.E23-09-0359-T</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9052817/</li>
<li>https://portlandpress.com/biochemsoctrans/article-abstract/48/5/1877/226727</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6410744/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC1134722/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC1222423/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/10564262/</li>
<li>https://portlandpress.com/biochemj/article/362/3/597/39684/The-appendages-of-the-four-adaptor-protein-AP</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3113253/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4359536/</li>
<li>https://onlinelibrary.wiley.com/doi/10.1111/tra.12028</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC7965410/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2488278/</li>
<li>https://www.childrenshospital.org/conditions-treatments/ap-4-associated-hereditary-spastic-paraplegia</li>
<li>https://onlinelibrary.wiley.com/doi/10.1111/tra.12375</li>
<li>https://elifesciences.org/articles/72276</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11554807/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10979513/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3611023/</li>
<li>https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0854.2011.01262.x</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9635302/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/35976721/</li>
<li>https://rupress.org/jcb/article/141/2/359/965/Mannose-6-Phosphate-Receptors-Are-Sorted-from</li>
<li>https://pdf.antibodies-online.com/productsheets/ABIN7552129.pdf</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q9Y6B7
gene_symbol: AP4B1
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  AP4B1 encodes the beta-1 subunit (beta4-adaptin) of the heterotetrameric adaptor protein complex 4 (AP-4),
  which consists of epsilon (AP4E1), beta4 (AP4B1), mu4 (AP4M1), and sigma4 (AP4S1) subunits.
  Unlike clathrin-associated AP-1, AP-2, and AP-3 complexes, AP-4 forms a non-clathrin coat
  on vesicles departing from the trans-Golgi network (TGN). AP-4 mediates signal-dependent
  sorting and export of transmembrane cargo proteins from the TGN to endosomal compartments
  and pre-autophagosomal structures, recognizing YXXOE-type sorting signals. Key cargoes include
  ATG9A (autophagy machinery), APP (amyloid precursor protein), DAGLB (endocannabinoid synthesis),
  SERINC1/3 (lipid scramblases), Sortilin (lysosomal enzyme trafficking), and AMPA/delta-2
  glutamate receptors (neuronal polarity). The beta4 subunit contains an N-terminal trunk domain
  involved in complex assembly and a C-terminal ear (appendage) domain that recruits the accessory
  protein tepsin through a conserved hydrophobic binding site. AP-4 complex assembly requires the
  AAGAB chaperone, which stabilizes subunits and prevents proteasomal degradation. AP-4 plays
  critical roles in autophagosome biogenesis (via ATG9A trafficking), lysosome function (via
  Sortilin), neuronal polarity (via glutamate receptor sorting), and axonal endocannabinoid
  signaling (via DAGLB). Loss of AP-4 function results in cargo retention at the TGN and impaired
  autophagy, particularly affecting axonal compartments in neurons. Biallelic loss-of-function
  mutations in AP4B1 cause spastic paraplegia type 47 (SPG47), part of the AP-4 deficiency syndrome
  characterized by severe intellectual disability, progressive spasticity, and structural brain
  abnormalities including thin corpus callosum.

existing_annotations:
- term:
    id: GO:0016192
    label: vesicle-mediated transport
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      IBA annotation based on phylogenetic inference. AP-4 mediates vesicle-mediated transport
      from the TGN to endosomal compartments. This is well-supported by literature showing AP-4
      exports cargo (especially ATG9A) via non-clathrin-coated vesicles.
    action: ACCEPT
    reason: &gt;-
      Vesicle-mediated transport is a core function of AP-4. The complex forms vesicle coats at
      the TGN and mediates cargo export to endosomes and peripheral sites. The IBA annotation
      appropriately captures this core function at the right level of specificity.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.&#34;
      - reference_id: PMID:10436028
        supporting_text: &#34;Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.&#34;
      - reference_id: file:human/AP4B1/AP4B1-deep-research-falcon.md
        supporting_text: &#34;AP-4 mediates signal-dependent export of selected cargos--most prominently ATG9A--from the TGN to endosomal/peripheral compartments that support autophagosome formation.&#34;

- term:
    id: GO:0005794
    label: Golgi apparatus
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: &gt;-
      IEA annotation based on UniProt subcellular location mapping. AP-4 localizes to the
      trans-Golgi network, which is part of the Golgi apparatus.
    action: ACCEPT
    reason: &gt;-
      While more specific TGN annotations exist (GO:0005802), this broader Golgi apparatus
      annotation is not incorrect. AP-4 is found at the TGN which is part of the Golgi.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.&#34;

- term:
    id: GO:0006886
    label: intracellular protein transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA annotation from InterPro domain mapping. AP-4 mediates intracellular protein transport
      by sorting cargo proteins from the TGN to endosomal destinations.
    action: ACCEPT
    reason: &gt;-
      Intracellular protein transport is a well-supported function of AP-4. The complex sorts
      cargo proteins including ATG9A from TGN to endosomes. This is an appropriate level of
      specificity for an IEA annotation.
    supported_by:
      - reference_id: PMID:10436028
        supporting_text: &#34;The mu4 subunit of the complex specifically interacts with a tyrosine-based sorting signal, indicating that, like the other three AP complexes, AP-4 is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs.&#34;

- term:
    id: GO:0008104
    label: intracellular protein localization
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: &gt;-
      IEA annotation from ARBA machine learning. AP-4 controls intracellular localization of
      cargo proteins by mediating their export from TGN.
    action: ACCEPT
    reason: &gt;-
      AP-4 is involved in protein localization as it determines where cargo proteins end up
      within the cell. The complex exports ATG9A and other cargos from TGN to endosomal/peripheral
      locations. This broader term is appropriate for computational annotation.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.&#34;

- term:
    id: GO:0015031
    label: protein transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      IEA annotation from combined automated methods. Protein transport is a parent term
      of the more specific vesicle-mediated transport.
    action: ACCEPT
    reason: &gt;-
      Protein transport is a core function of AP-4. The complex mediates transport of
      transmembrane cargo proteins from TGN to endosomal destinations. While broader than
      vesicle-mediated transport, this annotation is not incorrect.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.&#34;

- term:
    id: GO:0016192
    label: vesicle-mediated transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA annotation from InterPro domain mapping. Duplicate of the IBA annotation for the
      same GO term.
    action: ACCEPT
    reason: &gt;-
      This is the same term as the IBA annotation but with IEA evidence from InterPro. Both
      annotations are valid - the IEA provides domain-based evidence while IBA provides
      phylogenetic evidence. Vesicle-mediated transport is a well-established core function.
    supported_by:
      - reference_id: PMID:10436028
        supporting_text: &#34;Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.&#34;

- term:
    id: GO:0030117
    label: membrane coat
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA annotation from InterPro. AP-4 forms a membrane coat (non-clathrin) on vesicles
      budding from the TGN.
    action: ACCEPT
    reason: &gt;-
      AP-4 functions as a membrane coat complex on TGN-derived vesicles. The beta4 subunit
      is an integral component of this coat.
    supported_by:
      - reference_id: PMID:10436028
        supporting_text: &#34;Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.&#34;
      - reference_id: PMID:26542808
        supporting_text: &#34;The heterotetrameric (œµ-Œ≤4-Œº4-œÉ4) complex adaptor protein 4 (AP-4) is a component of a non-clathrin coat involved in protein sorting at the trans-Golgi network (TGN).&#34;

- term:
    id: GO:0030131
    label: clathrin adaptor complex
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA annotation from InterPro domain mapping (IPR015151). This annotation is INCORRECT.
      AP-4 is explicitly a NON-clathrin adaptor complex and does not associate with clathrin.
    action: REMOVE
    reason: &gt;-
      This annotation is incorrect and should be removed. AP-4 forms a non-clathrin coat and
      does not function as a clathrin adaptor complex. The GO term GO:0030124 (AP-4 adaptor complex)
      definition itself states &#34;it is not clear whether AP-4 forms clathrin coats in vivo.&#34;
      Multiple primary sources explicitly describe AP-4 as non-clathrin-associated. The InterPro
      domain mapping is too broad and fails to capture this critical distinction.
    supported_by:
      - reference_id: PMID:10436028
        supporting_text: &#34;Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.&#34;
      - reference_id: PMID:26542808
        supporting_text: &#34;The heterotetrameric (œµ-Œ≤4-Œº4-œÉ4) complex adaptor protein 4 (AP-4) is a component of a non-clathrin coat involved in protein sorting at the trans-Golgi network (TGN).&#34;
      - reference_id: PMID:26756312
        supporting_text: &#34;The adaptor protein 4 (AP4) complex (œµ/Œ≤4/Œº4/œÉ4 subunits) forms a non-clathrin coat on vesicles departing the trans-Golgi network.&#34;

- term:
    id: GO:0030276
    label: clathrin binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA annotation from InterPro domain mapping (IPR016342). This annotation is INCORRECT.
      AP-4 does not bind clathrin - it forms a clathrin-independent coat.
    action: REMOVE
    reason: &gt;-
      This annotation should be removed. AP-4 is a clathrin-independent adaptor complex and
      there is no evidence that AP4B1 binds clathrin. The InterPro domain family (IPR016342)
      includes beta subunits from multiple adaptor complexes, but AP-4 specifically is
      clathrin-independent.
    supported_by:
      - reference_id: PMID:10436028
        supporting_text: &#34;Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.&#34;
      - reference_id: PMID:26756312
        supporting_text: &#34;The adaptor protein 4 (AP4) complex (œµ/Œ≤4/Œº4/œÉ4 subunits) forms a non-clathrin coat on vesicles departing the trans-Golgi network.&#34;

- term:
    id: GO:0005802
    label: trans-Golgi network
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      IEA annotation from combined automated methods. AP-4 localizes to the TGN where it
      functions in cargo sorting.
    action: ACCEPT
    reason: &gt;-
      TGN localization is well established for AP-4. This IEA annotation is consistent with
      multiple experimental (IDA) annotations for the same term from PMID:10066790. The TGN
      is the primary site where AP-4 assembles and initiates vesicle formation.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.&#34;

- term:
    id: GO:0006605
    label: protein targeting
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      IEA annotation from combined automated methods. AP-4 targets proteins from TGN to
      endosomal/lysosomal destinations.
    action: ACCEPT
    reason: &gt;-
      Protein targeting is a core function of AP-4. The complex recognizes cargo sorting
      signals and targets proteins to specific cellular destinations.
    supported_by:
      - reference_id: PMID:10436028
        supporting_text: &#34;The mu4 subunit of the complex specifically interacts with a tyrosine-based sorting signal, indicating that, like the other three AP complexes, AP-4 is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs.&#34;

- term:
    id: GO:0061938
    label: protein localization to somatodendritic compartment
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &gt;-
      IEA annotation transferred from mouse ortholog via Ensembl Compara. AP-4 is involved
      in proper asymmetric localization of proteins in neurons.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      This is a legitimate function of AP-4 in neurons, but represents a specialized
      cell-type-specific function rather than a core molecular function. The annotation is
      valid but should be considered non-core as AP-4 is ubiquitously expressed and this
      function is neuron-specific.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.&#34;

- term:
    id: GO:0005802
    label: trans-Golgi network
  evidence_type: NAS
  original_reference_id: PMID:10436028
  review:
    summary: &gt;-
      NAS annotation from ComplexPortal referencing PMID:10436028. The study demonstrated
      AP-4 localization to TGN region by immunofluorescence and immunogold EM.
    action: ACCEPT
    reason: &gt;-
      PMID:10436028 provides direct evidence for TGN localization by immunofluorescence
      and immunogold electron microscopy. This is a well-supported core localization.
    supported_by:
      - reference_id: PMID:10436028
        supporting_text: &#34;Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.&#34;

- term:
    id: GO:0016192
    label: vesicle-mediated transport
  evidence_type: NAS
  original_reference_id: PMID:10436028
  review:
    summary: &gt;-
      NAS annotation from ComplexPortal referencing PMID:10436028. The study characterized
      AP-4 as an adaptor complex involved in vesicle-mediated trafficking.
    action: ACCEPT
    reason: &gt;-
      PMID:10436028 demonstrates AP-4 association with vesicles and its role in cargo
      recognition. This annotation correctly captures the vesicle-mediated transport function.
    supported_by:
      - reference_id: PMID:10436028
        supporting_text: &#34;The mu4 subunit of the complex specifically interacts with a tyrosine-based sorting signal, indicating that, like the other three AP complexes, AP-4 is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs.&#34;

- term:
    id: GO:0098541
    label: cytoplasmic side of trans-Golgi network transport vesicle membrane
  evidence_type: IDA
  original_reference_id: PMID:10066790
  review:
    summary: &gt;-
      IDA annotation based on direct experimental evidence from PMID:10066790, which
      characterized AP-4 as a peripheral membrane protein associated with TGN membranes.
    action: ACCEPT
    reason: &gt;-
      PMID:10066790 demonstrates that AP-4/beta4 exists in both cytosolic and membrane-bound
      forms and shows TGN association. The cytoplasmic side localization is appropriate for
      adaptor complexes that are peripheral membrane proteins recruited to vesicle membranes.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;An antibody to beta4 recognized in human cells an approximately 83-kDa polypeptide that exists in both soluble and membrane-associated forms.&#34;
      - reference_id: PMID:10066790
        supporting_text: &#34;Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.&#34;

- term:
    id: GO:0006605
    label: protein targeting
  evidence_type: IC
  original_reference_id: PMID:10066790
  review:
    summary: &gt;-
      IC (Inferred by Curator) annotation using GO:0030124 (AP-4 adaptor complex) as
      evidence. Since AP4B1 is part of AP-4, and AP-4 functions in protein targeting,
      this annotation is valid.
    action: ACCEPT
    reason: &gt;-
      This IC annotation correctly infers protein targeting function from AP-4 complex
      membership. The inference that a cargo-sorting adaptor complex is involved in
      protein targeting is sound.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.&#34;

- term:
    id: GO:0008104
    label: intracellular protein localization
  evidence_type: IC
  original_reference_id: PMID:10066790
  review:
    summary: &gt;-
      IC annotation using GO:0030124 as evidence. Infers protein localization function
      from AP-4 complex membership.
    action: ACCEPT
    reason: &gt;-
      This IC annotation correctly infers that AP-4 components are involved in protein
      localization based on the complex&#39;s established function in cargo sorting. By
      directing cargo from TGN to endosomal destinations, AP-4 determines protein
      localization within cells.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;We propose that, like the related AP-1, AP-2, and AP-3 complexes, AP-4 plays a role in signal-mediated trafficking of integral membrane proteins in mammalian cells.&#34;

- term:
    id: GO:0005802
    label: trans-Golgi network
  evidence_type: IDA
  original_reference_id: PMID:10066790
  review:
    summary: &gt;-
      IDA annotation based on immunofluorescence and biochemical fractionation data
      from PMID:10066790 showing AP-4 associates with TGN.
    action: ACCEPT
    reason: &gt;-
      PMID:10066790 provides direct experimental evidence for TGN localization.
      BFA sensitivity is characteristic of TGN-associated coat proteins.
      This is a core localization for AP4B1.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.&#34;

- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: PMID:10066790
  review:
    summary: &gt;-
      IDA annotation showing AP-4/beta4 exists in cytosolic form as well as membrane-bound.
      PMID:10066790 demonstrated both soluble and membrane-associated pools.
    action: ACCEPT
    reason: &gt;-
      PMID:10066790 explicitly shows beta4 exists in both soluble and membrane-associated
      forms. Adaptor protein complexes cycle between cytosolic and membrane-bound states
      as part of their function in vesicle formation. The cytosolic pool represents the
      inactive/unrecruited form.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;An antibody to beta4 recognized in human cells an approximately 83-kDa polypeptide that exists in both soluble and membrane-associated forms.&#34;

- term:
    id: GO:0030124
    label: AP-4 adaptor complex
  evidence_type: IDA
  original_reference_id: PMID:10066790
  review:
    summary: &gt;-
      IDA annotation establishing AP4B1 as a component of the AP-4 heterotetrameric complex.
      PMID:10066790 was the original identification paper for AP-4.
    action: ACCEPT
    reason: &gt;-
      This is the defining annotation for AP4B1 - it IS the beta subunit of AP-4.
      This annotation should be retained as a core component annotation.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;Gel filtration, sedimentation velocity, and immunoprecipitation experiments revealed that beta4 is a component of a multisubunit complex (AP-4) that also contains the sigma4 polypeptide and two additional adaptor subunit homologs named mu4 (mu-ARP2) and epsilon.&#34;

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:26756312
  review:
    summary: &gt;-
      IPI annotation for interaction with tepsin (TEPSIN/ENTHD2). PMID:26756312 characterized
      the molecular basis of the AP4B1-tepsin interaction.
    action: MODIFY
    reason: &gt;-
      The interaction with tepsin is well-documented and represents a specific, functionally
      important binding partner. However, &#34;protein binding&#34; (GO:0005515) is too generic and
      uninformative. The ear domain of beta4 specifically binds tepsin through a defined
      peptide motif interaction.
    proposed_replacement_terms:
      - id: GO:0060090
        label: molecular adaptor activity
    supported_by:
      - reference_id: PMID:26756312
        supporting_text: &#34;We show that tepsin harbors a hydrophobic sequence, LFxG[M/L]x[L/V], in its unstructured C-terminus, which binds directly and specifically to the C-terminal Œ≤4 appendage domain.&#34;

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:26542808
  review:
    summary: &gt;-
      IPI annotation for tepsin interaction from PMID:26542808, which mapped the bivalent
      interaction between tepsin and AP-4.
    action: MODIFY
    reason: &gt;-
      Like the previous annotation, this documents the specific tepsin-beta4 interaction
      but uses the overly broad &#34;protein binding&#34; term. PMID:26542808 demonstrates that
      tepsin contains two peptide motifs that bind to the ear domains of beta4 and epsilon
      subunits.
    proposed_replacement_terms:
      - id: GO:0060090
        label: molecular adaptor activity
    supported_by:
      - reference_id: PMID:26542808
        supporting_text: &#34;Using a variety of protein interaction assays, we found that tepsin comprises two phylogenetically conserved peptide motifs, [GS]LFXG[ML]X[LV] and S[AV]F[SA]FLN, within its C-terminal unstructured region, which interact with the C-terminal ear (or appendage) domains of the Œ≤4 and œµ subunits of AP-4, respectively.&#34;

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:22472443
  review:
    summary: &gt;-
      IPI annotation from proteomic study identifying tepsin as an AP-4 accessory protein.
    action: MODIFY
    reason: &gt;-
      PMID:22472443 identified tepsin as an AP-4-associated protein through proteomic
      analysis. While the interaction is valid, &#34;protein binding&#34; is too generic.
    proposed_replacement_terms:
      - id: GO:0060090
        label: molecular adaptor activity
    supported_by:
      - reference_id: file:human/AP4B1/AP4B1-deep-research-falcon.md
        supporting_text: &#34;Tepsin associates with AP-4 but is not required for ATG9A export from the TGN in HeLa/MEFs; AP-4 interacts with Arf1-GTP, and Œº4 binds canonical cargo motifs.&#34;

- term:
    id: GO:0031904
    label: endosome lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5229111
  review:
    summary: &gt;-
      TAS annotation from Reactome pathway &#34;AP4 transports APP from trans-Golgi network
      to endosome lumen.&#34; This represents the destination of AP-4-mediated cargo transport.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      This annotation represents the destination compartment of AP-4 cargo rather than
      where AP4B1 itself localizes. AP-4 sorts cargo like APP for delivery to endosomes,
      but the AP-4 complex itself localizes to TGN and cytoplasmic side of vesicle membranes.
    supported_by:
      - reference_id: file:human/AP4B1/AP4B1-deep-research-falcon.md
        supporting_text: &#34;AP-4 mediates signal-dependent export of selected cargos--most prominently ATG9A--from the TGN to endosomal/peripheral compartments that support autophagosome formation.&#34;

- term:
    id: GO:0032588
    label: trans-Golgi network membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5229111
  review:
    summary: &gt;-
      TAS annotation from Reactome showing AP-4 localization to TGN membrane where it
      initiates cargo sorting.
    action: ACCEPT
    reason: &gt;-
      TGN membrane is the site of AP-4 function. The Reactome pathway describes AP-4
      binding cargo at the TGN membrane for transport to endosomes. This is consistent
      with the IDA annotations for TGN localization from PMID:10066790.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.&#34;
      - reference_id: file:human/AP4B1/AP4B1-deep-research-falcon.md
        supporting_text: &#34;AP-4 localizes to the TGN (perinuclear), forms AP-4-derived vesicles, and facilitates cargo delivery to early/late endosomes and pre-autophagosomal structures (PAS).&#34;

- term:
    id: GO:0032588
    label: trans-Golgi network membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5229132
  review:
    summary: &gt;-
      TAS annotation from Reactome pathway &#34;AP4 binds APP&#34; showing AP-4 at TGN membrane
      where cargo recognition occurs.
    action: ACCEPT
    reason: &gt;-
      Duplicate of the previous annotation with different Reactome pathway reference.
      Both pathways describe AP-4 function at the TGN membrane. The annotation is valid
      and consistent with experimental evidence.
    supported_by:
      - reference_id: PMID:10066790
        supporting_text: &#34;Immunofluorescence analyses showed that AP-4 is associated with the trans-Golgi network or an adjacent structure and that this association is sensitive to the drug brefeldin A.&#34;

references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings:
    - statement: Provides IEA annotations based on domain similarity, but incorrectly assigns clathrin-related terms to AP-4
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings:
    - statement: IBA annotation for vesicle-mediated transport is well-supported by phylogenetic and experimental evidence
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
  findings:
    - statement: Provides valid Golgi apparatus localization based on UniProt subcellular location data
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
  findings:
    - statement: Transfers somatodendritic localization function from mouse ortholog
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings:
    - statement: Provides valid protein localization annotation based on machine learning inference
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings:
    - statement: Combines multiple computational sources for protein transport and targeting annotations
- id: PMID:10066790
  title: AP-4, a novel protein complex related to clathrin adaptors.
  findings:
    - statement: Original identification and characterization of AP-4 complex
      supporting_text: &#34;Here we report the identification and characterization of AP-4, a novel protein complex related to the heterotetrameric AP-1, AP-2, and AP-3 adaptors&#34;
    - statement: Established beta4 (AP4B1) as component of heterotetrameric complex with epsilon, mu4, and sigma4
      supporting_text: &#34;Gel filtration, sedimentation velocity, and immunoprecipitation experiments revealed that beta4 is a component of a multisubunit complex (AP-4) that also contains the sigma4 polypeptide and two additional adaptor subunit homologs named mu4 (mu-ARP2) and epsilon.&#34;
- id: PMID:10436028
  title: Characterization of a fourth adaptor-related protein complex.
  findings:
    - statement: Independent characterization of AP-4 complex demonstrating non-clathrin coat formation
      supporting_text: &#34;Immunogold electron microscopy indicates that AP-4 is associated with nonclathrin-coated vesicles in the region of the trans-Golgi network.&#34;
    - statement: Showed mu4 binds tyrosine-based sorting signals for cargo recognition
      supporting_text: &#34;The mu4 subunit of the complex specifically interacts with a tyrosine-based sorting signal, indicating that, like the other three AP complexes, AP-4 is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs.&#34;
- id: PMID:22472443
  title: Multivariate proteomic profiling identifies novel accessory proteins of coated vesicles.
  findings:
    - statement: Identified tepsin as AP-4-associated accessory protein through proteomics
- id: PMID:26542808
  title: Bivalent Motif-Ear Interactions Mediate the Association of the Accessory Protein Tepsin with the AP-4 Adaptor Complex.
  findings:
    - statement: Mapped two peptide motifs in tepsin that bind beta4 and epsilon ear domains
      supporting_text: &#34;Using a variety of protein interaction assays, we found that tepsin comprises two phylogenetically conserved peptide motifs, [GS]LFXG[ML]X[LV] and S[AV]F[SA]FLN, within its C-terminal unstructured region, which interact with the C-terminal ear (or appendage) domains of the Œ≤4 and œµ subunits of AP-4, respectively.&#34;
    - statement: Demonstrated AP-4 forms a non-clathrin coat at TGN
      supporting_text: &#34;The heterotetrameric (œµ-Œ≤4-Œº4-œÉ4) complex adaptor protein 4 (AP-4) is a component of a non-clathrin coat involved in protein sorting at the trans-Golgi network (TGN).&#34;
- id: &#34;PMID:26756312&#34;
  title: &#34;Molecular Basis for the Interaction Between AP4 \u03B24 and its Accessory Protein, Tepsin.&#34;
  findings:
    - statement: Determined NMR structure and binding site for tepsin on beta4 ear domain
      supporting_text: &#34;We show that tepsin harbors a hydrophobic sequence, LFxG[M/L]x[L/V], in its unstructured C-terminus, which binds directly and specifically to the C-terminal Œ≤4 appendage domain.&#34;
    - statement: Demonstrated AP-4 forms non-clathrin vesicles at TGN
      supporting_text: &#34;The adaptor protein 4 (AP4) complex (œµ/Œ≤4/Œº4/œÉ4 subunits) forms a non-clathrin coat on vesicles departing the trans-Golgi network.&#34;
- id: Reactome:R-HSA-5229111
  title: AP4 transports APP from trans-Golgi network to endosome lumen
  findings:
    - statement: Describes AP-4-mediated transport of APP cargo from TGN to endosomes
- id: Reactome:R-HSA-5229132
  title: AP4 binds APP
  findings:
    - statement: Describes cargo recognition step where AP-4 binds APP at TGN
- id: file:human/AP4B1/AP4B1-deep-research-falcon.md
  title: Deep research review of AP4B1 function
  findings:
    - statement: AP-4 mediates export of ATG9A from TGN to support autophagosome formation
      supporting_text: &#34;AP-4 mediates signal-dependent export of selected cargos--most prominently ATG9A--from the TGN to endosomal/peripheral compartments that support autophagosome formation.&#34;
    - statement: Loss of AP-4 causes ATG9A retention at TGN linking to autophagy defects
      supporting_text: &#34;Loss of AP-4 causes ATG9A retention in the TGN and alters LC3B lipidation readouts, linking AP-4 to autophagy pathways.&#34;
- id: file:human/AP4B1/AP4B1-deep-research-cyberian.md
  title: Deep research review of AP4B1 function (cyberian)
  findings:
    - statement: DAGLB is an AP-4 cargo protein critical for endocannabinoid signaling in neurons
      supporting_text: &#34;A landmark 2022 study by Davies et al. identified DAGLB as an AP-4 cargo protein with significant implications for neuronal development [davies-2022-daglb-endocannabinoid-abstract]. DAGLB is a serine lipase that hydrolyzes diacylglycerol (DAG) to generate 2-arachidonoylglycerol (2-AG), the most abundant endocannabinoid in the brain.&#34;
    - statement: AAGAB chaperone is required for AP-4 complex assembly and stability
      supporting_text: &#34;Mattera et al. demonstrated that AAGAB directly binds to the Œµ and œÉ4 subunits of AP-4 and stabilizes both endogenous and recombinant AP-4 subunits by preventing their proteasomal degradation [mattera-2022-aagab-chaperone-abstract].&#34;
    - statement: AP-4 regulates lysosome biogenesis via Sortilin trafficking
      supporting_text: &#34;Recent work by Majumder et al. showed that AP-4 regulates the trafficking of Sortilin (SORT1) from the TGN to endo-lysosomes in neurons [majumder-2022-lysosome-abstract].&#34;
    - statement: SERINC proteins are AP-4 cargoes with lipid scramblase activity
      supporting_text: &#34;Proteomic studies identified these multipass transmembrane proteins as AP-4 cargoes [davies-2018-ap4-vesicles-abstract]. Both proteins colocalize with ATG9A and exhibit altered localization in AP-4-deficient cells.&#34;
    - statement: AP-4 recognizes YXXOE consensus sorting signals
      supporting_text: &#34;AP-4 recognizes a distinct type of tyrosine-based sorting signal with the consensus sequence YXX√òE, where √ò represents a bulky hydrophobic residue [burgos-2010-app-sorting-abstract][mattera-2017-atg9a-export-abstract].&#34;

core_functions:
  - description: &gt;-
      AP4B1 is the beta-1 subunit (beta4-adaptin) of the heterotetrameric AP-4 adaptor
      complex. The complex forms a non-clathrin coat on vesicles at the trans-Golgi network
      to mediate cargo sorting and export to endosomal compartments. Key cargoes include
      ATG9A (autophagy), APP (Alzheimer disease), DAGLB (endocannabinoid signaling),
      SERINC proteins (lipid scramblases), Sortilin (lysosomal enzyme trafficking), and
      AMPA/delta-2 glutamate receptors (neuronal polarity). The beta4 subunit C-terminal
      ear domain specifically recruits the accessory protein tepsin.
    molecular_function:
      id: GO:0060090
      label: molecular adaptor activity
    directly_involved_in:
      - id: GO:0016192
        label: vesicle-mediated transport
      - id: GO:0006605
        label: protein targeting
    locations:
      - id: GO:0005802
        label: trans-Golgi network
      - id: GO:0005829
        label: cytosol
    in_complex:
      id: GO:0030124
      label: AP-4 adaptor complex

suggested_questions:
  - question: &gt;-
      What are all the cargo proteins sorted by AP-4? Beyond ATG9A, APP, DAGLB, and SERINCs,
      what other transmembrane proteins depend on AP-4 for proper trafficking?
  - question: &gt;-
      What is the precise role of tepsin in AP-4 function? Does it regulate cargo selection,
      vesicle formation, or coat stability?
  - question: &gt;-
      How does AP-4 vesicle formation occur without clathrin? What provides the mechanical
      force for membrane deformation?
  - question: &gt;-
      What is the relationship between AP-4 deficiency and other neurodegenerative diseases
      beyond SPG47? Does AP-4 dysfunction contribute to Alzheimer disease progression?

suggested_experiments:
  - description: &gt;-
      Systematic cargo identification using proximity labeling (BioID/TurboID) of AP4B1
      to identify all proteins in proximity to AP-4 at the TGN. This would identify additional
      AP-4 cargo proteins and regulatory factors beyond the currently known ATG9A, APP,
      DAGLB, and SERINC proteins.
  - description: &gt;-
      Cryo-EM structure determination of AP-4 bound to membrane and cargo to understand
      the mechanism of clathrin-independent vesicle formation. This would reveal how AP-4
      deforms membranes without clathrin and how cargo recognition is coupled to vesicle budding.
  - description: &gt;-
      Evaluation of endocannabinoid pathway modulation (e.g., MGLL inhibitors like ABX-1431)
      as potential therapeutic intervention for AP-4 deficiency syndrome, given the discovery
      that DAGLB mislocalization contributes to axonal growth defects.
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>